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Abstract

A COMPARISON OF ORDINARY LEAST SQUARES AND INSTRUMENTAL
VARIABLES REGRESSION FOR HIGH INTENSITY DISEASE MANAGEMENT
EVALUATION
Gerald A. Craver
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy in Education at Virginia Commonwealth University
Virginia Commonwealth University, 2008
Dissertation Director: Jim McMillan, Professor
Foundations in Education
Purpose: Disease management (DM) programs are typically evaluated using study

designs that are susceptible to selection bias and other internal validity threats because
participants are often allowed to self-select into the programs. As a result, DM
evaluation results are usually biased because researchers are unable to control for
preexisting differences between the DM participants and non-participants. Linden and
Adams (2006) offer an instrumental variables (IV) regression procedure as a means of
deriving unbiased estimates of DM program effectiveness. However, IV regression relies
upon the existence of one or more variables (or instruments) that produce considerable
variation in the program participation variable, but have no direct effect on the outcome
variable. Linden and Adams argue that participant three-digit zip codes meet these
criteria and can be used as instruments in IV regression.
Methods: To test the feasibility of their IV regression procedure, a series of ordinary

least squares (OLS) and instrumental variables (IV) regression models were used to

Vlll

evaluate the effects of a high intensity Medicaid diabetes DM program on annual
diabetes-related costs, emergency department visits, and hospital days. Program
participation was the endogenous variable and age, gender, and propensity scores were
the exogenous variable. Standard statistical tests were performed to assess the quality
and validity of the IV regression models and zip code instruments.
Results: The study found that using propensity scores as covariates in the regression

models appeared to offer a viable means of controlling for potential overt biases.
However, the statistical tests performed to assess the quality and validity of the IV
regression procedure using recipient three-digit zip codes as instruments indicated that it
may not be appropriate due to various issues such as multicollinearity, lack of significant
differences between the IV and OLS regression models, and weak instrument bias.
Conclusions: While the results of the present study do not support the use of participant

three-digit zip codes as instruments in IV regression, the quality of the results obtained
using this procedure may depend on the specific sample that is used in the analysis.
Researchers may thus still wish to consider this procedure when evaluating DM programs
because different samples may yield different results.

Chapter 1
Introduction

Two methods that can be used to estimate causal relationships using observational
(i.e., quasi-experimental) data are the focus of this study. Causal relationships are cause
effect relationships that occur when one variable produces an effect in another variable.
Effects are changes (or lack of changes) in outcome variables that can be attributed to
program participation (Davidson, 2005). Social researchers examine causal relationships
when they evaluate programs (or interventions) to determine if they caused certain
outcomes (Shadish, Cook, & Campbell, 2002; Trochim, 2005).
The desire to estimate causal relationships between independent and dependent
variables is an important objective in most quantitative social research (Winship &
Morgan, 1999). Under the quantitative paradigm, experimental studies are viewed as the
"gold standard" because they have the strongest internal validity due to random assignment
of subjects to experimental (i.e., treatment, program, or intervention) and control groups.
If executed correctly, randomization ensures that both groups are probabilistically
equivalent (Trochim, 2005). During such studies, the groups are treated the same except
that the treatment is administered to the experimental group. Ordinary least squares (OLS)
regression is a statistical procedure that can be used to estimate the average effects of
program participation for the treatment and control groups (Mohr, 1995). Differences that
exist between the groups are viewed as unbiased estimates of the program's effects
(Achen, 1986).
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True experimental designs are relatively rare in quantitative social research (Achen,
1986). This is due to the fact that social experiments are often very expensive to conduct
and subjects may be unwilling to cooperate with study requirements. Moreover,
researchers are often unable to control which individuals receive the treatment. For these
reasons, researchers usually rely on observational data generated through non-experimental
processes such as censuses, surveys, or administrative activities when assessing causal
effects of social interventions (Winship & Morgan, 1999). Relying on observational data
is problematic, however, because it involves the creation of nonequivalent treatment and
control groups, which can be a threat to the study's internal validity due to selection bias
(Shadish et al., 2002).
Selection bias exists whenever subjects cannot be assigned randomly to treatment
and control groups (McMillan & Schumacher, 2006). If present, it can interfere with the
ability of researchers to make appropriate inferences about program causal effects. In the
health care field, disease management (DM) programs are often evaluated using data
contaminated by selection bias due to participant self-selection (Linden & Adams, 2006).
The ability of DM evaluators to estimate program effects is therefore limited. Linden and
Adams (2006) offer an econometric technique known as instrumental variables (IV)
regression as a solution to the selection bias problem in DM evaluations. This study
explored the utility of Linden and Adams' (2006) IV regression procedure by using it to
analyze observational data on a group of Virginia Medicaid diabetes DM participants. The
results of the IV regression models were compared against the results obtained using OLS
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regression to determine if Linden and Adams' (2006) procedure can generalize to this
population.
Statement of the Problem

Since the early 1990s, many health plans and state Medicaid agencies have
implemented disease management (DM) as a model of care for patients with chronic
disease in an effort to reduce health care costs while improving the quality of care that
these individuals receive. DM is a coordinated system of health care communications and
interventions for populations that suffer from chronic diseases that require substantial
patient self-care efforts (Buntin, 2006; Congressional Budget Office, 2004; Gillespie &
Rossiter, 2003). Chronic diseases are prolonged illnesses that do not resolve
spontaneously and are generally not curable by medication or vaccinations (Florida
Department of Health, 2007). Examples of chronic diseases include kidney disease,
diabetes, heart disease, HIV/AIDS, depression, traumatic brain injury, and multiple
sclerosis (Johnson, 2003).
DM has evolved over the years from a model that focused on specific patients
identified as having chronic illnesses through retrospective reviews of medical claim
records to a population-based model focusing on all patients identified as having chronic
illnesses based on predictive modeling algorithms. These modeling algorithms typically
classify all patients with chronic illnesses into various high and low risk categories based
on their potential for future high costs and poor health outcomes (Sprague, 2003).
Despite their popularity, DM programs have been one of the least rigorously
evaluated developments in the health services area (Matheson, Wilkins, & Psacharopoulos,
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2006; Mattke, Seid, & Ma, 2007). In fact, Buntin, (2006) refers to many DM evaluations
as nothing more than marketing disguised as research. One difficulty surrounding rigorous
DM evaluation is that patients often self-select into the programs. Thus, comparisons
between participants and non-participants on costs and other outcome variables will
probably be skewed because participants may be healthier or more active in managing their
own care than non-participants (Congressional Budget Office, 2004).
Another obstacle to rigorous evaluation has been DM's shift to population-based
care, where all eligible individuals are automatically enrolled unless they specifically
request to be excluded. The emphasis on population-based care means that fewer control
subjects are available for comparison purposes in DM evaluations (Linden & Adams,
2006). In fact, this obstacle was encountered in the present study because all of the
Medicaid diabetes recipients were enrolled in the DM program. A way to overcome this
obstacle, however, is to use DM patients who receive the high intensity intervention as the
treatment group and DM participants who do not receive this intervention as the control
group, which was the approach adopted in this study. (Additional details on the treatment
and control groups are provided later in this chapter and in Chapter 3.)
The inability to evaluate DM programs rigorously calls into question the value of
disease management, which is under increasing scrutiny from a variety of stakeholders
including government agencies, managed care organizations, and self-insured employers
because they want to know how well these programs have performed. However, the
inability to conduct quality evaluations makes it extremely difficult to separate DM
program participation effects on outcomes from other external factors. Some observers
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argue that the lack of credible evaluations is the most important issue currently facing
disease management (MacDowell & Wilson, 2002).
IV regression, which is a member of a family of statistical models known as
selection bias models, can provide social researchers with a tool for evaluating DM
programs with more rigor. These statistically complex models were primarily developed
by economists and are often difficult to implement. The models are intended to adjust for
selection bias due to nonequivalent group designs by deriving unbiased estimates of
program participation effects (Shadish, et al. 2002). In order to implement IV regression,
researchers must identify one or more variables (referred to as instruments) that: 1) have a
causal effect on the program variable (a dichotomous variable coded as 1 = participant and
0 = non-participant), 2) affect the outcome variable only through the program variable, and
3) are independent of common causes of the outcome variable (Newhouse, 2005; Heman
& Robins, 2006).
Identifying such variables can be very difficult, especially in DM evaluations that
rely mostly on administrative claims data, which limits the number of variables for
researchers to select (Linden & Adams, 2006). 1 Linden and Adams (2006) argue that
recipient three-digit zip code (i.e., the first three digits of an individual's residential zip
code) can be used as an instrument in IV regression. Their argument is based on the
theoretical supposition that a valid instrument will function as a randomizer by assigning

1 In this study, administrative claims data represent records of the health services that Medicaid recipients
received from providers. More specifically, claims data represent the electronic versions of bills submitted
by health care providers for providing services to Medicaid recipients (Piecoro, Wang, Dixon, & Crovo,
1999; Wyant & Parente, n.d.).
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subjects to the treatment and control groups irrespective of the outcome variable (Leigh &
Schembri, 2004). While Linden and Adams' (2006) analysis suggests that three-digit zip
codes are feasible, there may be reason for some skepticism. For instance, the IV effect
estimate will be biased if the zip code instruments fail to meet conditions 1 and 3, which
are generally not statistically verifiable. The effect will also be biased if conditions 1 and 3
fail and the association between zip codes and program participation is weak (Heman &
Robins, 2006). Due to the importance of identifying rigorous statistical methods that can
be applied to DM evaluations, research needs to be conducted on the zip code instruments
to determine if they can generalize to other DM populations while meeting the IV
regression assumptions.
Purpose of the Study

The problem addressed in the present study is whether IV regression using the
three-digit zip code instrumental variables procedure can generalize to a group of Virginia
Medicaid diabetes DM patients. In other words, the main purpose of this study is not to
evaluate the effectiveness of the Virginia Healthy ReturniM DM Program or to determine
the appropriateness of IV regression in general, but rather to assess the feasibility of an
instrumental variables procedure developed by Linden and Adams (2006) for DM
evaluations. The study is motivated by the problem of using observational data in lieu of
experimental data to draw causal inferences about program effects. Specifically, the
purpose of the study was to compare OLS regression and IV regression using patient three
digit zip codes as instrumental variables, to use these procedures to estimate the effects of
high intensity DM program participation on three outcome variables, and then to determine
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which procedure offered the best means for estimating program participation effects when
analyzing observational data. 2 Implications ofthe analytical findings are provided in
Chapter 5.
Rationale and Significance of the Study

The article by Linden and Adams (2006) provides the rationale for this study. In
the article, Linden and Adams argue that IV regression using patient three-digit zip codes
as instrumental variables can be used to provide unbiased estimates ofthe effects of
program participation in DM evaluations. 3 A key aspect ofIV regression for program
evaluation is that the researchers must be able to find one or more variables that are
predictive ofan individual's program participation, but not associated with any unobserved
confounding variables that influence the outcome. This task can be very difficult when
dealing with administrative claims data due to the limited number ofvariables that are
available. Linden and Adams (2006) hypothesize that patient zip codes are appropriate
instruments to use when employing IV regression for DM evaluations for two reasons: 1)
residing in a DM covered area makes the individual eligible for participation, but does not
guarantee that the individual will participate, and 2) living in a given zip code may be
independent ofunobserved covariates. While these covariates are often unmeasured or

Generally, researchers test the feasibility of IV regression models by comparing them to OLS regression
models which are usually viewed as being more efficient. This is often accomplished by testing whether the
treatment variable is correlated with the error term. Rejecting the null hypothesis ofno correlation ( or
endogeniety) suggests that there is sufficient difference between the OLS and IV coefficients to reject the
OLS model in favor ofthe IV model (Hadley et al., 2003).
3 According to Linden and Adams (2006), IV regression can be used to derive an unbiased estimate of
program participation effects. However, Angrist and Krueger (2001) and Wooldridge (2002) argue that
while IV estimators are consistent, they are not unbiased because they represent a ratio ofrandom quantities.
Nevertheless, because this study sought to assess the feasibility ofLinden and Adams' procedure, their
terminology was adopted.
2
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even unimagined, examples may include motivation, illness level, health status, and selfcare diligence (Diamond, 1999; Greenland, 2000; Fetterolf &Olson, 2008).
To test their hypothesis, Linden and Adams (2006) collected one year's worth of
claims data (excluding pharmacy claims) for a group of diabetes DM patients and then
estimated a series ofOLS and IV regression models for different outcome variables. 4 They
compared parameter estimates produced by both models and concluded that IV estimation
using patient zip codes as instruments can be useful whenOLS estimates are influenced by
selection bias. However, the authors' note that they failed to perform a sensitivity analysis
on their results and that the zip code IV procedure may not generalize to other DM
programs. Sensitivity analyses are important in observational studies because they can
provide insights into the extent to which the empirical results are sensitive to proxies for
the treatment variable (Kennedy, 2003; Rosenbaum, 2005). It should be noted that the
article by Linden and Adams (2006) is the only study that the author has found to date that
uses IV regression to evaluate DM program effectiveness. This finding is not surprising
since IV methods, which are commonly used in econometrics, are still relatively new to
medical and epidemiological research (Greenland, 2000; Leigh & Schembri, 2004;
Newhouse, 2005).
This study extended Linden and Adams' (2006) work by examining the feasibility
of usingOLS and IV regression analyses to evaluate DM programs, testing to determine if
the zip code IV procedure generalized to other DM program populations, and performing a
sensitivity test on the program indicator variable.
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Overview of the Literature

Four relevant bodies of literature provide important background information on the
study topic: general disease management, patient self-management education and self
efficacy theory, diabetes disease management evaluation, and instrumental variables
regression. While a detailed review of these bodies is beyond the scope of this chapter, a
cursory review will be provided. The general disease management literature provides the
foundation for the relevancy of the present study, while the patient self-management
literature provides the theoretical justification for the education component ofDM.5 The
diabetes disease management evaluation literature provides insights into the designs that
researchers have employed to evaluate these programs, the variables they have analyzed,
and their study findings. The IV regression literature provides information on how to
estimate IV regression models as well as procedures for checking the adequacy of the
models. It also provides information on how other researchers have employed IV
regression to reduce the influence of selection bias in observational studies. Additional
information on these bodies of literature is provided below.

4 Linden and Adams (2006) did not indicate why they excluded pharmacy claims from their analysis.
5

While not discussed in the present study, the counterfactual model of causality provides the theoretical
justification for the statistical methods used in this analysis. Briefly stated, the counterfactual is what
researchers would ideally like to determine because it represents what would have happened to individuals
who participated in the program if they had never received the intervention. However, the counterfactual
state cannot be observed because it is not possible for individuals who participated in a treatment to go back
in time in order to not participate. As a result, researchers have employed a variety of statistical methods,
including OLS, IV, and propensity score regression procedures, in an effort to approximate counterfactual
states. Additional information on the counterfactual model of causality can be found in Winship and Morgan
(1999), Gelman and Hill (2007), Morgan and Winship (2007), and Schneider et al. (2007).
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Overview of Disease Management
Disease management has become one ofthe latest fads in government and health
foundations due to its promise oflowering health care costs by reducing emergency
department visits and hospital stays for patients with costly chronic illnesses (Fireman,
Bartlett, & Selby, 2004). In fact, approximately 97 percent ofUS health plans and at least
43 state Medicaid agencies are developing or have implemented disease management
programs (Center on an Aging Society, 2004; Afifi, Morisky, Kominski, & Kotlerman,
2007). Chronic diseases are the leading cause ofdeath in the United States, accounting for
approximately seven out often deaths in 2004. During that time, care for patients with
chronic diseases accounted for approximately 75 percent ofthe $1.4 trillion spent on health
care and almost 80 percent ofall Medicaid expenditures (Department ofMedical
Assistance Services [DMAS], 2005a).
Disease management seeks to improve outcomes for individuals with chronic
diseases by promoting prevention ofdisease-related complications and exacerbations using
patient empowerment tools and evidence-based guidelines. It strives to improve the
overall health ofselected populations with chronic conditions by supporting the patient
clinician relationship. Major DM program components include the identification and
enrollment ofpatient populations, the use ofevidence-based practice guidelines by patients
and health care providers, the provision ofservices that enhance patient self-care, and
patient-provider communication and collaboration (Gillespie & Rossiter, 2003).
Private and public health insurance organizations have developed DM programs in
an effort to ease individuals and society ofthe social, psychological, physical, and

11
economic pressures related to chronic illnesses. The intent behind these programs is to
reduce health care costs while improving the quality ofcare that patients receive. When
considering that people who suffer from chronic diseases account for approximately 72
percent ofall physician office visits, 76 percent ofall inpatient hospital stays, and 88
percent ofall prescription drug fills, DM programs offer a means ofcontaining, or even
reducing, health care costs by focusing on prevention rather than acute care services for
these individuals (DMAS, 2006).
Due to the potential to achieve positive outcomes, many state Medicaid agencies
have implemented DM programs for their respective Medicaid populations, which tend to
be less educated, poorer, and more likely to suffer from disabilities than the general U.S.
population (Gillespie & Rossiter, 2003). In Virginia, the Department ofMedical
Assistance Services (DMAS) provides DM services to Medicaid recipients who are not
enrolled in managed care organizations through the Healthy Returns5M Disease
Management Program, which became operational in January 2006. As ofJuly 2008, the
Healthy Returns5M program provided DM services to 5,308 Virginia Medicaid recipients
who suffered from either asthma, diabetes, coronary artery disease, congestive heart
failure, or chronic obstructive pulmonary disorder (DMAS, 2006; Health Management
Corporation [HMC), 2008).
Substantial resource investments have been made in the development ofDM
programs since the early 1990s. For example, the nation invested more than $1 billion in
the development ofDM programs and related activities in 1999 alone. Despite the
considerable investments that have been made in these interventions, however, the
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availability ofinformation on their effectiveness and safety is limited. According to some
critics, the poor quality ofDM outcome information stems from statistical biases,
abbreviated study periods, and small patient universes, which may cast some doubt on the
success claims ofmany DM programs (Ofrnan, Badamgarav, Henning, Knight, Gano,
Levan, Gur-Arie, Richards, Hasselbald, & Wingarten, 2004).
Patient Self-Management Education and Self-Efficacy Theory
Chronic diseases often result in debilitating conditions for individuals who suffer
from them. However, research shows that certain lifestyle changes such as eliminating
tobacco use, improving diet and nutrition, and participating in regular exercise regimens
can enhance the physical and mental health ofchronically ill patients. Research further
suggests that adopting improved health behaviors can delay or even prevent the onset of
some chronic illnesses (Lorig, Stewart, Ritter, Gonzalez, Laurent, & Lynch, 1996).
Because chronic diseases cannot be cured, conventional medical care that is focused on
diagnosing and treating acute health care problems is often inappropriate for chronically ill
individuals. Consequently, many individuals with chronic diseases may fail to receive the
level ofcare needed to achieve optimal health outcomes (Funnell & Anderson, 2002).
Due to the inability ofthe traditional medical system to provide the support and
education that individuals with chronic diseases require to effectively care for and live with
their illnesses, the responsibility for the daily management ofthese conditions often falls
entirely upon the individuals who have them (Funnell & Anderson, 2002). Disease
management (DM) programs attempt to prepare participants for this task by emphasizing
patient self-management education (Disease Management Association ofAmerica, n.d.).
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Self-management education differs from traditional patient health education that
focuses on providing individuals with disease-specific information and technical skills
(i.e., learning how to monitor blood glucose levels). Self-management education
complements traditional patient health education by focusing on developing individual
problem-solving skills. In particular, self-management education teaches patients how to
identify problems, make decisions, implement appropriate actions, and even alter ac;tions
as their diseases or personal circumstances change. The development of patient short-term
action plans is a central feature of self-management education. Action plans are short
plans that identify behavior changes that patients can realistically make in order to
effectively manage their diseases (i.e., walk three times a week before lunch)
(Bodenheimer, Lorig, Holman, & Grumbach, 2002; Nuovo, 2007).
An important concept in DM self-management education is self-efficacy theory,
which refers to the confidence that individuals have in their ability to change behaviors in
order to meet specific goals. Self-efficacy is derived from four sources of information:
performance attainment, vicarious experiences, verbal persuasion, and physiological states.
Of the four sources of information, performance attainment is the most influential because
it is derived from individual experiences of success. Because people tend to avoid tasks
that they believe they cannot successfully perform and undertake tasks that they believe
they can successfully perform, self-management education uses self-efficacy theory to
assist patients with developing tools and strategies to successfully change their behaviors
(Lorig et al., 1996).
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Action plans are an example of one such tool that DM programs use. The plans are
based in part on the role that performance attainment plays in self-efficacy. Self-efficacy
theory posits that the successful achievement of the action plans is more important than the
content of the actual plans because success will motivate individuals to undertake
behavioral changes. An important characteristic of the action plans is that they are not
dictated by physicians. Instead, they are developed by the patients as something that they
want to achieve. In other words, the plans are intended to give individuals the confidence
and motivation needed to manage their diseases effectively (Bodenheimer et al., 2002).
While not a central focus of the present study, self-efficacy theory can provide a
means of understanding how self-management education promotes healthy behavioral
changes (or disease management behavior) among DM participants. Organizations that
purchase DM programs that promote patient self-management education may achieve
certain outcomes over time, such as reduced health care costs and utilizations, if patients
are knowledgeable, motivated, and confident in their abilities to change unhealthy
behaviors that exacerbate their chronic conditions. However, this can only occur if the
self-management education curriculum is appropriate for the DM target population. One
way to evaluate the effectiveness ofDM programs may be to examine the effectiveness of
their education interventions in terms of self-efficacy theory (Lorig, Sobel, Rittner,
Laurent, & Hobbs, 2001; Siu, Chan, Poon, Chui, & Chan, 2007).
Diabetes-Related Disease Management Evaluations
Because the present study only examined data on a group of diabetes DM patients,
this section is limited to diabetes-specific DM program evaluations and/or evaluations of
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DM programs that provide services on several chronic illnesses including diabetes. (For
clarity, these two program types will be referred to as diabetes-related DM programs.)
The review found that a variety of methods and statistical procedures have been
employed in both published and unpublished studies to evaluate diabetes-related DM
interventions. For instance, Meigs, Cagliero, Dubey, Murphy-Sheehy, Gildesgame,
Chueh, Barry, Singer, and Nathan (2003), Choe, Mitrovich, Dubay, Haywood, Krei_n, and
Vijan (2005), and Landon et al. (2006) used experimental designs to study various diabetes
DM elements. In these studies, several statistical procedures were employed to analyze
data including significance tests, parametric and non-parametric analysis of variance, and
linear and logistic regression models.
While these studies all found that DM interventions tended to produce positive
results for the enrolled diabetes patients, they were impacted by a number of shortcomings
that may limit their applicability. In particular, Meigs et al. (2003) noted that their study
was limited due to inadequate patient self-care data and because some of the participating
physicians were unable to consistently integrate the intervention into their normal patient
encounters. Choe et al. (2005) reported that their results may not generalize to other sites
due to their small sample size and because the intervention was performed in a single
suburban university-affiliated clinic. Finally, Landon et al. indicated that their findings are
limited because they were forced to rely on subject matching rather than pure random
assignment, which limited their ability to control for unobserved confounding variables.
While experimental studies are preferred for determining the effects of health care
related interventions, their widespread use is limited. This results from the fact that
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employing true experimental designs in health care settings is often very difficult due to
various financial, ethical, and practical issues (Harris & Remler, 1998). Thus, the review
found that many researchers have used quasi-experimental and non-experimental designs
to study DM programs.
The quasi-experimental studies employed a variety of statistical procedures similar
to the procedures used in the experimental studies to evaluate DM programs. For e;x.ample,
Christakis, Connell, Richardson, and Maciejewski (2004) used linear, logistic, and Poisson
regression models to evaluate Washington State's Medicaid DM program, while Afifi et al.
(2007) used the two-part model and propensity scores to evaluate Florida's Medicaid DM
program. The two-part model is similar to IV regression and was developed by
econometricians in an effort to obtain statistically unbiased outcome estimates for
programs in which participation decisions may be related to unobserved variables that
influence outcomes (Wendel & Durnitras, 2005). The propensity score procedure is used
to balance out the treatment and control groups in terms of their observed covariates when
patients are allowed to self-select into programs (Ettner, 2004). Finally, Berg and Wadhwa
(2007) used propensity score matching and non-parametric analysis of variance procedures
to evaluate a telephonic DM program for elderly diabetic patients in three states using a
matched-cohort study design .
While these studies tended to find that DM program participation had positive
effects on outcome variables, their findings may also be limited. Christakis et al. (2004)
found that the DM program resulted in improved outcomes for patients with kidney
disease, asthma, and diabetes, but not for congestive heart failure. Their findings may be
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skewed because they were unable to control for many of the preexisting differences that
existed between the treatment and control groups. Afifi et al. (2007) found that Florida's
DM program appeared to reduce hospital stays and emergency department visits for
individuals with chronic conditions; however, their findings may be limited if their
statistical analysis did not address all sources of unobserved bias adequately. The analysis
by Berg and Wadhwa (2007) revealed that a commercially delivered DM program c:an
reduce hospitalizations, while improving self-management activities for diabetes patients.
However, their study could be limited because propensity score matching only adjusts for
observed differences.
The non-experimental studies used statistical procedures that were similar to the
ones used in the experimental and quasi-experimental designs. These studies also
produced similar results. Coberly et al. (2007) used trend lines to examine the association
between the number of phone calls patients received and healthy behaviors measured as
the frequency with which patients obtained required hemoglobin and lipoprotein tests.
They argued that these findings suggest that telephonic strategies should be used in order
to promote healthy behaviors among diabetics. Mangione, Gerzoff, Williamson, Steers,
Kerr, Brown, Waitzfelder, Marrero, Dudley, Kim, Herman, Thompson, Safford, and Selby
(2006) used hierarchical mixed-effects regression models to examine the association
between quality of care and the intensity of diabetes disease management. They randomly
surveyed 8,661 diabetics who were receiving DM services through 63 physician groups
located within seven health plans. The analysis revealed that increased use of DM services
was significantly related to enhanced diabetes care.
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As with the experimental and quasi-experimental designs, the findings from the
non-experimental studies may also be limited. Coberly et al. (2007) reported that their
outcome variables (number of tests received) do not necessarily proxy for healthy
behaviors and that these variables may contain errors because they were developed using
administrative claims data and not medical chart reviews which are the preferred source for
this information. Mangione et al. (2006) reported that their findings were also limited due
to the short participation time period for many of the subjects in the disease management
programs (less than three years) and because they did not randomly select the physician
groups from which they selected their subjects.

Instrumental Variables Regression and Selection Bias
The instrumental variables (IV) regression literature provided the justification for
using the IV method in the present study. The objective of health outcomes research is to
estimate the effects of medical interventions on patient health and well-being. The most
appropriate study designs for achieving this result are experimental. However, these
designs are often not employed for various reasons. As a result, interest is growing among
health services researchers in the use of IV regression in non-experimental studies (Posner,
Ash, Freund, Moskowitz, & Shwartz, 2002). An IV is an observable variable (or set of
variables) that can be used as a proxy for random assignment of subjects to treatment and
control groups in order to calculate unbiased (or consistent) program effect estimates
(Harris & Remler, 1998).
IV regression is conducted in two stages. In the first stage, the instrument (or set of
instruments) is used to predict program exposure status and in the second stage, the
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differences in the outcome variables are examined as a function of the differences in the
predicted exposure status in order to evaluate the causal effect of participation on the
outcome variable. Variables that are selected as instruments must not be related to the
outcome variable (at least beyond its effect on participation) or be related to unobserved
confounding variables that are not included in the model. This lack of association must be
acceptable conceptually since it cannot be tested empirically (Posner et al., 2002).6 I:he
two IV stages are usually executed simultaneously using the two-stage least squares
(2SLS) regression procedure. If the stages are performed separately, then incorrect
estimates of the model sum of squares and parameter standard errors will be obtained
(Linden & Adams, 2006).
The basis for IV regression is as follows. IfX and Y are the observed treatment
and outcome variables, then their relationship to a third variable Z (the instrument or set of
instruments) should also be observed. Z is presumed to be associated with X but not Y
except through its association with X. Under this condition, the Z-Y association can be
depicted as the product of the Z-X and X-Y associations:
Associationzv = Associationzx * Associationxv
This equation allows for the solution of the X-Y association and is useful when the
observed X-Y association is confounded by unmeasured covariates. IV estimation acts as
a randomization device if properly executed, thus allowing researchers to estimate the
effect ofX on Y (Greenland, 2000; Leigh & Schembri, 2004).
6 However, if researchers have more instrumental variables than are needed, they can test whether the
additional instruments are uncorrelated with the disturbance term in the regression model (Wooldridge,
2002).
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The importance of a valid IV estimator lies in the fact that it can be viewed as a
ratio representing the joint projection of Y and X on Z, thus isolating a specific portion of
the covariance between X and Y. If this covariation is to be used as the basis of a valid
causal inference of the effect ofX on Y, then it must not be attributable to any extraneous
variables that cause both Z and Y. The regression coefficient for X must be assumed to be
constant for all subjects in the target population in order to justify the causal effect estimate
obtained through the covariation as the population-level causal effect ofX on Y (Morgan
& Winship, 2007).
While IV regression is widely used in program evaluations, its use is somewhat
controversial with some critics arguing that the procedure is sensitive to violations of its
assumptions and that it fails to produce results that approximate an experimental design
(Harris & Remler, 1998; Shadish et al., 2002). Moreover, there is no guarantee that IV
regression will produce estimates that are more robust than those produced through OLS
regression. For instance, Posner et al. (2002) and Hadley, Polsky, Mandelblatt, Mitchell,
Weeks, Wang, Hwang, and the OPTIONS Research Team (2003) examined the
effectiveness of early stage breast cancer screening and three breast cancer treatment
interventions for elderly women respectively. In these studies, the researchers compared
OLS and IV regression models to determine which methods offered the best adjustments
for selection bias.
Posner et al. found that both methods produced similar results, which they argued
strengthen the credibility of the OLS model. (Researchers often select the OLS model if it
produces results similar to the IV model because OLS is considered to be an efficient

21
estimator.) They recommended that researchers use several statistical procedures to
determine how selection bias affects their results before deciding upon which method
offers the best estimates of program participation effects. Hadley et al. (2003) also found
similar results and argued that researchers should consider using both methods to estimate
a range of possible outcome effects.
However, other studies have found that IV regression produced better results tpan
standard regression. For example, Fortney, Booth, Zhang, Humphrey, and Wiseman
(1998) evaluated an Alcoholics Anonymous (AA) treatment program using both logistic
and IV regression to test for the influence of selection bias. (Logistic regression is similar
to OLS, but is used when the outcome variable is dichotomous.) Their analysis indicated
that the IV model produced better estimates of program effects than the logistic regression
model due to the influence of selection bias. Linden and Adams (2006) compared OLS
and IV regression models in their diabetes DM analysis. They concluded that IV
regression using zip code instruments could control for selection bias. However, they also
indicated that researchers should use both OLS and IV regression models and select the
one that produces the best estimates.
Research Questions
The present study was guided by the following three research questions:
1. Which statistical method provides the best unbiased estimates of high intensity DM
program participation on the outcome variables?
2. Do the parameter estimates and confidence intervals for the predictor variables
differ depending upon which statistical method is used?
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3. What are the advantages and disadvantages of using OLS and IV regression to
evaluate high intensity DM program effectiveness?
The study hypothesis was that the three-digit zip code instrumental variables procedure
will provide an unbiased estimate of the effects of disease management program
participation on a group of high intensity Virginia Medicaid diabetes patients enrolled in
the Virginia Healthy ReturniM Disease Management Program.
Methodology

As previously mentioned, the purpose of this study was to compare and contrast
OLS and IV regression using three-digit zip code instruments, which are two methods that
can be employed to estimate the effects of participation in the Healthy ReturniM DM
Program for a group of high intensity diabetes patients. Comparisons between the
magnitudes, direction, and significance of the treatment effect estimates produced through
both methods were made (Hadley et al., 2003). The Hausman specification test was
performed to determine if the differences obtained between the OLS and IV regression
models were significantly different and the relevancy of the zip code instruments was
assessed by using both the Sargon chi-square test and the first stage model F-statistics
from the IV regressions (Ender, n.d.; Hadley et al., 2003; Greene, 2003; Baum, 2006;
Stock & Watson, 2007). Additional information on the study population, data source, and
study variables is provided below.
Population
The population of interest for the present study consisted of all Virginia Medicaid
diabetes recipients who were continuously enrolled in the Virginia Medicaid Healthy
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ReturniM DM Program during calendar (CY) year 2007. Individuals eligible for the
program are classified as either high intensity or standard intensity participants. 7 Because
the Healthy Returns5M DM Program operated as an opt-out program during the study
period, almost all Medicaid recipients with diabetes were automatically enrolled.
Recipients who were identified as high intensity based on their probability ofincurring
high future medical costs were given the option ofparticipating in the high intensity
intervention. Those who agreed were enrolled in the high intensity program, while those
who declined were enrolled in the standard intensity program as high intensity on demand
patients. (High intensity participants who were enrolled in the standard intensity program
were excluded from this study. Additional information on the study population is
presented in Chapter 3.)
Standard intensity patients receive DM services such as an initial enrollment phone
call, a welcome kit providing detailed information on their respective chronic condition,
and quarterly educational newsletters. These recipients also have access to a 24 hour seven
day-a-week call line that is staffed by licensed medical professionals. High intensity
patients receive the standard services plus regularly scheduled phone calls from HMC
nurses who have access to their prescribed plans ofcare or nationally recognized evidence
based guidelines. The nurses use this information to assist the recipients in managing their
illnesses. As part ofthis process, high intensity open recipients complete annual health
7 Since the data for this study were obtained, the contractor that operates the Healthy Returns™ Program for
the Virginia Department of Medical Assistance Services changed its classification ofDM participants.
Participants are now classified as high, moderate, and low risk (HMC, 2008). However, this classification
was not used in the present study because the data were collected under the previous administrative structure.
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assessments that measure their mental and physical functioning abilities (Health
Management Corporation [HMC], 2007).
Enrolling a majority ofrecipients into the DM program prevents the use ofa
control group composed ofnon-participants. Linden, Adams, and Roberts (2005) argue
that this issue can be addressed by treating high intensity DM patients as the treatment
group and standard intensity patients as the control group. The rationale for this
comparison is that the high intensity patients actively receive the intervention, while the
standard intensity patients do not (Linden et al., 2005). As a result, the treatment group for
this study consisted ofthe high intensity diabetes patients, while the control group
consisted ofthe standard intensity patients.
Data Source
The analysis data came from the Virginia Medicaid Management Information
System (VaMMIS) and consisted ofrecipient and paid claims records. VaMMIS is the
Virginia Department of Medical Assistance Services' (DMAS) administrative database
that is used to perform both recipient and provider eligibility/enrollment as well as
provider payment functions (i.e., providers are physicians, hospitals, clinics, etc. that
participate in the Virginia Medicaid program). All Medicaid records within VaMMIS are
maintained as SAS files; however, the data obtained for this study were analyzed using
SAS, SPSS, and ST ATA statistical programs.
Because the analysis data contains protected health information (PHI) (i.e.,
recipient names, addresses, social security numbers, and Medicaid identification numbers),
the researcher was required to enter into a formal written agreement with DMAS as
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stipulated under the federal Health Insurance Portability and Accountability Act of 1996
before receiving any Medicaid recipient claims data. Under the agreement, the researcher
was required to appropriately safeguard all data containing PHI, report to DMAS any
misuse of PHI data, provide a copy of the study to DMAS, and either return or destroy all
analysis data upon study completion.
Variables
Three outcome variables were examined in the present study: total diabetes costs,
total emergency department visits, and total hospital stays (Linden & Adams, 2006).
Predictor variables included actual program participation, gender, age, and a propensity
score. The rationale for selecting these predictor variables was twofold: 1) they were
available, and 2) they (or similar variables) were used in other studies (Christakis et al.,
2004; Linden & Adams, 2006, Afifi et al., 2007). Medicaid claims data were collected for
the study subjects for the CY 2007 time period and quantitative variables were summed for
all subjects (i.e., each subject had one total diabetes-related cost number).
Summary

The purpose of the present study was to compare ordinary least squares and
instrumental variables regression using Linden and Adams' (2006) three-digit zip code
instrument procedure in order to estimate the effects of high intensity participation in the
Virginia Medicaid Healthy Return?M Disease Management Program. The purpose of the
comparison was twofold: 1) to test the utility of the zip code instrumental variables
procedure and 2) to determine which method offered the best solution to issues involving

26
selection bias in observational research. Future research implications resulting from the
analytical findings are discussed in Chapter 5.
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Chapter 2
Literature Review

This chapter provides a context for understanding the importance of the present
study, the statistical procedures that were used, and the findings and conclusions that
resulted from the analysis. Studying methods for evaluating disease management
programs is important because chronic disease represents a serious issue that is facing .the
U.S. health care system. With more than 90 million Americans suffering from chronic
illnesses, providing care to these individuals accounts for approximately 75 percent of the
nation's health care costs, which total more than $1 trillion annually (Centers for Disease
Control and Prevention [CDC], 2005a). However, chronic disease patients often receive
inadequate care due to a variety of factors including the prevalence of the diseases among
low-income people and the substantial amount of resources that are required to manage the
conditions (Lohr, Keeler, Calabro, & Brook, 1986; Bodenheimer, 2000; Center on an
Aging Society, 2004).
Since the early 1990s, disease management (DM) has been promoted as a
mechanism for improving quality of care for chronic disease patients, while reducing
health care costs. In fact, the disease management industry has actively promoted its
ability to achieve these ends (Bodenheimer, 2000). Even though millions of individuals
currently receive services through DM programs, little evidence exists on the cost
effectiveness of disease management or on its ability to improve patient health outcomes
(Linden, 2006). These shortcomings may stem from the influence of two factors: 1) the
availability of data for evaluating DM program effectiveness and 2) the use of weak
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observational designs that are subject to internal validity threats such as selection bias
(Linden & Adams, 2006, Ofman et al., 2004).
The purpose of this study was to examine the utility of an econometric procedure
proposed by Linden and Adams (2006) for evaluating disease management program
effectiveness using data collected on a group of diabetes OM patients. The authors argue
that the method is appropriate for OM evaluations because it can reduce the influence of
selection bias. Additional information on disease management, patient self-management
education and self-efficacy theory, diabetes-related disease management evaluations, and
the statistical analyses examined in the present study are provided in the following
sections.
The literature reviewed in this study was identified through several avenues. First,
the instrumental variables (IV) regression references used by Linden and Adams (2006)
were obtained. Second, searches for key phrases such as disease management, diabetes
disease management, disease management evaluation, instrumental variables regression,
instrumental variables regression and disease management evaluation, instrumental
variables regression and selection bias, selection bias models, self-efficacy theory and
disease management, propensity scores, and observational research were performed on the
MEOLINE/PubMed, Psychinfo, Social Sciences Index, and the Cumulative Index to
Nursing and Allied Health search engines available through the Virginia Commonwealth
University library. Additional information on the study topic was identified in research
design and regression/econometrics textbooks.
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Overview of Disease Management

Disease management is a coordinated intervention and communication system for
individuals with chronic conditions that can be managed effectively through patient self
management efforts (Linden & Adams, 2006). While DM programs were initially
implemented by pharmaceutical companies, most OM services are currently provided by
disease management companies that sell their services to health maintenance organizations
(HMOs), large companies, and public entities such as Medicaid (Bodenheimer, 2000).
This section provides information on disease management, state Medicaid agencies'
involvement in disease management activities, and the Virginia Healthy Returns'M Disease
Management Program.
Disease Management
Disease management is a population-based approach to providing health care
services to individuals suffering from chronic illnesses. Population-based means that DM
applies to all eligible recipients enrolled in a health care program offering these services.
Generally, the eligible beneficiaries are identified through a predictive modeling analysis
of their medical claims history. The claims analysis is used to evaluate recipients' support
needs and to stratify them into high and standard risk levels. DM has evolved from a
system that typically focused on opt-in recruitment, where individuals with a chronic
condition were invited to participate, to opt-out care where all individuals with a chronic
condition are automatically enrolled unless they specifically request to be excluded (Foote,
2003).
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Under the disease management paradigm, patients are viewed as individuals who
receive consistent medical care from the same providers over the course of their disease
rather than as individuals who only receive discrete or fragmentary medical care. Disease
management is suitable for chronic illnesses that have large research bases. Due to the
amount of information that exists on these diseases, it is relatively easy for health care
providers to develop evidence-based treatment protocols and to identify and measure
appropriate evaluation outcomes. For these reasons, disease management programs are
often developed around conditions such as diabetes, heart disease, cancer, asthma,
hypertension, AIDS, angina, and kidney disease (Hunter & Fairfield, 1997).
Disease management generally consists of six main components: 1) population
identification processes, 2) evidence-based practice guidelines, 3) collaborative practice
models, 4) patient self-management education, 5) process and outcome measurement, and
6) routine reporting and feedback between patients, providers, and health plans.
Population identification involves identifying a group of patients with a specific disease
and then enrolling those individuals into the DM program. Identification is often
accomplished through predictive modeling that uses demographic, health care usage, and
expenditure variables to identify patients who are most likely to benefit from program
participation. Evidence-based practice guidelines consist of providing participating
physicians with disease-specific treatment standards to ensure that they provide patients
with consistent care based on the latest clinical evidence guidelines. Collaborative practice
involves assembling a multidisciplinary health care team (physicians, nurses, pharmacists,
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dieticians, etc.) to provide comprehensive health care services to DM patients (Center on
an Aging Society, 2004).
Patient education is based on the concept that educated patients receive better care
because they are more knowledgeable about their conditions. Appointment reminders, 24hour call centers, home visits, and counseling are examples of services used to educate
patients about their illnesses. Process and outcome measurement must be established prior
to DM program implementation. It involves measuring variables, such as health care
expenditures, patient satisfaction, and health care service usage, to evaluate the impact of
the DM program. Finally, routine reporting and feedback consists of periodic
communication between patients, physicians, and other multidisciplinary health care team
members to ensure that patients are properly managing their conditions and receiving
appropriate levels of care (Center on an Aging Society, 2004).
Because data on diabetes patients were analyzed in the present study, an example of
a hypothetical diabetes DM program is presented to illustrate how disease management
works. Diabetes is a disease characterized by high levels of blood glucose (or sugar) that
occur when individuals are unable to regulate their insulin production (CDC, 2005b). As a
result, diabetics must monitor their blood glucose and may take insulin or other drugs to
control their conditions. Failure to monitor blood sugar levels can have serious
consequences for diabetics, including blindness, limb amputations, stroke, or kidney
disease. Thus, patient self-management plays a vital role in controlling diabetes, which
makes it an ideal illness for inclusion in a disease management program (Congressional
Budget Office, 2004).
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A diabetes DM program may work by targeting resources toward improving
process outcomes for the enrolled population. For example, a diabetes program may focus
on increasing the number of patients who receive regular blood pressure screenings, annual
foot and eye exams, annual cholesterol tests, annual kidney function tests, and biannual lab
tests for hemoglobin Ale, which is a blood sugar monitoring test. The DM program may
attempt to motivate diabetes patients into complying with these periodic measures in order
to achieve both short and long-term positive health outcomes. Examples of short-term
outcomes may include reductions in enrollee hospital stays and emergency department
visits, while long-term outcomes may include reduced rates of amputations, heart attacks,
and kidney disease occurrences (Congressional Budget Office, 2004).
The arguments made by the disease management industry on the benefits of DM
services may be justified to a degree because some research suggests that these programs
can both improve patient quality of care and reduce health care costs. For instance, Ofman
et al. (2004) report that many DM programs are associated with improvements in the
quality of care received by chronically ill patients, while Gillespie and Rossiter (2003)
report that DM programs can reduce costs for Medicaid recipients by almost 33 percent
due to reductions in hospital emergency department and urgent care visits.

State Medicaid Programs
Due to disease management's potential for reducing health care costs and
improving the quality of care for chronically ill patients, many state Medicaid agencies
have become interested in these services (Gillespie & Rossiter, 2003). Disease
management appears to be well suited for Medicaid programs because they provide health
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insurance coverage to individuals who are more likely to be physically disabled and less
educated than the general population, which are conditions that may contribute to the
development of chronic disease. In fact, more than 60 percent of all adult Medicaid
recipients suffer from chronic ailments such as diabetes, hypertension, and asthma.
Chronically ill Medicaid recipients require more care than their healthier counterparts
(Williams, 2004). In fact, one study found that average annual health care costs for
chronically ill Medicaid recipients were approximately $6,672 compared to $432 for
recipients without these conditions (Williams, 2004).
According to some observers, increasing health care expenditures have probably
been the driving force behind the development of many state Medicaid DM programs
(Gillespie & Rossiter, 2003). For instance, national Medicaid expenditures increased from
$205.7 billion to $275.5 billion (or by about 25 percent) between fiscal years 2000 and
2003 (Holahan & Ghosh, 2005). Many states anticipate that their Medicaid populations
will increase due to current economic conditions, which will force Medicaid programs to
compete with other state programs for increasingly limited funding (Gillespie & Rossiter,
2003). As a result, 42 states have either implemented or are planning to implement DM
programs along with other initiatives in an effort to be more cost effective (Afifi et al.,
2007).
In addition to being classified as either opt-in or opt-out, state Medicaid disease
management programs can generally be grouped into one of three models: pay for
performance, centers for excellence, or the health outcomes partnership. As described by
Gillespie and Rossiter (2003), the pay for performance model involves the enlistment of
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nontraditional providers in the care of patients with diseases such as Alzheimer's,
HIV/AIDS, schizophrenia, and chronic ear infections. The fees paid to nontraditional
providers are based on improved patient outcomes or reduced health care costs. 8
The centers for excellence model focuses on providing services to specific high
cost, high-volume Medicaid recipients through a network of hospitals, physicians, and
other health care providers participating in the state Medicaid program. Examples of .
diseases covered under this model include cystic fibrosis, epilepsy, hemophilia, and sickle
cell anemia. Medicaid programs using this model are responsible for determining the
number of centers for excellence that will operate within their states. This model requires
the centers to have official written documentation on the quality of care that will be
provided to Medicaid recipients with specific diseases as well as the outcomes that will be
measured. Once the documentation is developed, the Medicaid agency furnishes a single
prospective payment to the center to cover the costs for all DM services that are provided
to Medicaid recipients. The centers are also responsible for reporting health outcome
improvements to the state Medicaid agencies (Gillespie & Rossiter, 2003).
Finally, the health outcomes partnership approach is a model typically used to
provide DM services to fee-for-service (FFS) Medicaid recipients (individuals who are not
enrolled in a managed care program) who have high-priority diseases such as diabetes,
asthma, hypertension, congestive heart failure, and chronic obstructive pulmonary disease.

8 Since 2004, pay for performance (P4P) has evolved in Great Britain and the Unjted States into a model that
promotes value based health care by paying providers financial incentives for achieving certain clinical
quality, patient experience, and information technology outcomes (Doran, Fullwood, Gravelle, Reeves,
Kontopantellis, Hiroeh, & Roland, 2006; Cutler, Palmjeri, Khalsa, & Stebbins, 2007; O'Kane, 2007).
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Medicaid programs that use this DM model usually provide claims-based feedback reports,
treatment guidelines, and other support systems to help health care providers better serve
the Medicaid recipients assigned to them (Gillespie & Rossiter, 2003). The Virginia
Healthy ReturnssM Disease Management Program is an example of such a model because it
operates as a partnership between the Department ofMedical Assistance Services and a
private contractor to provide disease management services to FFS Medicaid recipients.
Virginia Healthy ReturnsSM Disease Management Program
The Department ofMedical Assistance Services (DMAS) is the state agency
responsible for administering both the Medicaid Program and the State Children's Health
Insurance Program (SCHIP) within the Commonwealth ofVirginia. Medicaid and SCHIP
are public insurance programs that provide health care coverage to qualified low-income
individuals. Both programs are financed using state and federal funds and are administered
by the state in accordance with rules and regulations promulgated by the federal
government (DMAS, 2005b).
Due to the current popularity surrounding DM programs, coupled with the
expectation ofreduced health care costs, the General Assembly directed DMAS to develop
a DM program for FFS Medicaid recipients diagnosed with diabetes, asthma, coronary
artery disease, or congestive heart failure (DMAS, 2005b). (Chronic obstructive
pulmonary disease was included in 2007.) Although not explicitly stated, the intent ofthe
General Assembly's directive was to improve health outcomes for Medicaid FFS recipients
with certain chronic conditions while reducing state Medicaid costs. Examples ofhealth
outcomes include patient satisfaction with the treatment program, cholesterol testing rate,
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use of hospital emergency departments for non-emergency care, number of days
hospitalized, diabetes hemoglobin Ale (blood sugar) testing rate, use of appropriate
medications, and mortality.
To solicit proposals from vendors interested in administering a Medicaid DM
program, DMAS prepared a request for proposals in May 2005 that outlined the program's
requirements. The agency received four solicitations from interested vendors and spent
several months reviewing them. DMAS eventually awarded the contract to a local disease
management vendor on September 22, 2005, and the Virginia Healthy Returns5M Program
became operational on January 13, 2006. The purpose of the program is to improve health
outcomes for Medicaid recipients with certain chronic conditions while saving the State
money by reducing overall health care costs for program participants. It is designed to
achieve a variety of objectives including an overall reduction in hospital admissions,
improper use of hospital emergency departments, and medical expenditures for program
participants, increased participant and provider education on managing chronic conditions,
and enhanced participant and provider satisfaction with the program (DMAS, 2005a).
Under the current DM contract, the contractor is required to operate the Healthy
Returns5M DM Program as a voluntary opt-in program for Medicaid recipients who have
diabetes, asthma, coronary artery disease, congestive heart failure, or chronic obstructive
pulmonary disease. The contractor is required to identify recipients with one of the
chronic conditions through an analysis of Medicaid claims data using a proprietary
predictive modeling procedure. Once the recipients are identified, the contractor is then
required to contact them to determine if they are interested in participating. Recipients

37
who are interested are enrolled, while recipients who are not interested are contacted later
to determine if they have become interested in participating (DMAS, 2005a). However,
the contractor did not administer the Healthy ReturniM Program as an opt-in program.9
Instead, it administered the program as opt-out and automatically enrolled recipients once
they were identified through the claims analysis.
Healthy ReturniM offers Medicaid recipients three main interventions: care
management, a 24-hour telephone call center, and use of evidence-based treatment
protocols. The care management component consists of the following services:
continuing health status assessments of all program participants, educating patients about
self-management, monitoring patient compliance with self-management protocols, and
providing participants with educational materials on their respective chronic conditions.
Care management services are provided through either telephone calls or in-person visits at
the participants' residences (DMAS, 2005a).
The call center component consists of a center with a toll-free telephone number
that is staffed by licensed medical professionals on a 24-hour, seven day-a-week basis.
The medical professionals are primarily available to provide participants with referral
numbers needed to obtain services from specialty providers. They are also available to
answer any basic health-related questions that the participants may have about their
respective chronic conditions (DMAS, 2005a).
Finally, the evidence-based treatment protocol component involves providing the
primary care providers of the participating Medicaid recipients with evidence-based
9 The program has been administered as opt-in since March 2008 (I-IMC, 2008).
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treatment guidelines that are based on the latest scientific literature and are approved by
nationally recognized experts. It is anticipated that participating Medicaid recipients will
experience improved health outcomes because providers will follow the guidelines when
developing their treatment regimens (DMAS, 2005a).
The contractor classifies Medicaid recipients with one of the chronic conditions as
either high intensity open, high intensity on demand, or standard intensity based on their
predicted risk for incurring future health care costs. When patients are identified as high
intensity, the contractor contacts them to determine if they want to receive the high
intensity intervention. Those who agree are classified as high intensity open and receive
periodic telephone calls, individualized care plans, 24-hour access to program nurses, and
quarterly mailings of disease-specific information. High intensity recipients who decline
are classified as on demand and receive periodic educational mailings and have 24-hour
access to program nurses if they choose to use it (which is not reflected in the claims data).
Individuals identified as standard intensity are automatically enrolled and also receive the
periodic mailings and have 24-hour access to program nurses (HMC, 2007).
Between January and July 2008, 18,166 Virginia Medicaid recipients were enrolled
in the Healthy ReturniM program. The breakdown for program participation was as
follows: 10,378 asthma participants, 3,823 diabetes participants, 1,615 coronary artery
disease participants, 1,478 chronic obstructive pulmonary disease participants, and 872
heart failure participants (HMC, 2008). The number of participants enrolled in the
program changes often due to the frequency with which Virginia Medicaid recipients enter
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and leave the Medicaid program as well as the frequency with which recipients are
diagnosed with these conditions.
Patient Self-Management Education and Self-Efficacy Theory

Chronic diseases affect more than 90 million Americans and account for at least
half of the nation's total health care costs. The prevalence of chronic illnesses in the US
population is growing. In fact, it is estimated that these diseases will affect at least half of
the US population by 2020 (Redman, 2005). 10 According to Nuovo (2007), the nation's
health care system is ill prepared to deal with patients who suffer from these illnesses
because it is heavily oriented toward treating individuals with urgent care needs. Such
conditions mean that poorly treated chronic diseases usually lead to personal care
limitations, poor quality of life, premature wage losses, and high mortality before the age
of 65 for individuals who suffer from them (Marks, Allegrante, & Lorig, 2005).
Because many chronic disease patients receive inadequate care from their health
care providers, the responsibility for managing these conditions falls primarily on the
individuals who suffer from them. Even if the health care system was structured to
provide better care, chronic disease patients would still be responsible for approximately
90 percent of the care that is needed to manage their conditions (Suter, Hennessey,
Harrison, Fagan, Norman, & Suter, 2008). As a result, chronically ill patients are the ones
who are ultimately responsible for managing their conditions, despite the advice and care
that they may receive from health care providers. In fact, patients self-manage their
conditions every day by deciding what foods they will eat, how much they will exercise, if
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they will use tobacco products, and even if they will consume prescribed medications.
Unfortunately, some patients do not (or cannot) manage their illnesses as well as others
(Bodenheimer et al., 2002).
In response to these realities, the Disease Management Association of America
(n.d.) recommends that disease management (DM) programs provide patients with selfmanagement education services in order to teach them how to effectively manage their
conditions.11 Self-management education services are intended to compliment traditional
DM patient education services that focus on technical competence and disease-specific
information by teaching patients problem solving skills (Bodenheimer et al., 2002). In
particular, self-management education services may teach DM participants techniques for
dealing with everyday problems such as depression, anger, and fatigue; exercise regimens
to maintain strength and cardiovascular fitness; appropriate use of prescription
medications; behavior modification procedures; and strategies for evaluating new
treatments and decision making (Farrell, Wicks, & Martin, 2004).
DM self-management education emphasizes enabling patients to use the technical
information that they learn about their diseases to solve problems that are relevant to the
daily management of their conditions. The goal of self-management education is to assist
patients with developing a greater sense of confidence in their ability to live with and

The growth in chronic diseases is due in part to the fact that the baby boomer generation is reaching the
age of increased chronic disease prevalence (Bodenheimer et al., 2002).
11 W
hile the Virginia Healthy Return/M Program includes a self-management education component, the
information presented in this section is not descriptive of that component. Instead, this information is
intended to illustrate how self-management education and self-efficacy theory are applied in DM programs in
general.
10
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manage their chronic diseases on a daily basis (Nuovo, 2007). Short action plans that are
similar to New Year's Eve resolutions play a key role in DM self-management education.
The plans are developed by the patients and propose specific behavior changes that they
are confident they can achieve. Examples of such behavior changes may include walking a
certain number of minutes each day or losing a certain amount of weight each week. By
accomplishing the plans, patients begin to build confidence in their ability to successfully
manage their diseases through appropriate behavioral modifications (Bodenheimer et al.,
2002; Nuovo, 2007).
Because DM self-management education seeks to instill confidence in patients to
make life-long behavioral changes, self-efficacy theory plays a central role in these
interventions (Allen, Iezzoni, Huang, Huang, & Leveille, 2008). Self-efficacy, which is
based on social learning theory, is viewed as fundamental to successful behavioral change.
It refers to the level of confidence that individuals have in their ability to perform specific
tasks needed to achieve desired goals or outcomes (Clark & Dodge, 1999; Marks et al.,
2005).
Self-efficacy results from the interaction of four sources of information:
performance attainment, vicarious experiences, verbal persuasion, and physiological states.
Performance attainment exerts the strongest influence on self-efficacy because it concerns
the successful completion of a task. Vicarious experiences exert the second strongest
influence on self-efficacy and occur when patients gain confidence in their ability through
the successes and failures of others who were confronted by similar challenges. Verbal
persuasion is the third influence and manifests itself through reassuring words and praises
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that allow individuals to feel confident in their ability to succeed. Finally, physiological
states represent the actual senses that patients feel when they experience success or failure
(Wolf, 2006). When successfully implemented, self-efficacy can exert a powerful
influence in how individuals with chronic illnesses respond to their attempts to achieve
appropriate disease management behavior.
Chronically ill individuals develop self-efficacy when they successfully achieve
personal goals such as performing a desired level of physical activity or reducing the
amount of fast foods they consume. By successfully achieving personal goals, the patients
become more confident in their ability to perform the same behaviors again. This in turn
increases the likelihood that they will repeat those behaviors (Clark and Dodge, 1999).
This is the end state that DM self-management education seeks to instill in patients through
the use of action plans. The ultimate goal of the plans is not so much to ensure that
patients undertake difficult major life-long behavioral changes, but rather to ensure that
patients identify and undertake simple easy to complete tasks that will eventually lead to
these major changes.
Promoting self-efficacy is thus a critical issue for DM self-management
interventions. In fact, research suggests that favorable self-efficacy beliefs influence
depression, disability, medication use, diet, weight loss, and self-care behaviors (i.e.,
receiving the recommended number of blood glucose tests or cholesterol tests in a year)
among chronically ill individuals (Marks et al., 2005). Moreover, research also indicates
that DM self-management programs promoting self-efficacy can reduce health care costs
and improve outcomes for chronic disease populations (Farrell et al., 2004).
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While self-efficacy provides an important theoretical framework for understanding
how DM interventions work, readers should note that it was not the central theme in the
present study, which focused on examining statistical methodologies. However, self
efficacy theory could be used to guide DM evaluations. For instance, Lorig et al. (2001)
evaluated the effects of a DM intervention that promoted self-management education and
self-efficacy on four outcomes: health behavior, self-efficacy, health status, and health
utilization. The researchers found that the intervention was associated with statistically
significant improvements in health status, health behavior, and self-efficacy as well as a
statistically significant decrease in health utilizations. Sui et al. (2007) also evaluated the
effects of a self-efficacy based DM program in a Chinese population on various outcomes
including self-management behavior, self-efficacy, coping strategies, and health outcomes.
They found that participation in a DM program that promoted self-management education
was associated with statistically significant increases in self-efficacy, coping strategies, and
health outcomes.
Diabetes-Related Disease Management Evaluations
While the Virginia Healthy ReturniM Disease Management Program currently
covers five chronic diseases, the present study only examined data on diabetic Medicaid
recipients. Diabetes was selected because it is important for policymakers to understand
how disease management effects participants who suffer from this disease because it is a
serious condition that has reached epidemic proportions, affecting approximately 18
million Americans (Shojania, Ranji, McDonald, Grimshaw, Sundaram, Rushakoff, &
Owens, 2006; Choe et al., 2005). Diabetes is the fifth leading cause of death in the country

and contributes to morbidity by placing people at increased risks for heart disease,
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blindness, and other chronic conditions. Substantial costs are also associated with
diabetes. For instance, it is estimated that diabetes cost the nation approximately $132
billion in health care expenditures and lost productivity in 2002 (American Diabetes
Association, 2003). Diabetes places substantial clinical and economic burdens on
American society (Knight, Badamgarav, Henning, Hasselblad, Gano, Ofman, &
Weingarten, 2005), but studies suggest that self-management services such as intensive
glucose control can substantially reduce diabetes complications (Rothman & Elasy, 2005).
For these reasons, it is important to study methods that can be used to evaluate the
effectiveness of diabetes-related DM interventions.
The literature review is not limited to evaluations of specific diabetes DM
programs. Instead, it includes evaluations of both diabetes specific and related DM
programs and services to develop an understanding of the research designs and statistical
methods that have been used to evaluate this topic. A variety of designs and statistical
procedures have been employed. However, only two studies were identified that used
statistical methods similar to the ones that were used in this study. While the studies
tended to find that diabetes DM produced positive outcomes for patients, they encountered
various methodological shortcomings that limited their usefulness. Additional information
on the reviewed diabetes DM studies is provided in the subsections below.
Experimental Designs
The experimental design with random assignment of subjects to treatment and
control groups is considered the gold-standard in research and program evaluation studies.
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Random assignment reduces the influence of selection bias and other internal validity
threats by giving each subject in the population of interest an equal chance of being
included in the study groups. However, implementing experimental designs can be
difficult unless they are conducted in controlled settings (Linden et al., 2005).
Five diabetes-related DM evaluations using experimental designs were identified in
the literature review. The statistical procedures used in these studies come from the
generalized linear model (GLM), which provides the foundation for most of the statistical
analyses performed by social science researchers. The GLM underlies statistical
procedures such as the !-test, analysis of variance (ANOVA), analysis of covariance
(ANCOVA), regression analysis, factor analysis, cluster analysis, and discriminant
function analysis. The GLM is important because it allows researchers to summarize a
variety of outcomes. However, model specification is a major limitation faced by
researchers who use the GLM because they must specify statistical models that best
summarize their data. If important variables are not included in the models, then the
parameter coefficients will be biased, which will result in statistical equations that do not
correctly describe the data (Trochim, 2005).
GLM procedures used in the reviewed studies included !-tests, ANOVAs,
regression analyses ( ordinary least squares, logistic, and Poisson), and generalized
estimating equations (GEE). GEE is a specialized regression procedure that is used to
analyze longitudinal and other correlated data, especially when the outcomes are binary or
count variables (Hanley, Negassa, Edwards, & Forrester, 2003). Odegard, Goo, Hummel,
Williams, and Gray (2005) and Meigs et al. (2003) used !-tests and GEE procedures to
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evaluate the effectiveness of a pharmacist intervention on diabetes self-management, and
to test the effects of a web-based decision support tool to improve the management of
diabetes patients using evidence-based treatment protocols, respectively. Outcome
variables examined included hemoglobin Ale tests (used to monitor blood sugar levels),
use of appropriate diabetes control medications, cholesterol tests, blood pressure, and eye
and foot examinations.
Odegard et al. (2005) found that the pharmacist intervention did not significantly
improve A 1 c test adherence for the treatment group and that no significant differences
existed between the study groups on the use of appropriate medications. Meigs et al.
(2003) concluded that the web-based decision support tool for diabetes management
appeared to have the potential to improve evidence-based care of diabetes patients.
However, both studies had limitations that may influence the usefulness of their results.
For instance, Odegard et al. (2005) reported that their results may be influenced by
regression to the mean because they specifically focused on diabetes patients with poor
self-management skills. In addition, they randomized subjects within clinics as opposed to
randomly selecting clinics for the study. As a result, providers who participated in the
experiment could have provided services to both treatment and control subjects that may
have caused treatment diffusion (i.e., treatment effects being spread to control group
members) (McMillan & Schumacher, 2006).
The study by Meigs et al. (2003) also had several limitations. In particular, it was
plagued by incomplete documentation that may have resulted in lower rates of patient
compliance for some diabetes care activities used as outcome variables. Meigs et al.
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(2003) also reported that some participating providers did not consistently use the webbased tool as intended when treating diabetes patients, which may have further skewed
their results.
The GLM procedures used by Landon et al. (2007), Choe et al. (2005), and Sadur,
Moline, Costa, Micalik, Mendlowitz, Roller, Watson, Swain, Selby, and Javorski (1999)
included t-tests, and ordinary least squares (OLS), logistic, and Poisson regression
analyses. Landen et al. (2007) used OLS and logistic regression to examine changes in
disease-specific quality of care indicators for 9,658 randomly selected diabetes, asthma,
and hypertension patients who received care at 64 (44 treatment and 20 control)
community health centers. Diabetes-related indicators that served as outcome variables
included Ale tests, cholesterol tests, and blood pressure. Choe et al. (2005) used OLS and
logistic regression to examine treatment and control group differences in an evaluation of
the effectiveness of pharmacist-provided DM services on blood sugar and preventive care
measures for a group of randomly assigned diabetes patients. Outcome variables included
Ale tests, eye examinations, and urine microalburnin tests. Finally, Sadur et al. (1999)
used t-tests and Poisson regression to examine differences between the treatment and
control groups on various outcome measures including Ale tests, self-reported measures of
self care practices, satisfaction with general medical care, and health utilizations (e.g.,
number of visits to hospital emergency departments and visits to physician offices).
Landon et al. (2007) found that the diabetes and asthma patients who received care
from the community health centers demonstrated greater improvements in the monitoring
and treatment of their conditions, while hypertension patients did not. Choe et al. (2005)
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found that proactive diabetes case management provided by a pharmacist substantially
improved glycemic control for diabetes patients, and Sadur et al. (1999) determined that
DM services improved glycemic control, self-efficacy, and patient satisfaction for diabetes
patients, while reducing their health care utilization.
However, these studies also encountered limitations. Landon et al. (2007) reported
that they had to rely on matching treatment and control subjects because they were unable
to perform a pure randomized trial where subjects were randomly assigned to study
groups. Thus, their analysis may not have accounted for all potential confounding
variables, which could bias their regression models. They also reported that their results
may have been overstated because some of the community health centers may not have
fully implemented the intervention. Choe et al. (2005) reported that the generalizability of
their study was hampered due to its small scope (it only involved 80 patients at one site),
while Sadur et al. (1999) reported that they failed to obtain complete information on all
study subjects, which could influence the accuracy of their findings.
Quasi-Experimental Designs
According to Trochim (2005), quasi-experimental designs are similar to
experimental designs, but lack random assignment of subjects to treatment and control
groups. These designs are more commonly used than experimental designs due to the
difficulties that researchers encounter when implementing experimental studies (Trochim,
2005). Six quasi-experimental studies were identified in the literature review. The studies
employed a variety of statistical procedures to examine the effects of DM interventions on
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various outcome variables. While the studies tended to find that diabetes DM produced
positive results, limitations were present that may reduce their usefulness.
Two studies were identified that used GLM procedures similar to instrumental
variables (IV) regression. In the first study, Wendel and Dumitras (2005) tested the
feasibility of using a two-part selection bias regression model for DM program evaluations.
The model was developed by James Heckman (an econometrician) in the 1970s to control
for selection bias in observational studies. In the first step, probit regression is used to
create a selection model that predicts the probability of program participation using
observable patient characteristics. The residuals from this equation are then used to create
the Inverse Mills Ratio (IMR), which represents the predicted probability of program
enrollment. In the second step, linear or probit regression is used to produce unbiased
estimates of the impact of program participation on the outcome variable, while controlling
for the IMR and other observed confounders (Ettner, 2004; Sales, Plomondon, Magid,
Spertus, & Rumsfeld, 2004). The regression steps are performed simultaneously. The
Heckman method adjusts for potential selection bias by including the IMR as a variable in
the outcome equation in order to model the correlation between the treatment variable and
the error term (Ettner, 2004).
To perform the study, Wendel and Dumitras (2005) obtained administrative data
from a managed care diabetes DM program. Because they were interested in assessing the
change in health care costs generated by DM program participation, they used costs as the
outcome variable. Their analysis found that DM program participation had a statistically
significant effect on the outcome variable. Based on the analysis, the authors concluded
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that the Heckman method offered a viable means of evaluating a DM program using
observational data. While Wendel and Dumitras (2005) did not report any study
limitations, their analysis may be limited because the Heckman method is highly sensitive
to model specification. As a result, they could have calculated biased (e.g., incorrect)
estimates if important variables related to either recipients' participation decisions or the
outcome variable were omitted (Sales et al., 2004).
In the second study, Afifi et al. (2007) used a variant of the two-part model to
evaluate the effects of the Florida Medicaid disease management program on four
utilization outcomes: number of annual inpatient hospital stays, emergency department
visits, inpatient days, and outpatient visits. The first part of their modeling procedure used
logistic regression to predict whether a recipient had any utilization, while the second part
applied only to recipients who utilized one of the four health care services. OLS regression
was used in the second stage to model the logarithm of the annualized utilization variables.
According to Mullahy (1998), the two-part model is an appropriate procedure to use in
health outcomes research settings (such as disease management) where information may
only be available on subjects who utilized particular services.
As part of the analysis, Afifi et al. (2007) also calculated propensity scores for the
treatment and control group subjects for use as a covariate in the regression analysis. The
propensity score (which is estimated using logistic regression) is a method that corrects for
selection bias. It differs from IV regression in that it can only control for bias resulting
from observed variables, while IV corrects for bias due to unobserved variables. The
propensity-score method allows researchers to match subjects on the observed covariates
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that may account for bias in the sample (Schneider, Carnoy, Kilpatrick, Schmidt, &
Shavelson, 2007).
Based on their analysis, Afifi et al. (2007) found that the Florida OM program
appeared effective at reducing hospital inpatient and emergency department visits for
diabetes, congestive heart failure, and asthma patients, but not for hypertension patients.
They concluded that some cost savings might be associated with the OM program because
hospital stays and emergency department visits are two of the most expensive components
of care. Their analysis further revealed that OM services do not appear to be effective until
after recipients have been exposed to the treatment for some time. However, Afifi et al.
(2007) reported that their analysis could have been hampered by selection bias because the
propensity score procedure does not control for unobserved confounding variables. If any
of the variables in their regression models were associated with unobserved confounders,
then their parameter estimates could be biased.
Another Medicaid study identified during the literature review involves an
evaluation of a Virginia Medicaid disease management program. Zhang, Wan, Rossiter,
Murawski, and Patel (2008) employed GLM procedures to evaluate a OM program that
was operated by DMAS prior to the implementation of the Healthy Return�M OM
Program. This program was known as the Disease State Management (DSM) Program and
it operated between 1999 and 2001. Chronic diseases covered under the DSM Program
included diabetes, hypertension/congestive heart failure, depression, peptic ulcer disease,
and asthma/chronic obstructive pulmonary disease. Zhang et al. (2008) used analysis of
variance and covariance procedures to evaluate the effects of the program on several
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outcome variables including drug compliance, quality of life, hospitalizations, physician
office visits, and emergency department visits. They also performed a cost savings
analysis as part of their study. Their analysis indicated that the DSM program significantly
improved participants' drug compliance and quality of life, while reducing
hospitalizations, physician office visits, and emergency department visits. They also
estimated that the program saved the Commonwealth of Virginia approximately $3
million. However, they reported that their analysis may be influenced by two limitations:
selection bias because participants were allowed to self-select into the study groups and
attrition because many of the control subjects left during the study.
The studies by Berg and Wadhwa (2007), Christakis et al. (2004), and Villagra and
Ahmed (2004) also used GLM procedures to evaluate diabetes DM effects. For instance,
Berg and Wadhwa (2007) evaluated a telephonic DM program for elderly diabetes patients
using t-tests and propensity scores. Outcome variables consisted of utilization measures
including number of hospitalizations, emergency department visits, and physician visits.
In an unpublished study, Christakis et al. (2004) used OLS, logistic, and Poisson regression
to evaluate Washington State's Medicaid DM program for patients with kidney disease,
asthma, congestive heart failure, and diabetes. While outcome variables were examined
for all four diseases, the diabetes specific outcomes were emergency department visits,
number of hospitalizations, length of hospital stays, A le tests, and eye tests.
Finally, Villagra and Ahmed (2004) used t-tests and an intention-to-treat analysis to
evaluate the first year effects of a multistate diabetes DM program on several outcome
variables including health care costs, emergency department visits, and number of days
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hospitalized. Because the OM programs were phased in over a three-year period,
researchers used the sites where the diabetes OM programs operated as historical controls.
Berg and Wadhwa (2007) found significant differences between the treatment and
control groups on health care service utilizations, prescription drugs, and diabetes testing
procedures. They concluded that a commercially delivered diabetes OM program could
significantly reduce hospitalizations, while increasing the use of diabetes related
prescription drugs and clinical procedures. Their study may be limited because they did
not have complete information on the control group members, which was needed in the
analysis.
Christakis et al. (2004) also found that OM services were associated with improved
care for Medicaid patients with kidney disease, asthma, and diabetes, but not for patients
with hypertension. They reported that their findings might be hampered by selection bias
because patients were not randomized into the OM program. Finally, Villagra and Ahmed
(2004) determined that the overall costs of care were significantly lower for the OM
subjects in their study. They also determined that quality of care (e.g., Ale testing,
diabetes control drugs, and eye exams) was significantly better for the OM subjects.
Villagra and Ahmed (2004) reported that their study was limited by its design, which may
not have controlled for all biases and confounders that could influence the results, and that
the data were susceptible to regression to the mean.
Non-Experimental Designs
Non-experimental designs are used when researchers are unable to manipulate
variables, or are interested in either describing various phenomena or examining
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relationships. Examples include descriptive, relational (comparative and correlational),
and causal-comparative designs (McMillan & Schumacher, 2006). Five non-experimental
studies were identified for review. These studies also tended to find that diabetes DM
interventions produced positive results for participants. The studies employed GLM
procedures such as t-tests, ANOVAs, generalized estimating equations (GEE), mixed
methods regression models, and logistic regression models. In addition, one study
performed a trend line analysis, while another study used a cost-comparison approach to
evaluate a DM program. These studies are discussed in more detail below.
Morisky, Kominski, Afifi, and Kotlerman (2008) used both generalized estimating
equations and linear mixed-method regression models to estimate the effects of the Florida
Medicaid DM program on behavioral health and physiological limitations for participants
with congestive heart failure, hypertension, diabetes, and asthma. Their outcome variables
included mental and physical health assessment scores, medication compliance scores,
blood glucose levels, and cholesterol scores. Coberly, McGinnis, Orr, Coberly, Hobgood,
Hamar, Gandy, Pope, Hudson, Hara, Shurney, Clarke, Crawford, and Goldfarb (2007)
performed a trend line analysis of a DM program to determine the relationship between
DM telephonic contact and increased clinical testing rates. The outcome variables were
Ale and cholesterol testing rates for patients during their first 12 months of participation in
a diabetes DM program. Mangione et al. (2006) used mix-effects regression models to
determine whether DM services provided by physician groups are associated with
improved diabetes care processes and control of diabetes outcomes. Their main outcome
variables included blood pressure, Ale tests, and cholesterol tests.
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Krein and Klamerus (2000) used logistic regression to determine if patients who
were enrolled in the Michigan Diabetes Outreach Network program received
recommended diabetes-level care. Their main outcome variable was whether or not the
patients received the recommended level of diabetes care. Finally, Fireman et al. (2004)
analyzed financial data from a commercial DM program to determine if it had produced
any cost savings. Variables examined in the study included number of emergency
department visits, hospital admissions, hospital days, and clinic visits.
Four of the reviewed studies concluded that DM services were beneficial. Morisky
et al. (2008) found that participation in the DM program was associated with increased
health behaviors conducive to better health outcomes such as a reduced rate of smoking
and adherence to medical regimes for hypertension and diabetes patients. Coberly et al.
(2007) found a positive relationship between the frequency of telephone contact and
increased Ale and cholesterol testing among diabetes DM patients. Mangione et al. (2006)
determined that diabetes DM strategies were associated with better diabetes care, while
Krein and Klamerus (2000) concluded that diabetes patients were more likely to receive
Ale and eye exams after participating in the program. However, Fireman et al. (2004)
reported that their analysis did not reveal any evidence of cost savings. Thus, they
concluded that the rationale for DM programs should rest on effectiveness and value rather
than the potential to reduce costs.
Despite these findings, however, the five studies also had limitations. For example,
Morisky et al. (2008) used data that was subject to social desirability bias because it was
collected through self-reported behavioral assessments. Coberley et al. (2007) reported
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that they used metrics that were less comprehensive than those recommended by national
guidelines for evaluating health outcomes. Moreover, they relied upon administrative
claims data as opposed to medical records (which are preferred) for measuring clinical
testing outcomes. Thus, their findings may be distorted. Mangione et al. (2006) reported
that their statistical analysis was not sensitive enough to detect modest associations, which
may have prevented them from detecting treatment effects on all outcome variables.
Krein and Klamerus (2000) indicated that their study was unable to determine how
much of the increase in the recommended level of diabetes care received by patients was
attributable to the program and not to other factors. They further reported that their study
was plagued by missing data. Finally, Fireman et al. (2004) reported that their findings
may be biased because they did not have access to a control group composed of similar
chronic disease patients which was needed in order to make meaningful comparisons.
They also indicated that they lacked data on their subjects' functional status and work
productivity, which would have allowed them to determine if these factors had improved
over time while the subjects were enrolled in the DM program.
Conclusions
The primary purpose of this section was twofold: 1) to identify some of the
designs, statistical procedures, and variables that researchers have used to evaluate DM
programs, and 2) to determine if any researchers have employed IV or similar regression
procedures to evaluate these programs. By addressing these purposes, additional
justification for the analytical procedures that were employed in the present study can be
obtained.

57
This review found that various experimental, quasi-experimental, and nonexperimental designs were employed for the evaluations, and that most of the statistical
procedures used came from the GLM. The review also revealed that some researchers
have used the propensity score method to control for selection bias when evaluating DM
programs. In addition, the review revealed that while many studies use clinical outcome
measures, such as Ale and cholesterol testing rates, a number also use cost and utilization
measures, such as hospital emergency department visits, as outcome variables. Finally, the
review found that no evaluations were performed using IV regression, which is not
surprising because this procedure has only obtained limited popularity among health
services researchers (Newhouse, 2005). However, IV regression, which will be discussed
further in the next section, is an appropriate procedure to use when analyzing data
influenced by selection bias (Basu, Heckman, Navarro-Lozano, & Urzua, 2007).
While the primary justification for the analytical procedures that were used in this
study come from Linden and Adams (2006), the reviewed articles provide additional
justification for the study's design, statistical procedures, and outcome variables. In
particular, the analysis was performed using a quasi-experimental design with treatment
and control groups (e.g. Afifi et al., 2007), and program effects were estimated using the
propensity score method and OLS and IV regression (e.g., Landon et al., 2007 and Afifi et
al., 2007) to control for selection bias due to observed and unobserved confounders. The
outcome variables were total diabetes costs, hospital emergency department visits, and
hospitalizations for a 12-month time period (Berg & Wadhwa, 2007, Christakis, et al.,
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2004, and Villagra & Ahmed, 2004). The reviewed articles provide the justification for the
study's design, statistical procedures, and outcome variables.
Statistical Models for Program Evaluation
The present study examined two methods that could be used to evaluate the effects
of participation in a disease management program for Medicaid diabetes recipients.
Because the analysis data came from administrative claims, this study was conducted as an
observational (or quasi-experimental) study. According to Rosenbaum (1995), an
observational study is an empirical investigation that seeks to derive cause-and-effect
relationships under situations where controlled experimentation is not feasible.
Observational studies focus on treatments, interventions, and public policies and their
associated effects. Non-experimental studies that lack these characteristics are not
considered observational (Rosenbaum, 1995).
In experiments, researchers randomly assign subjects to treatments. Subjects who
receive the treatment form the experimental (i.e., program, intervention, or treatment)
group, while subjects who do not receive the treatment form the control group.
Randomization ensures that the treatment and control subjects are comparable. However,
researchers conducting observational studies cannot control subject assignments. Because
researchers lack this ability, systematic differences (i.e., selection bias) may exist among
the study subjects (McMillan & Schumacher, 2006). Comparing outcomes across subjects
in an observational study may subsequently confound the effects of the treatment with the
effects of the subjects' preexisting differences. More specifically, the estimated treatment
effect may be biased. Ordinary least squares (OLS) and instrumental variables (IV)
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regression are two generalized linear modeling procedures that can be used in
observational studies to derive unbiased treatment effect estimates (Haro, Kontodimas,
Negrin, Ratcliffe, Suarez, & Windmeijer, 2006). Additional information on these
procedures is provided in the following subsections.
Ordinary Least Squares Regression
OLS regression is a widely recognized statistical methodology that involves
relating a quantitative outcome variable to one or more quantitative and/or qualitative
predictor variables. The end result is a mathematical model that predicts the outcome
variable for the given set of predictors (Mendenhall & Sinich, 2003). Equation 1 depicts a
bivariate (or simple) regression model.
[1]

Y; = a+�X;+ u;

In this equation, Y is the outcome variable (annual diabetes costs), Xis the predictor
variable (high intensity open DM program participation coded as 1 = participant and O =
non-participant), i refers to the ith individual (any individual in the study), a is the Y
intercept (or the value of Y when X= 0),� is the slope of the regression line (the change in
Y when Xincreases by one, or in causal terms, the effect ofXon Y), and u is the
disturbance or error term. This term is assumed to have a mean of zero and to be randomly
distributed across study subjects (Mohr, 1995). In a regression model, only one a is
calculated; however, a� (parameter estimate or coefficient) is calculated for each predictor
variable that is included.
When a simple regression analysis is used to model the effects of a treatment (or
program), the two regression parameters- a and� - have special meanings. For a
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treatment variable with only two categories, the regression line (P) will always pass
through the mean ofY for each category of the predictor. If the treatment variable equals
zero, then a represents the mean outcome value for the control group. If the treatment
variable equals one, then a+ PX; represents the mean outcome variable for the treatment
group. Because pdenotes the causal effect of the treatment variable, X, on Y, pis the
treatment effect (subject to selection and other internal validity threats). The discovery of
pis the purpose of a summative program evaluation study. Moreover, because pis defined
as the change in Y when it's associated X variable increases by one, pis the mean value of
the outcome variable for the treatment group minus the mean value of the outcome variable
for the control group (Mohr, 1995). An example of a bivariate regression is presented
below in Figure 1.
The bivariate regression model can be extended by including additional predictors
(or covariates). When additional variables are included, the procedure is known as
multiple regression, which is illustrated in Equation 2.
[2]

Y; =a+ P 1 Xli + P2X2; + ... + PnXn; + U;

This equation shows that two or more predictors (up to the nth predictor) can be added to
the model. In a multiple regression model, the ps are interpreted differently than in a
bivariate model. For instance, P 1 represents the mean change in Y for every one-unit
increase in its associated X variable, when holding fixed all other predictors in the model.
The remaining Ps and their respective variables are interpreted similarly (Mendenhall &
Sincich, 2003). As another example, consider a model that includes two predictors:
treatment program (coded as 1 = participant and O = non-participant) and age. Then P 1

61
Figure 1: Bivariate Regression
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(and its respective treatment variable) answers the question, What is the difference in Y
(e.g., diabetes costs) for subjects in the different study groups who are the same age?
Specifically, it allows for the determination of the treatment effect given the age of the
subjects (Mohr, 1995).
Statistical significance tests are performed on the parameter estimates (�s) in the
regression model to test whether the estimates differ from zero. If the tests are significant,
then it can be assumed that the estimates differ from zero, which indicates that the
observed relationship between the predictor and outcome variable is probably not due to
chance. A statistically significant test for the treatment variable's parameter estimate
would indicate that the treatment had a significant effect on the outcome variable.
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The primary function of including additional variables in multiple regression is to
reduce the influence of imperfect randomization or even the lack of randomization. If
subjects are not randomized, then the researcher must be concerned about important
differences that may exist between the treatment and control group subjects, which could
explain the observed results (Mohr, 1995). Addressing selection bias through OLS
regression works if the researcher can account for all preexisting group differences that are
related to the outcome variable. This is difficult to accomplish because program
participants often differ in a variety of observable and unobservable ways from non
participants (Weiss, 1998). If the researcher is aware of preexisting differences (and can
measure them), then they can be controlled by including them as covariates in the
regression analysis. However, if the researcher is unaware of the preexisting differences
(or is unable to measure them) then they will not be controlled, which may lead to
confounding in the data (Wunsch, Linde-Zwirble, & Angus, 2006).
In regression, observable and unobservable factors that affect the outcome variable
but are not included in the model represent the error term in the relationship (Wooldridge,
2006). In observational studies, the error term can include factors such as preexisting
differences between the treatment and control groups. Selection bias occurs when these
differences (if correlated with one or more of the predictors and the outcome) are not
statistically controlled (Salkever, Slade, Karakus, Palmer, & Russo, 2004). In other words,
selection bias occurs when at least one of the predictors is correlated with the error term
(Ettner, 2004). One assumption of multiple regression is that the error term has an
expected (or mean) value of zero given any of the values of the other predictors in the
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model. Failing to include important variables that are related to the predictors causes this
assumption to fail, thus producing biased regression results (Wooldridge, 2006).
OLS regression can be used to estimate treatment effects in observational studies if
overt selection bias is controlled (Haro, et. al., 2006). However, OLS regression cannot
effectively address hidden selection bias. When hidden selection bias is a concern,
researchers typically use other methods to estimate treatment effects such as IV regression
(Winship & Morgan, 1999).
Instrumental Variables Regression and Selection Bias
A structural equation modeling technique known as instrumental variables (IV)
regression was developed by econometricians in the 1920s to address instances in which
the OLS predictor(s) are correlated with the error term (Linden & Adams, 2006;
Newhouse, 2005). IV regression was first used to estimate supply and demand curves, but
has since been applied to issues involving measurement error and omitted variables bias
(Schneider et al., 2007). In fact, IV regression is widely used to control for selection bias
in observational studies (Basu et al., 2007). The popularity of IV regression in
observational studies stems from its ability to estimate unbiased relationships between
outcome variables and predictors by purging the predictors of the portion of their variance
that is not independent of the error term.
In regression, a predictor variable that is correlated with the error term is known as
an endogenous variable (Winship & Morgan, 1999). In a program evaluation context
where hidden selection bias may be suspected (e.g., a situation where subjects self-selected
into the program or were otherwise assigned nonrandornly), a good IV would be a variable
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that is associated with the treatment variable, but is uncorrelated with the omitted variables
and has no association with the outcome, except through the treatment variable. Because
the IV is related to the treatment variable, but is uncorrelated with other predictors of the
outcome variable, the causal effect of the instrument on the outcome is therefore
proportional to the causal effect of the treatment on the outcome (Schneider et al., 2007).
Based on this information, an IV must satisfy two assumptions: 1) it is independent
of the error term in the regression model, and 2) it affects the problematic predictor
variable (i.e., the treatment variable that is influenced by selection bias), but not the
outcome. If the first assumption fails (that is, if the IV actually affects the outcome
directly or if there are no observed variables that do not affect the outcome directly), then
the results of the IV regression will be biased and the effect of the treatment will be
unidentified. If the second assumption fails (that is, if the IV's variation does not produce
much variation in the treatment variable), then the random error term may mask the effect
of the treatment variable. If this occurs, then IV regression will produce results similar to
OLS regression. Thus, these two assumptions must be satisfied in order for IV regression
to produce useful results (Newhouse & McCellan, 1998). Essentially, an IV is a variable
(or set of variables) (Z) that is correlated with the program variable (X), but not related to
unobserved confounding variables of the outcome variable (Y). 12 Thus, the IV can only
impact the outcome variable through the program intervention. This relationship is
graphically depicted in Figure 2.
12 More than one variable can be used as an instrumental variable (IV). When this occurs, the IV can be
referred to as the set of instruments.
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Figure 2: Instrumental Variable Estimation
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IV regression is performed using a structural (or simultaneous) equation modeling
process known as two-stage least squares (2SLS) regression (Linden & Adams, 2006). In
the first stage, the instrument (or set ofinstruments) and any covariates are used to predict
the endogenous variable in a regression equation. In the second stage, the outcome
variable is regressed on the fitted values from the first stage regression plus any covariates.
Ifthe IV is uncorrelated with the omitted variables, the predicted value ofthe outcome is
also uncorrelated with the omitted variables. Thus, the bias in estimating the outcome
variable from the exclusion ofthe variables that account for preexisting differences from
the model is eliminated (Schneider et al., 2007).
2SLS regression is formally presented in equations 3 and 4.
[3]

X-hat = a0 + a1Z; + v;

[4]

Y = �o + �1X-hat; + l::i

In equation 3, Z represents the instrument (or set ofinstruments) that is used to
estimate X- hat, which is the predicted value ofX. This value is then used in equation 4
instead ofthe actual X variable. It is assumed that Z is a significant predictor ofwho is
likely to participant in the program (X- hat). Ifthe actual treatment variable was used
(indicating ifthe subjects actually participated), the result would be confounded due to
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selection bias. Using X - hat given Z allows for an unbiased estimate of the program's
impact on an outcome because Z predicts X in equation 3, but remains independent of the
X - Y relationship. In the second stage, IV regression essentially becomes OLS regression
and its results are interpreted in a similar manner. It is important to note that IV regression
must be performed using 2SLS. Using OLS twice to estimate each stage results in
incorrect estimations of the model residual sum of squares and standard errors (Linden &
Adams, 2006).
Generally, researchers estimate both OLS and IV regression models and compare
them using a Hausman specification test to determine whether significant differences exist
between the models (Ender, n.d., Greene, 2003, Hadley et al., 2003; Baum, 2006). If
significant differences do exist, then the IV model is normally accepted because the OLS
estimates are presumed to be biased. If the test is not significant, then the OLS results are
accepted because this procedure produces more efficient parameter estimates than IV
regression. This is due to the fact that IV estimates always have larger variances than the
OLS estimates. In fact, sometimes researchers may even prefer the biased OLS estimates
if they have smaller mean squared errors compared to the IV estimates (Winship &
Morgan, 1999). In other words, IV regression does not always offer a good solution to
selection bias issues in observational studies.
A number of articles using IV regression to control for selection bias were
identified in the literature review. Six of these articles are reviewed in this subsection in
order to provide insights into how these researchers applied IV regression. The researchers
used a variety of instrumental variables to control for selection bias, some of which were
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based on geographic location. This observation suggests that some research may support
Linden and Adams' (2006) decision to use three-digit zip codes, which represent large
geographic areas, as instruments. In addition, some of the researchers indicated that IV
regression is more suitable for addressing policy questions about the average treatment
effects of health interventions than clinical questions about the possible effects that certain
interventions may have on specific patients. Finally, some of the researchers found that IV
regression offered a suitable solution to selection bias, while others did not. This may be
due to the fact that finding variables that meet the two IV assumptions can be challenging.
The article by McCellan, McNeil, and Newhouse (1994) was probably the first
health services study to use IV regression (McClellan & Newhouse, 2000). The authors
used differential distances, a geographic location variable, as an instrument to account for
selection bias in an observational study examining the effect of cardiac catheterization on
mortality among Medicare patients with acute myocardial infarction (AMI). Specifically,
they sought to determine if more intensive treatment of AMI in elderly patients reduced
mortality. The researchers hypothesized that patient location independently affected
choice of hospitals for AMI procedures. The instrument represented whether or not the
patients' nearest hospital was a catheterization hospital. It was calculated by subtracting
the distance between each patient's zip code and the zip code of the hospital where they
received treatment. The outcome variables examined included mortality within one day,
mortality within seven days, and mortality within 30 days. They found that treatment at
high volume AMI hospitals yielded survival benefits for elderly patients (McClellan et al.,
1994).

Landrum and Ayanian (2001), Stukel, Fisher, Wennberg, Alter, Gottlieb, and
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Vermeulen (2007), and Basu et al. (2007) also employed geographic location variables as
instruments in IV regressions. Landrum and Ayanian (2001) used the density of
cardiologists in a patient's county ofresidence as an instrument to estimate the effect of
ambulatory specialty care on mortality following myocardial infarction, while Stukel et al.
(2007) used regional cardiac catheterization rate as an instrument to estimate the effect of
invasive cardiac management on acute myocardial infraction (AMI) survival. Basu et al.
(2007) used a regional dummy variable to represent variations in physician practice
patterns and a continuous variable that represented Medicare physician fee differentials at
the three-digit zip code level to estimate the effect on five-year medical costs ofbreast
conserving surgery with radiation therapy compared to mastectomy in patients with breast
cancer.
Based on their analysis, Landrum and Ayanian (2001) reported that simple and
multiple IV regressions indicated that cardiology care was associated with 9.5 and 1.0
percent reductions in mortality rates, respectively. Stukel et al. (2007) reported that their
IV analysis showed that cardiac catheterization was associated with a 16 percent reduction
in mortality, while Basu et al. (2007) reported that breast-conserving surgery with radiation
therapy was associated with an average cost of$41,493. Landrum and Ayanian (2001) and
Stukel et al. (2007) both reported that IV regression appeared suitable for answering policy
questions about the effects ofhealth system factors on patient health outcomes rather than
clinical questions concerning the effect ofa particular medical procedure on specific
patients. In addition, Basu et al. (2007) indicated that IV regression estimates were

suitable for answering "economic" questions about the average or marginal treatment
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effects of certain interventions.
Long, Coughlin, and King (2005) also used IV regression to address a policy
question while controlling for selection bias in a study that estimated the effects of
Medicaid on access and use of health care services by low-income mothers relative to
private insurance coverage or no insurance coverage. The authors replaced subjects' actual
insurance status with a predicted insurance status using four instruments: accessibility of
private insurance, availability of public coverage, and family and community attitudes
toward public assistance. They performed the analysis by estimating both OLS and IV
models. The Hausman test was used to determine whether there was a significant
difference between the models. They also found that IV regression produced better results
than OLS regression due to selection bias. Thus, they concluded that the Medicaid
program improved access to care for low-income mothers.
Hadley et. al. (2003) had a slightly different experience with OLS and IV
regression. They used these procedures to estimate the outcomes of three treatments for
early stage breast cancer in elderly women. Medicare fees, woman's place of residence,
and geographic areas were used as instruments. The Hausman test was used to determine
if significant differences existed between the OLS and IV models. Hadley et al. (2003)
found that the OLS regression results were not significantly different from the IV results.
They found that the OLS estimates were preferable to the IV estimates because the latter
were substantially larger and more unstable. Hadley et al. (2003) concluded that whether
one accepts OLS or IV regression results should depend on three factors: 1) the extent to
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which observable information can be used as controls in OLS regression, 2) the results of
statistical tests ofthe validity ofthe IV method, and 3) the similarity ofthe OLS and IV
results.
Posner et al. (2002) used the propensity score method and logistic and IV
regression to determine the effectiveness of screening in the identification ofearly stage
breast cancer in elderly women. They also used a geographic location variable, the region
in which the women lived, as the instrument. Posner et al. found that all three methods
produced similar results, which they argued helped strengthen the credibility ofthe logistic
regression model. They recommended that researchers performing observational studies
consider the sources ofbias that may affect their results and use the propensity score
method to address overt selection bias and IV regression to control for hidden bias.
Finally, Malkin, Broder, and Keeler (2000) used IV regression to determine the
effect ofpostpartum length ofstay on new born readmissions. They used hour ofdelivery
and method ofdelivery as instrumental variables and compared their analysis against
standard statistical methods (which was probably OLS regression although they did not
specifically state that). Their analysis found that IV regression might provide a better
indication ofthe effects oflength ofstay on new born readmissions due to selection bias
because standard statistical methods appeared to underestimate the effects. They
concluded that lengthening postpartum hospital stays reduces readmissions.
The above information suggests that IV regression can offer a viable means of
addressing both policy questions about the average effects of health care interventions and
hidden selection bias when performing observational studies. The information further
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suggests that using geographic location variables as instruments can induce variation in an
endogenous explanatory variable. However, finding suitable IVs that comply with the
required assumptions may be challenging. In addition, the information suggests that OLS
can sometimes provide better estimates of the effects of a particular treatment or program
than IV regression. This may stem from the fact that finding a suitable instrument can be
difficult.
Summary

This chapter provided a review of the literature on disease management, self
management education and self-efficacy theory, diabetes disease management evaluations,
and OLS and IV regression. The intent was to provide a foundation for understanding the
analytical design and methods that were used in the study. The review found that disease
management has become very popular since the early 1990s, in part, due to efforts to both
control costs and improve the quality of medical care that chronically ill individuals
receive. Moreover, it found that disease management appears to be well suited for state
Medicaid agencies because these programs serve a population that is more susceptible to
chronic ailments than the general U.S. population.
The literature review further found that a variety of research designs, statistical
methods, and outcome variables have been employed to evaluate the effectiveness of
diabetes DM programs and services. While the primary justification for the study's
analytical design comes from Linden and Adams (2006), the reviewed articles provide
further justification for the study's design which was quasi-experimental and employed
regression procedures to evaluate the effectiveness of diabetes DM services on three

72
outcome variables. Of particular importance is the fact that no evaluations were identified
that used IV regression, which was the focus of this study. IV regression is a widely used
econometric procedure, but has received limited attention by the health services research
community (Newhouse & McCellan, 1998). This may be due to the fact that IV regression
has only recently been used by health services researchers. In fact, the first health services
study that employed IV regression was only conducted in 1994 (McCellan & Newhouse,
2000). Finally, the literature review considered some of the technicalities involved with
performing OLS and IV regression and how some health services researchers have
employed these procedures. Of particular importance here is the fact that IV regression
does not always provide a suitable solution to selection bias issues that are encountered in
observational studies.
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Definitions of Important Terms

Definitions for important terms used in the present study are provided below.
Administrative Claims Data: Medicaid claims data created for payment purposes rather

than for research purposes. Claims data represent electronic versions of bills submitted by
Medicaid providers (i.e., physicians, hospitals, pharmacies, etc.) for recipient office visits,
hospital stays, pharmacy purchases, laboratory tests, or other encounters. Administrative
claims data contain information on items such as: 1) the date and location of services, 2)
type and cost of services, 3) procedures performed, 4) extent of services (i.e., hospital
stays), and 5) recipient demographics (Piecoro, Wang, Dixon, & Crovo, 1999; Wyant &
Parente, n.d.).
Diabetes: Diabetes is a chronic disease that occurs when an individual is unable to

produce or use insulin, which is a hormone needed to convert sugar, starches, and other
food products into energy (HMC, 2007).
Disease Management (DM): DM is a system of coordinated health care interventions and

communications for populations with chronic disease (i.e., illnesses or conditions lasting
more than three months in duration) that can be mostly controlled through patient self-care
activities (Linden & Adams, 2006).
Disturbance (or Error) Term: The variable in an OLS regression model that contains

unobserved factors affecting the outcome variable. The error term may also include
measurement errors in the outcome or predictor variables (Wooldridge, 2006).
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Endogenous Explanatory Variable: In OLS regression, an independent variable that is
correlated with the disturbance term due to measurement error, omitted variables, or
simultaneity (Wooldridge, 2006).
Estimate: The numerical value of an estimator derived from data on subjects in a specific
sample (Stock & Watson, 2007).
Estimator: A procedure for using sample data to estimate the value of a population
parameter. Ideally, researchers prefer estimators that get as close as possible to the
unknown true value of the population parameter (Stock & Watson, 2007).
Exogenous Variable: Any variable in an OLS regression model that is uncorrelated with
the disturbance term (Wooldridge, 2006).
High Intensity On Demand: Virginia Medicaid recipients who were contacted by HMC
and declined to received the high intensity intervention, lost contact with HMC, or were
never contacted by HMC. These individuals receive educational mailings (HMC, 2007).
High Intensity Open: Virginia Medicaid recipients who agree to receive the high
intensity intervention. These individuals receive regular follow-up calls, individualized
care plans, 24-hour access to program nurses, and quarterly condition-specific information
(HMC, 2007).
Instrumental Variables (IV) Regression: An IV regression model is a linear equation
that is used when one or more instrumental variables are available for the endogenous
predictor (Wooldridge, 2006). IV regression is usually performed using two-stage least
squares regression.
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Instrumental Variable (IV): In a regression model containing an endogenous
independent (or predictor) variable, the IV is a variable (or set of variables) that is not
contained in the model, is uncorrelated with the model's disturbance term, and is partially
correlated with the endogenous predictor (Wooldridge, 2006).
Observational Study: A study in which variables are observed instead of manipulated
and subjects are not randomly assigned to treatment conditions (i.e., a quasi-experimental
study) (Shadish et al., 2002).
Ordinary Least Squares (OLS) Regression: OLS regression is a statistical methodology
that relates a quantitative outcome (or dependent) variable to one or more quantitative
and/or qualitative independent (or predictor) variables. OLS estimates parameter
coefficients for the predictors by minimizing the sum of squared residuals. The end result
is a mathematical model that predicts the outcome variable for the given set of predictors
(Mendenhall & Sinich, 2003; Wooldridge, 2006).
Propensity Score: The propensity score is the probability that an individual will be
assigned to the treatment group instead of the control group based on a set of observed
variables Z;. The propensity score is formally defined as P(Z;) = Prob(T = 1 IZi) (Winship
& Morgan, 1999).
Selection Bias: Nonrandom assignment to treatment conditions that result in subject
characteristics between conditions that may be related to differences in outcome (Shadish
et al., 2002).
Standard Intensity: Virginia Medicaid members who are considered at standard risk for
future health care expenses and are able to manage their conditions with limited external

76
support. They receive mail-in assessments, educational materials, quarterly diseasespecific information, and 24-hour access to program nurses (HMC, 2007).
Two-Stage Least Squares Regression: An IV regression procedure, where the IV for an
endogenous explanatory variable is obtained by regressing the endogenous variable on all
exogenous variables (Wooldridge, 2006).
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Chapter 3
Methodology

The purpose of this study was to compare and contrast ordinary least squares (OLS)
regression and instrumental variables (IV) regression using a three-digit zip code
instrument procedure developed by Linden and Adams (2006). OLS and IV regression are
two statistical methods that can be used to estimate treatment effects in observational (or
quasi-experimental) studies. OLS regression is used in observational research to assess the
relationship between a treatment variable and an outcome, while adjusting for important
explanatory variables to ensure comparability between the treatment and control groups
(Newgard, Hedges, Arthur, & Mullins, 2004). However, OLS regression may fail to
produce consistent effect estimates if certain important variables that are correlated with
the treatment are excluded from the analysis (Foster & McLanahan, 1996; Guo, Barth, &
Gibbons, 2006). This often occurs in observational studies because individuals who
participate in treatments (or programs) usually differ systematically from those who do not.
IV regression, which approximates a pseudo-randomization, can ameliorate this by
inducing variation in the treatment variable, but not in the outcome (Newhouse &
McClellan, 1998; Scheider et al., 2007). To implement IV regression, researchers have to
find one or more variables (called instruments) that produce this variation. Unfortunately,
finding suitable variables that meet this criterion can be very challenging (McClellan &
Newhouse, 2000). This study specifically examined the feasibility of using patient three
digit zip codes as instruments in an IV regression analysis to evaluate the effects of
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participation in the Virginia Healthy ReturnlM DM program. 13 Linden and Adams (2006)
argue that patient three-digit zip codes can function as instruments by inducing variation in
the treatment variable (i.e., the DM program participation variable). Thus, they reason that
zip code instruments can offer a means of providing an unbiased estimate ofDM causal
effects on certain outcome variables.
This chapter reviews the methodology that was employed during the present study.
Additional information on the study design, database, population, variables, and statistical
procedures is provided in the sections below.
Study Design and Research Questions

Researchers seek to make causal inferences when evaluating social and medical
interventions. Causality is strongest when researchers conduct controlled randomized
experiments where subjects are randomly assigned to the study groups. Randomization
balances the groups in terms of all relevant factors other than treatment exposure. It is
because of randomization that causation can be inferred from experimental studies.
However, experimental studies are usually difficult to implement for a variety of financial,
ethical, and practical reasons. When experimental studies are not feasible, social scientists
normally turn to observational research designs (Freedman, 2005).
Because Medicaid recipients self-select into the high intensity open treatment
option of the Virginia Healthy Returns5M Program, this study was conducted as an
observational study (Freedman, 2006). A key characteristic of an observational study is
13 The study did not attempt to determine the feasibility of IV regression in general. Instead, it sought to
determine the appropriateness of a particular instrumental variables procedure that was proposed for
evaluating DM programs.
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that subjects are assigned nonrandomly to the treatment and control groups. The
investigators simply observe what occurs during the study because they are unable to
manipulate the treatment. For example, medical studies that examine issues, such as the
effects ofsmoking, are observational because researchers cannot ethically randomize
subjects to the treatment and control groups. A second characteristic ofobservational
studies is that researchers try to estimate the effects ofan intervention by comparing the
treatment group to the control group on an outcome variable (Freedman, 2005). A third
characteristic is that an observational study usually involves the analysis ofdata from a
large administrative database to establish the consequences ofsocial or medical
interventions (Newhouse & McClellan, 1998).
Based on the above information, the present study employed an observational
design because: 1) the high intensity open subjects self-selected into the treatment group,
2) the effects ofthe DM program were estimated by comparing the treatment and control
groups on several outcome variables, and 3) the analysis data came from a large pre
existing administrative database. Because the study by Linden and Adams (2006) used a
one year experience ofa diabetes DM program, the study period for this analysis was from
January 1, 2007 to December 31, 2007. 14 The objective ofthe study was to determine ifan
IV zip code procedure similar to the one developed by Linden and Adams using data from
an Oregon managed care diabetes DM population could generalize to a Virginia Medicaid
diabetes DM population. Three research questions were addressed in the study:

14 The Healthy Return/M Disease Management program officially began in January 2006. Calendar Year
(CY) 2007 was selected because it represents the program's most recent year of operation.
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1. Which statistical method provides the best unbiased estimates of high intensity
open DM program participation on the outcome variables?
2. Do the parameter estimates and confidence intervals for the outcome variables
differ depending upon which statistical method is used?
3. What are the advantages and disadvantages of using OLS and IV regression to
evaluate high intensity open DM program effectiveness?
Database

The study data came from the Virginia Medicaid Management Information System
(VaMMIS), which is a large administrative database that the Virginia Department of
Medical Assistance Services (DMAS) uses to process medical claims submitted by health
care providers for providing services to Virginia Medicaid recipients. In January 2008, the
contractor that administers the DM program for DMAS provided the researcher with a list
of Medicaid recipient identification numbers for 2,741 diabetes recipients who were
enrolled as either high intensity open, high intensity on demand, or standard intensity
patients in the DM program during calendar year (CY) 2007.
The high intensity open participants served as the treatment group and the standard
intensity participants served as the control group. The rationale for using the high intensity
open recipients as the treatment group was that these individuals actively participated in
the DM program, while the standard intensity recipients did not. According to Linden et
al. (2005), this comparison is appropriate when evaluating population-based DM programs
because most (i.e., 95 percent or more) of the eligible recipients will be enrolled, which
limits the number of subjects available for comparison purposes.
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All recipient-level claims and demographic data are stored within VaMMIS as SAS
files. The researcher worked with staff in the DMAS information management division to
develop SAS programs that used the recipient identification numbers to collect claims and
demographic data on each subject. As part of this process, 339 subjects who were not
continuously enrolled in both the Virginia Medicaid program during CY 2006 and 2007
and the Healthy ReturnssM DM program during CY 2007 were deleted from the analysis·
dataset. Recipients who participated in a DM pilot program that operated prior to January
2006 were also deleted. In addition, 775 high intensity on demand recipients were deleted
from the dataset. The purpose of these deletions was to ensure that the treatment and
control groups contained subjects who had equally experienced the study outcomes (i.e.,
hospitalizations, ED visits, and diabetes-related costs) (Linden et al., 2005) and to increase
the chances of detecting treatment effects by reducing potential extraneous variability (i.e.,
background noise) due to the high intensity on demand recipients (Mendenhall & Sincich,
2003). 15 The data were then collapsed to form the study variables. Once the variables
were developed, they were compiled into a dataset for use in the study's analysis stage.
The computer programming needed to assemble the dataset occurred during February
2008.
Population and Sample

For this study, the population of interest was Virginia Medicaid diabetes recipients
who were enrolled continuously in either the high intensity open or standard intensity
15 High intensity on demand recipients can receive high intensity open services, which are not reflected in the
claims data.
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options of the Healthy Return?M program during CY 2007 (N= 1,627) and had not
participated in the DM pilot program. (Continuous enrollment was defined as DM
participation beginning on January 1, 2007 and ending on December 31, 2007.) The unit
of analysis was the individual diabetes DM participant. The treatment group consisted of
the 229 high intensity open participants, while the control group consisted of the 1,398
standard intensity participants. 16
Study Variables

This section consists of two subsections. The first subsection provides information
on the outcome variables, while the second presents information on the independent
variables. Detailed information on both the zip code instruments and propensity score
variables employed by Linden and Adams (2006) is provided in the second section.
Outcome Variables
Three outcome variables were examined in the present study: CY 2007 annual
diabetes costs, hospital emergency department (ED) visits, and hospital days. The
operational definitions of these variables are as follows:
•

annual diabetes costs are costs related to any medical claim submitted to
Virginia Medicaid during CY 2007 for one of the diabetes patients where

16 According to Stevens (2002), studies involving treatment and control groups that consist ofabout 100
subjects each will achieve a power ofat least 0.94. Thus, the probability ofa type II error (or failing to find
significant relationshjps that actually exist) would be 0.06 or less in these studies. Based on this information,
power was not an issue in this study because the treatment and control groups consisted of229 and 1,398
subjects respectively. These large samples made it highly probable that the statistical analyses identified
significant relationships that actually exist in the study population.

diabetes was indicated as a diagnosis using international classification of
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diseases version 9 clinical modification (ICD-9-CM) codes 250.0 to 250.9, 17
•

hospital ED visits are the total number of ED visits made by recipients during
CY 2007 for either emergency or non-emergency related conditions, and

•

hospital days are the total number of days that recipients stayed in hospitals
during CY 2007.

It should be noted that both the hospital ED and hospital days outcome variables
may include data on both diabetes related and non-diabetes related conditions. It should
also be noted that the hospital days variable may overstate the number of days that some
recipients stayed in the hospital due to how the variable was calculated. 18 In addition, all
outcome variables include a substantial number of zeros because many of the DM patients
did not visit EDs, stay in hospitals, or incur diabetes-related medical costs during the study
period. As a result, the zeros in these variables were not considered missing values
because they represented legitimate observations.
The outcome variables were selected for three reasons: 1) Linden and Adams
(2006) used them in their IV analysis, 2) several articles reviewed for this study used
similar outcomes (Berg & Wadhwa, 2007, Christakis, et al., 2004, and Villagra & Ahmed,
2004), and 3) the Virginia Healthy ReturniM DM Program is intended to reduce these
17
According to the National Center for Health Statistics (2007) website, the ICD-9-CM is used to assign
codes to diagnoses related to inpatient, outpatient, and physician office visits in the U.S. Searching for
claims where diabetes is indicated as a diagnosis should eliminate claims that are not associated with
diabetes, such as claims submitted for broken bones or sore throats.
18
The variable was calculated using the "through" and "from" dates on hospital and physician
inpatient/outpatient medical claims. Because there are no admittance or release dates on medical claims, this
variable should probably be viewed as a proxy for the number of days that recipients were hospitalized
during a calendar year.
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outcomes for program participants. While justification exists for using these variables,
several caveats are associated with their use. In particular, Linden (2006) reports that costs
can be problematic due to fluctuations in provider reimbursements, insurance coverage,
and technological innovations, which are beyond the control of most DM programs.
Observed cost changes may thus not be entirely attributable to DM interventions. Linden
(2006) further reports that ED visits and hospitalizations may be low in the target
population prior to program implementation. If this occurs, then statistical analyses may
not detect any significant program effects on these two outcomes. These caveats should be
considered when interpreting the study's analytical results.
Independent Variables
Five independent (or predictor) variables were used in the study: actual program
participation, predicted program participation, propensity scores, age, and gender. The
program participation variable was a dichotomous variable coded as 1 = high intensity
open participant and O = standard intensity participant. Following guidance from Linden
and Adams (2006), predicted program participation represented the probability of a given
individual enrolling in the Virginia Healthy ReturniM DM Program. This variable was
calculated using recipient zip codes. The actual program participation variable was used in
the OLS regression models for comparison purposes. This variable was presumed to be
influenced by selection bias due to preexisting differences between the treatment and
control subjects (Wooldridge, 2006). 19
19 In structural equation modeling terms, predictor variables that are correlated with the error term are known

as endogenous variables, while variables that are independent of the error term are referred to as exogenous
(Freedman, 2006).
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To perform IV regression, a researcher should select one or more instruments that
are related to the endogenous predictor, but are not related to the outcome variable (Foster
& McLanahan, 1996). For DM evaluations, this means that a variable must be identified
that is predictive of a recipient's DM enrollment status, but is not associated with any of
the unobserved covariates that influence the outcome variables. Linden and Adams (2006)
argue that recipient three-digit zip codes make good instruments for two reasons: 1) a ·
recipient who lives in a DM covered service area would be eligible for enrollment, but not
necessarily enroll, and 2) living in a particular zip code may be independent of specific
unobserved confounding variables.
Zip codes (i.e., zone improvement plans) are five-digit numbers that identify
specific geographic mail delivery systems. Five-digit zip codes are assigned to every
address in the United States. The first digit designates a general area of the country. For
example "2" designates the District of Columbia, Maryland, North Carolina, South
Carolina, Virginia, and West Virginia. The second and third digits refer to a US Postal
Service sectional center facility (SCF). Each SCF functions as a distribution and
processing center for approximately 40 to 150 surrounding post offices that are located
within the facility's designated geographic area. The fourth and fifth digits designate one
of the surrounding post offices. Zip codes are composed of clusters of addresses identified
for mail delivery purposes. Urban and suburban zip codes are usually comprised of
approximately located streets, while rural zip codes are comprised of selected roads or
delivery routes (www.carrierroutes.com/ZIPCodes .html).

For this study, the instrumental variables were generated using the procedure
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developed by Linden and Adams (2006). The process began by identifying the number of
unique five-digit zip codes for the study subjects. The zip codes were then collapsed based
on the first three digits in order to produce new zip codes that represent larger contiguous
geographical areas (e.g., each three-digit zip code represents a larger geographic area than
each five-digit zip code). These zip codes were further examined to identify categories·
with less than nine frequency counts, which were collapsed into a category called "other"
(Linden & Adams, 2006).
Linden and Adams (2006) argue that this zip code model mimics a "natural
experiment" by assuming two types of zip codes: Zip Code-1, which represents high
program participation, and Zip Code-2, which represents low program participation.20
Linden and Adams argue that this "experiment" models how the differences in outcomes
between these two zip codes are related to the differences in DM program participation
rates. Because three-digit zip codes represent larger geographic areas than five-digit zip
codes, they also argue that these larger areas may make participants and non-participants
more similar on unmeasured confounders, which they indicate is true for measured
demographic variables. They further argue that within a given three-digit zip code, the
correlation between program participation and unmeasured confounders may be smaller
than the correlation between zip codes. Thus, they reason that zip codes should have an

20 Natural experiments refer to exogenous events that change subjects' environments (Wooldridge, 2006).
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indirect effect on the outcome variables that is interceded only by DM program
. .
·
21 22
part1c1patlon.

Once the three-digit zip code categories were developed, logistic regression was
used to estimate the probability of a given individual enrolling in the high intensity DM
program using the participants' actual program participation status as the dependent
variable (1 = high intensity open participant and O = standard intensity participant) and k-1
dummy variables to represent the three-digit zip code categories. (Categorical variables
are always modeled as dummy variables with one less than the actual number of levels to
prevent situations of perfect multicollinearity from occurring.) Additional covariates
included in the logistic regression model were age, gender, and propensity scores, which
were considered to be exogenous variables in this study. The estimated probability of
program participation was used as the endogenous variable in the IV regression models
and the zip code dummy variables were used as instruments (Linden & Adams, 2006;
Linden, personal cornrnunication, June 16, 2008).
The feasibility of the logistic regression model was assessed using the likelihood
ratio chi-square, c-statistic, Somer's D, and Gamma statistics. Descriptive statistics were
also used to compare the characteristics of the treatment and control groups for the actual
and predicted program participation variables to determine if significant differences existed
Linden and Adams (2006) did not offer any empirical evidence to support their zip code model nor did
they elaborate on how the differences in outcomes are related to differences in program participation.
22
The US Census Bureau collects socio-economic data at the five- and three-digit zip code levels. While
these data could potentially be analyzed to determine whether significant observable differences exist
between the individuals who reside in the three-digit zip codes used in the present study, such an analysis
was not performed because it was outside the study's scope. However, these data could be used in a future
study examining the feasibility of three-digit zip code instruments.
21

88
between the groups (Peng, Lee, & Ingersoll, 2002; Mendenhall & Sincich, 2003; Linden &
Adams, 2006). In addition, simple regressions were performed to determine ifthe
predicted probability of program participation and the actual program participation
variables were related to the zip code instruments (Wooldridge, 2006). As part ofthis
process, a sensitivity analysis was performed. The analysis consisted ofregressing the
upper and lower 95% confidence limits for the predicted probability ofprogram
participation on the zip code instruments to determine ifthe relationship between the
probability of program participation and zip codes was sensitive to the specific form ofthis
variable.
Linden and Adams (2006) include a propensity score as an explanatory variable in
their OLS and IV regression models.23 The propensity score is the conditional probability
ofassignment to a particular treatment given a vector ofobserved variables (Rosenbaum &
Rubin, 1983). The propensity score (PS), which is calculated using logistic regression, is
defined as: PS = Pr{ t = 11.x}, where t denotes whether a subject received the treatment and
Pr{ t = 1 Ix} is the probability ofreceiving the treatment given the observed covariates, x.
Propensity scores allow researchers to estimate program causal effects by directly
comparing treatment and control subjects on various outcomes. For this reason,
researchers can relax the typical assumptions ofregression (linearity, multicollinarity,
parsimony, etc.) when calculating propensity scores (Love, 2004; Frank, Sykes,
Anagnostopoulos, Cannata, Chard, Krause, & McCrory, 2008).

23 Linden and Adams (2006) referred to the propensity score as a risk score in their article. Linden (personal
communication, October 19, 2007) indicated that the risk score was actually a propensity score.
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By collapsing the observed covariates into one score, the propensity score
represents the probability that a particular subject would have received the treatment over
another subject based on a larger collection ofcovariates. As such, the propensity score
functions as a balancing score. In observational studies where subjects are nomandomly
assigned to the treatment and control groups, systematic differences are assumed to exist
that can bias treatment effect estimates. Researchers use propensity scores to reduce overt
bias by integrating this mechanism into the analysis in order to improve study group
comparability. This process can be viewed as a means ofreducing bias to obtain better
program effect estimates through a quasi-randomization of the study groups (Newgard et
al., 2004).
Propensity scores are generally employed using one or more ofthe following
methods: 1) regression - where the propensity scores are added to the model as a
covariate, 2) stratification - where the sample is divided into quintiles based on propensity
scores to allow for the assessment oftreatment effects within stratums, and 3) matching where treatment and control subjects are matched based on similar propensity scores to
allow for less biased estimates ofprogram treatment effects (D' Agostino, 1998; Newgard
et al., 2004). Weighting, which is rarely used in medical research, is another method of
employing propensity scores (Austin, 2008; Frank et al., 2008). In this scenario, weights
such as 1/PS and 1/(1 - PS) for the treatment and control subjects are created as a means
for better estimating average program causal effects (Gelman & Hill, 2007). (The use of
propensity score weighting is further explored in Appendix A.)

In their article, Linden and Adams (2006) did not specify which propensity score
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method they used; however, Linden (personal communication, October 19, 2007) reported
that matching was employed. While matching is the preferred method of using propensity
scores, it eliminates subjects from the analysis who cannot be matched, which can result in
the loss of considerable data (Frank et al., 2008). It also requires the development of
sophisticated matching algorithms and computer programs that are capable of matching
pairs (or groups) of subjects and then either removing them from the pool of all available
subjects or keeping them in for additional matching (Shadish et al., 2002; Morgan &
Winship, 2007). For these reasons, the propensity score was simply used as a regression
covariate in the study. The benefit of this approach is that the propensity score serves as an
explanatory variable that controls for observable background characteristics in the
regression analysis, while maintaining the integrity of the study sample (Wooldridge,
2002; Frank et al., 2008).
Linden and Adams (2006) estimated their propensity score regression model by
using actual program participation status as the dependent variable and 150 clinical,
financial, demographic, and utilization variables. Such an endeavor was not feasible for
this study because the data came from a large preexisting database that contains thousands
of raw data elements. Converting these elements into meaningful variables would require
substantial computer programming efforts. Because variable selection for propensity score
calculations is ad hoc (Brookhart, 2006; Sturmer, Joshi, Glynn, Avorn, Rothman, &
Schneeweiss, 2006), the propensity scores were calculated using several variables selected
because of their availability. These variables included CY 2006 diabetes-related costs, CY
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2006 health care utilizations, age, gender, race, region of residence, country of origin, and
citizenship status. The appropriateness of the propensity scores was assessed by
examining the overlap in the distribution of scores between the treatment and control
groups. A series of simple regressions were also performed to determine if the scores
controlled for significant differences between the study groups on the covariates.
Finally, CY 2007 recipient age and gender were included as covariates in both the
OLS and IV regression models. These variables were operationalized using the same
definitions employed by Linden and Adams (2006) where age was measured in years and
gender was coded as 1 = female and O = male.
Data Screening

Data screening consisted of calculating descriptive statistics for both the outcome
and independent variables (Cohen, Cohen, West, & Aiken, 2003). Means, standard
deviations, ranges, histograms, and box plots for the quantitative variables and frequency
distributions for the qualitative variables were calculated as part of the initial data
screening process. As previously mentioned, zeros in the outcome variables were not
considered missing since some recipients did not incur costs or utilize inpatient services
during CY 2007. Data screening was performed using SPSS version 15.0.
During data screening, particular attention was focused on identifying univariate
and multivariate outliers because they can distort regression coefficients, standard errors,
and model R2 statistics (Tabachnick & Fidell, 2001; Cohen et al., 2003).24 Outliers usually
24 In regression, outliers are observations that deviate from other cases on the dependent variable, while
leverage points are observations that deviate from others on the independent variables. Observations that
deviate on both the dependent and independent variables are influential data points (Mays, personal
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represent either contaminated data (i.e., measurement or coding errors) or accurate
observations ofrare cases (Cohen et al., 2003). For this study, univariate outliers were
identified using box plots and standardized scores greater than 3.29 (Tabachnick & Fidell,
2001).25 The data were screened for multivariate outliers by calculating Mahalanobis
distance statistics for all study subjects in the dataset. Mahalanobis distance represents the
distance that a subject is from the centroid ofall subjects, where the centroid represents the
intersection ofthe variables' averages. Mahalanobis distances were calculated by
regressing each outcome variable on the predictors and then saving the distance statistics
generated as part ofthe regressions. Mahalanobis distances were evaluated using the chi
square distribution (p < 0.001) with degrees offreedom equal to the number ofpredictors
in the models. Cook's distances were also calculated as part ofthis process. Cook's
distance is a leverage measure that assesses change in regression coefficients when
observations that differ from others in the independent variables are deleted. Observations
with distance scores greater than 1.0 were identified as outliers (Tabachnick & Fidell,
2001).
Based on these analyses, a number ofoutlier observations were identified. To
determine ifoutliers should be deleted or retained, a series ofregressions were performed
with the outliers included and excluded and the variables containing them transformed
using either the natural logarithm, reciprocal, or square root transformations to reduce their

communications, January 7, 2008). However, for simplicity the term "outlier" (i.e., outliers, leverage points,
and influential data points) was defined in this study as a case with an extreme value on one variable (a
univariate outlier) or a combination of extreme values on two or more variables (a multivariate outlier).
25 Tabachnick and Fidell (2001) report in their textbook on multivariate statistics that among continuous
variables, cases with very large standardized scores in excess of 3 .29 are potential outliers.
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impact on the regression models. Transformations can reduce the influence of outliers by
changing the variables' distributions to be approximately normal (Tabachnick & Fidell,
2001). Diagnostic statistics were performed on the transformed variables and the variables
with deleted values to determine if these options reduced the outliers' influence.
As part of this process, regression analyses were performed to allow the researcher
to determine if the outlier adjustments produced any notable changes in the overall
regression models. Specifically, the researcher sought to determine if the significance of
the model F statistics or predictors changed or if the R2 statistics fluctuated substantially.
If no noticeable changes are observed, then little is probably gained by transforming the
variables or deleting observations from the dataset. However, if changes are observed,
then a decision can be made as to whether the transformed variables or the original
variables should be used in the analysis.
Normality, linearity, and homoscedasticity were assessed to ensure that the data
met these required OLS regression assumptions. Normality refers to the extent to which
the variables have distributions that are approximately normal. Linearity is the degree to
which a straight line relationship exists between two variables, and homoscedasticity is the
extent to which the residual distribution has equal variances for all predicted values of the
outcome variable (Cohen et al., 2003). Assessment of these assumptions was performed
by calculating skewness and kurtosis statistics (they should be near zero) for each variable,
and by regressing each outcome on the predictors to generate residual plots, where
standardized residuals are plotted against the outcomes' predicted values.

Evidence for violations of the OLS regression assumptions exists if the skewness
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and kurtosis statistics are large, if noticeable patterns exist in the residual plots, or if the
residuals are predominately located above or below the residual plots' mean zero lines
(Stevens, 2002; Tabachnick & Fidell, 2001). The key to working with transformed
variables is to identify the transformation that produces skewness and kurtosis values near
zero, the cleanest residual scatter plot, and/or the least number of outliers. As a result, .
several transformations were applied before the most appropriate transformations were
identified for use in the study (Tabachnick & Fidell, 2001).
Finally, the data were screened for bivariate and multivariate multicollinearity,
which are serious conditions that exist when independent variables are highly correlated
(i.e., contain redundant information). Multicollinearity can weaken statistical analyses by
inflating error terms, which can cause parameter estimates to be non-significant
(Tabachnick & Fidell, 2001). For this study, bivariate multicollinearity was defined as
intercorrelations of at least 0.80 in a correlation matrix and multivariate multicollinearity
was defined as variance inflation factors (VIF) that exceed 10 (Stevens, 2002). VIFs are
calculated by regressing the outcomes on the predictor variables. Large VIFs indicate that
there is a strong linear association between a particular predictor and the remaining
predictors, suggesting the presence of multivariate multicollinearity. Screening for
multivariate multicollinearity is important because it is possible for a predictor to only
have weak or moderate bivariate correlations with other predictors, but then have a high
multiple correlation when regressed with the other variables. If detected, multicollinearity
can be addressed through variable deletion (Stevens, 2002).
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As part of the multicollinearity screening process, particular attention was focused
on determining if the predicted probability of program participation and the propensity
score variables produced multicollinearity in the IV regression models since both variables
represent the same concept (i.e., the probability of program participation). In addition to
performing the correlation and VIF analyses, a quintile propensity score variable (levels 1
- 5) was calculated and included in the IV regressions in lieu of the quantitative propensity
score variable (0.0 - 1.0) to determine if the models were sensitive to this variable's
specific form.
Research Questions and Data Analysis
This section discusses the data analysis procedures that were used to answer the
present study's three research questions. Additional information is provided in the
subsections that follow.
Analysis ofResearch Questions One and Two
The first two research questions developed for the study were:
1. Which statistical method provides the best unbiased estimates of high intensity
DM program participation on the outcome variables? and
2. Do the parameter estimates and confidence intervals for the predictor variables
differ depending on which statistical method is used?
These questions were addressed by using STATA version 10.1 to estimate a series ofOLS
and IV regression models for each outcome variable. Statistically significant results were
determined using an alpha level of 0.05.

96
Research question one was addressed by estimating several OLS and IV regression
models. The OLS models were estimated by regressing the outcomes on the actual DM
program participation, propensity score, age, and gender variables. Three blocks ofOLS
and IV regression models were developed for the study (i.e., a total of 18 regression
models were developed). In the first block, the IV models were estimated following the
method used by Linden and Adams (2006) where each outcome was regressed on the
predicted probability of program participation (the endogenous variable), zip code
instruments, age, gender, and propensity score variables. In the second block, the
predicted probability of program participation was replaced with the actual program
participation variable to determine if the IV regression models were sensitive to the
specific form of the endogenous variable used in the regressions. In the third block, the
propensity score variable was replaced by a quintile variable to determine if the regressions
were sensitive to this variable's specific form.
The IV regressions were performed using two stage least squares regression
(2SLS), which estimates two least squares equations simultaneously. In the first equation,
both the zip code instruments and exogenous variables (which were age, gender, and
propensity scores) were used to estimate X-hat (the predicted value of program
participation). This variable was then inserted into the second equation instead of the
actual endogenous variable and the outcomes were regressed on the predicted value of
program participation and the exogenous variables. 2SLS must be used for the IV
regression procedure because running OLS regression twice to perform the IV procedure
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results in incorrect estimations of the residual sum of squares across all observations and
their standard errors (Linden & Adams, 2006; Gelman & Hill, 2007).
The feasibility of the IV regression models was assessed using a variety of
statistical tests. For instance, a series of simple regressions were performed to determine if
the instruments were related to both the program participation and predicted program
participation variables. The residuals from each IV regression model were also regressed
on the outcome variables to test the assumption that the IV estimates were not related to
the outcome variables. The Sargon chi-square test was used to test the assumption that at
least some of the zip code instruments were uncorrelated with the disturbance terms in the
IV models. The Hausman specification test was used to determine if significant
differences existed between the OLS and IV regression coefficients. Finally, the relevancy
of the instruments was assessed by examining the first-stage F-statistics from the IV
regressions (Hadley et al., 2003; Baum, 2006; Linden & Adams, 2006; Wooldridge, 2006;
Stock & Watson, 2007).26
Research question two was addressed by comparing the OLS and IV coefficients
and confidence intervals for the variables in the three regression blocks. Particular
attention was directed toward discussing why IV regression produces large coefficient
variances and how these variances can lead to model instability. As part of the discussion,
the calculations used to produce the OLS and IV estimates were briefly reviewed.

26 Linden and Adams (2006) appeared to use the Durbin-Wu-Hausman F-test to determine if significant
differences existed between their OLS and IV regression models. The Hausman specification test can be
performed either as a chi-square or F-test. The Durbin-Wu-Hausman F-test was not used in this study
because the "hausman" subcommand in the "ivregress 2sls" command in STATA version I 0. I reports a chi
square test (Ender, n.d.; Hadley et al., 2003; Greene, 2003).
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Information on the relevancy of the zip code instruments (or the extent to which the
instruments explain variation in the program participation variable) and the limitations of
using instruments from natural experiments to estimate average treatment effects were also
included.
Analysis ofResearch Question Three
The final research question developed for the present study was:
3. What are the advantages and disadvantages of using each statistical method to
evaluate high intensity DM program effectiveness?
This question was addressed through the researcher's assessment of the advantages and
disadvantages of using both methods for DM program evaluations. Particular emphasis
was directed toward discussing the feasibility and limitations of using each method.
Institutional Review Board

Even though this study involved the analysis of preexisting administrative data, the
researcher still had to link subjects to their confidential health records in order to create the
study variables. The study thus involved human subject research, which required it to fall
under the purview of Virginia Commonwealth University's Institutional Review Board
(IRB). However, because the researcher protected the identifies of all subjects by
removing their Medicaid recipient identification numbers from the analysis dataset, the
university's IRB determined that the study qualified for an exemption under 45 Code of
Federal Regulations (CFR) 46.101 (b)(4), which states that research activities are exempt as
long as subject identities are protected (U.S. Department of Health and Human Services,
2007; Ann Nichols-Casebolt, personal communication, April 9, 2008).
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Summary

This chapter reviewed the methodology that was employed in the present study.
Information was presented on the study design, database, population, variables, and
statistical procedures. The study was conducted as an observational study because data
from a large preexisting database was used to determine whether an instrumental variables
regression procedure proposed by Linden and Adams (2006) could generalize to a Virginia
Medicaid population. The planned analysis attempted to follow their procedure, albeit
with some modifications.
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Chapter4
Results

The results of the study are presented in this chapter, which begins with a
discussion of the propensity score and instrumental variables calculation procedures. The
data screening procedures employed to assess the appropriateness of the variables for the
ordinary least squares (OLS) and instrumental variables (IV) regression models are next
reviewed followed by a discussion of the analytical results from the OLS and IV regression
models. The chapter concludes with a summary of important study findings.
Propensity Score Variable Calculation

According to some observers, selecting covariates from which to estimate
propensity scores is a critical step that should be based on a-priori theoretical grounds and
previous research (Yanovitzky, Zanutto, & Hornik, 2005; Guo et al., 2005). However,
Linden et al. (2005) maintain that disease management (DM) evaluators should use any
variables that are available because they often have access to limited amounts of data. For
this reason, the propensity score variable was calculated using the variables presented in
Table 1.27•28 As can be seen from this information, most of the study subjects were female
(1,152), white (1,377), and resided in the western part of the State of Virginia (1,336).
This information also shows that considerable variability exists in the 2006 age (M =
45.16, SD= 15.51), hospital days (M= 1.07, SD = 11.39), emergency department (ED)
27 An argument could be made that the variables used in the propensity score model were selected based on
prior research because Linden et al. (2005) used age, sex, geographic location, number of hospital
admissions, number of emergency department visits, and total costs to calculate propensity scores for a group
of congestive heart failure DM participants.
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Table 1
Descriptive Statistics for Observed Covariates Used in the Propensity Score Regression
Model (N = 1,627)
Variable
Frequency(%)
Mean (SD)
Gender/Male
475 (29.2%)
GenderIFemale

1,152 (70.8%)

Race/White

1,377 (84.6%)

Race/Black

208 (12.8%)

Race/Other

42 (2.6%)

Region/Coastal

70 (4.3%)

Region/Northem

72 (4.4%)

Region/Central

149 (9.2%)

Region/Westem

1,336 (82.1%)

Country of Origin/US

1,568 (96.4%)

Country of Origin/Other
Primary Language/English
Primary Language/Other

59 (3.6%)
1,612 (99.1 %)
15 (0.9%)

US Citizen/Yes

1,581 (97.2%)

US Citizen/No

46 (2.8%)

Age (2006)

45.16 (15.51)

Hospitalizations (2006)

1.07 (11.39)

ED Visits (2006)

1.62 (3.28)
(continued)

28 At a minimum, Linden, Adams, and Roberts (n.d.) argue that participant age and sex should be included in
the propensity score calculation.
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Diabetes Related Costs (2006)

$1,963.09 ($7,084.46)

visits (M = 1.62, SD = 3.28), and diabetes-related cost (M = $1,963.09, SD = $7,084.46)
variables. The standard deviations for the hospital days, ED visits, and cost variables are
much larger than the means, which indicates that the variables are positively skewed due to
the presence of a large number of zeros. This finding is not too surprising because large
numbers of zeros are frequently found in many variables that are examined in health
services research (Mullahy, 1998).
Ideally, actual pre-program (i.e., CY 2005) cost, utilization, and clinical variables
should be used to calculate propensity scores (Linden et al., 2005)29, but the researcher did
not have access to this information. In addition, while both quadratic and interaction terms
can be included in propensity score regression models, only three interaction terms for the
age, utilization, and cost variables were included in the propensity score model developed
for the present study. These terms were added in order to maximize model fit and because
previous research suggests that health care costs and utilizations may be influenced by
patient age (Lynn & Adamson, 2003; Jones & Richmond, 2006). Interaction terms were
used sparingly in the regression model because the inappropriate use of these terms may
alter the estimated propensity scores by inflating coefficient variances (Baser, 2006).

29 Debate exists among researchers as to which variables to include in propensity score models. Some argue
that only variables that predict treatment assignment should be included, while others argue that all variables
that are potentially related to the outcome should be included. Still others argue that propensity scores
should only be calculated using variables that are related to both the treatment and outcome variables
(Austin, Grootendorst, & Anderson, et al., 2007).

103
The propensity scores were estimated using the logistic regression option in SPSS
version 15.0. The program participation variable (coded as 1 = high intensity open
participant and O = standard intensity participant) was used as the dependent variable in the
regression model. The results of the regression for the propensity to be a high intensity
open participant are presented in Table 2, Only the 2006 ED visits, cost, and age x ED
visits variables were significantly related to the participation variable; however, all
Table 2
Logistic Regression for Propensity ofParticipating in the High Intensity Open DM
Intervention (N = 1,627)
p-value
Waldi
Estimate
Independent Variable
Std. Error
0.003
8.934
-3.492
1.168
Constant
Female

0.133

0.179

0.548

0.459

Race/White

-0.254

0.741

0.117

0.732

Race/Black

0.198

0.743

0.071

0.790

Race/Other

Reference

Region/Coastal

0.580

0.371

2.438

0.118

Region/Northern

0.411

0.451

0.831

0.362

Region/Central

0.265

0.292

0.824

0.364

Region/Western

Reference

Country of Origin US

0.281

1.056

0.071

0.790

English Language

-0.166

0.772

0.046

0.829

US Citizen

1.043

1.324

0.620

0.431

Age (2006)

0.001

0.007

0.008

0.928

(continued)
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ED Visits (2006)

-0.370

0.124

8.926

0.003

Hospital Days (2006)

0.191

0.140

1.858

0.173

Cost (2006)

0.000

0.000

6.680

0.010

Age x ED Visits

0.009

0.003

11.303

0.001

Age x Hospital Days

-0.004

0.003

2.799

0.094

Age x Costs

0.000

0.000

0.733

0.392

13 variables were retained because propensity scores should include all variables that may
play a role in the treatment assi gnment process, even if they are not statistically significant
(Shadish et al., 2002).30
The results of the overall propensity score regression model appeared adequate.
The regression model correctly classified 79.0 percent of the subjects using 14 percent as
the classification cutoff score (14.0 percent of the subjects were in the treatment group).
The likelihood ratio chi-square statistic of the propensity score model was significant (I=
218.50, df= 16,p = 0.000), indicating that the model provided a good fit to the data. More
importantly, the propensity score model c-statistic was 0.783, indicating that the model
discriminated effectively between the individuals in the treatment and control groups based
on the observed covariates. In other words, the model assigned a high probability of

30 It is acceptable to use nonparsimonious models to estimate propensity scores. In fact, some researchers use
hundreds of variables to estimate propensity scores (Stukel et al., 2007).
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treatment assignment to the treatment subjects in 78.3% of all possible subject pairs
31 32
(Hosmer & Lemeshow, 2000; Peng et al., 2002). ,

After performing the regression, the adequacy of the actual propensity scores was
assessed by examining the overlap in the distribution of scores between the treatment and
control groups. This was accomplished by reviewing the ranges of the estimated
propensity scores for the treatment and control subjects as well as two histograms that
depicted the distribution of scores for both groups (Love, 2003; Linden et al., 2005).
Overlap between the two study groups is necessary for comparability between the
treatment and control subjects. A lack of overlap implies that there are combinations of
covariate values that are found in only one of the two study groups, suggesting that the
treatment and control subjects cannot be meaningfully compared (Landrum & Ayanian,
2001).
Based on this examination, substantial overlap appeared to exist between the treatment and
control groups. The estimated propensity scores for the treatment subjects ranged between
0.03 and 1.00 (M = 0.30, SD = 0.28), while the estimated propensity scores for the control
31 While propensity score methods have been in existence for more than two decades, debate still exists over

how best to calculate and evaluate propensity score regression models (Weitzen, Lapane, Toledano, Hume, &
Mor, 2004; Austin et al., 2007; Baser, 2006; Hill, 2008; and Caliendo & Kopeinig, 2008). For instance,
some researchers use goodness of fit measures such as the Hosmer-Lemeshow chi-square test and c-statistics
in addition to propensity score overlap and covariate balance to assess propensity score models (Baser,
2006), while others use c-statistics and likelihood ratio tests to assess the models (Normand, Sykora,
Mamdani, Rochon, & Anderson, 2005; Jones & Richmond, 2006). Still, others argue that goodness of fit
measures are of little value in assessing propensity score models (Love, 2004). Due to this debate, the
researcher assessed the appropriateness of the propensity score model using the likelihood ratio test, c
statistic, propensity score overlap, and covariate balance. While not reported in the text, the researcher did
calculate the Hosmer-Lemeshow test statistic to assess the model's classification power. The statistic was
significant(;(= 17.22, df= 8,p = 0.000) indicating that the model did not have good classification power.
However, Allison ( 1999) reports that this statistic is "ad hoc" and may not be very powerful.
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subjects ranged between 0.00 and 0.97 (M= 0.12, SD= 0.10). This overlap is illustrated in
Figure 3, which shows that a majority (86.7%) of the scores fell in the 0.00 - 0.20
categories. This finding suggests that the treatment group mirrors the larger population of
diabetes DM recipients from which they were selected (Linden et al., 2005). Figure 3 also
shows that a slightly larger percentage of treatment subjects had scores greater than 0.40.
Overall, these findings indicate that the treatment and control groups had reasonable
overlap at all but the highest values of the propensity scores (Newgard et al., 2004).
Finally, simple regression analyses were performed to determine if the propensity
scores produced balance between the two study groups on the covariates (Table 3). To
Figure 3
Propensity Score Distributions
Control
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32 The c-statistic ranges between 0.5 and 1.0, with a value of 0.5 indicating that the model is no better than
_ _ _
assigning subjects randomly to the treatment and control groups and a value of 1.0 md1catmg that the model
assigns high probabilities to all subjects in the treatment group (Peng et al., 2002).
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Table 3
SimpJe Regression Analysis to Assess Covariate Balance (N = I, 627)
Treatment
Control
Unadjusted
(n = 229)*
Variables
(n = 1,398)*
,e-value**
Female
166 (72.5%)
986 (70.5%)
0.546

Adjusted
,e-value**
0.771

Nonwhite Race

52 (22.7%)

198 (14.2%)

0.001

0.441

Western Region

170 (74.2%)

1,166 (83.4%)

0.001

0.485

Country of Origin US

225 (98.3%)

1,343 (96.1%)

0.110

0.507

English Language

226 (98.7%)

1,386 (99.1%)

0.511

0.964

US Citizen

226 (98.7%)

1,355 (96.9%)

0.147

0.507

Age

46.6 (14.25)

44.93 (15.70)

0.131

0.577

Hospital Days

4.90 (29.75)

0.44 (1.91)

0.000

0.644

ED Visits

2.36 (3.65)

1.50 (3.20)

0.001

0.933

$7,473.33
($16,962.42)

$1,060.48
($2,380.31)

0.000

0.191

Diabetes Related Costs

*Frequencies and (percentages) are presented for the categorical variables, and means and
(standard deviations) are presented for the quantitative variables.
**Adjusted p-values were calculated with the propensity score included in a logistic
regression analysis modeling the relationship between each covariate and the program
participation variable.
perform these analyses, the treatment variable was regressed separately on each covariate
with and without the propensity scores. To simplify the analyses, the race and geographic
region variables were transformed into two new dichotomous variables: nonwhite race (1
=yes, 0 =no) and western region (1 = yes, 0 =no). After examining the p-values
unadjusted for the propensity scores, it was determined that significantly different
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covariate distributions existed between the study groups on the nonwhite race, western
region, and 2006 age, utilization, and cost variables. Using the covariate distributions as a
proxy for comparability between study groups indicated that the two groups were not
comparable on these variables. However, after adjusting for the propensity scores, no
significant differences remained in the covariate distributions ofthe study groups
(Newgard et al., 2004). These results suggest that the propensity scores could control for
some potential overt confounding variables and were appropriate to use in the OLS and IV
regression models.
Instrumental Variables Calculation

The instrumental variables calculation procedure began by identifying the unique
number offive-digit zip codes in the sample (Linden & Adams, 2006). A total of337
unique five-digit zip codes were identified. By collapsing these based on the first three zip
code digits, 32 new zip code categories were developed. An examination ofthese zip code
categories revealed that 14 categories contained nine or less participants. (A total of54
participants were contained in these nine categories.) Following guidance by Linden and
Adams (2006), these participants were grouped into a zip code category called "other".33
A new categorical variable was then created (called zip-code identifier) that contained 19
levels corresponding to the 19 three-digit zip code categories. The frequencies ofthe zip
code categories used as instrumental variables in the study are depicted in Figure 4. These

33 The researcher originally intended to group individuals in zip code categories with nine or less participants
into geographically similar zip code categories with more than nine participants. However, upon examining
a three digit zip code map of Virginia, it was not readily apparent which zip code categories these individuals
should be grouped in because the categories cover large geographic areas bordering multiple three-digit zip
code categories.
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Figure 4
Frequency Distribution for the Three-Digit Zip Code Identifier Variable
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results are comparable to the results reported by Linden and Adams (2006). The zip code
categories were used as dummy variables in the first stage of the two stage least squares
(2SLS) IV regression models.
A logistic regression model was next developed to estimate the probability of a
given individual participating in the high intensity open option of the Virginia Healthy
Return�M DM program using age (years), gender (1 = female and O = male), propensity
scores (0.0 - 1.0), and the zip code categories (Linden & Adams, 2006). While not
specifically stated, Linden and Adams (2006) apparently performed this calculation to
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determine if the IV assumption that Z is associated with X was satisfied, and to calculate
the probability of program participation that they used as the endogenous variable in the
two-stage least squares (2SLS) IV regression models.34 In other words, they did not use
actual program participation as the endogenous variable in the IV regression models.
The reasoning of Linden and Adams (2006) for doing this is unclear, however,
because 2SLS automatically performs this calculation through two simultaneous least
squares regressions (Greene, 2003). Essentially what the two stages do simultaneously is
this: the first stage uses a set of instruments (and the other exogenous variables in the
model) to generate least squares predictions of the endogenous variable, X, and then uses
these predictions in lieu of the actual X to explain variation in the outcome variable in the
second stage.35
Because the present study sought to test the feasibility of Linden and Adams' IV
procedure, logistic regression was used to estimate the probability of program
participation. The predicted values of program participation from the logistic regression
were then used to determine if Z is associated with X, and a 2SLS regression model was
developed for each outcome variable using this value as the endogenous variable in the

34

Specifically, they reported (p.151) that "[i]ndependent variables included those exogenous variables from
the first stage regression: age, gender, risk score, as well as the 'plug-in' or predicted value of program
participation." Linden reported that the predicted probability of program participation was used as the
endogenous variable instead of actual program participation (Linden, personal communication, June 16,
2008).
35
The first stage attempts to identify variation in the treatment variable that is uncorrelated with the
disturbance term. The second stage uses OLS regression to regress the outcome on just that portion of the
treatment variable identified as being uncorrelated with the disturbance term in the first stage. This occurs
because the predicted value of the treatment variable from the first stage is a linear combination of the
instruments and the other exogenous variables. Because the instruments are uncorrelated with the
disturbance term, the treatment variables' predicted value is uncorrelated with the disturbance term (Judd &
Kenny, 1981).
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first stage and its least squares predictions as the plug-in values in the second stage.
(These regressions are referred to as the block one models in the OLS and IV regression
section in Chapter 4.)
However, using the estimated probability of program participation as the
endogenous variable in 2SLS appears unnecessary because this variable is calculated in the
first stage. Based on the information presented in their article, Linden and Adams (2006)
calculated the probability of program participation using gender, age, propensity scores,
and zip code categories in a logistic regression model. They then used this value as the
endogenous variable instead of actual program participation in the first stage where they
appear to re-estimate this probability again by regressing it on the same set of variables
used to calculate it in the logistic regression. (In other words, the estimated probability of
program participation served as the dependent variable in the first stage of 2SLS instead of
the treatment variable.) This procedure does not appear to comply with the 2SLS guidance
provided by Greene (2003), Wooldridge (2002 and 2006), Gelman and Hill (2007), and
Stock and Watson (2007). As a result, the researcher recalculated the three 2SLS models
using actual program participation as the endogenous variable in the first stage and its least
squares predictions as the plug-in value in the second stage to determine if the models were
sensitive to the specific form of the program participation variable used in the analysis.
(These regressions are referred to as the block two models in the OLS and IV regression
section of Chapter 4.)
The logistic regression model developed to predict the probability of program
participation contained 18 dummy variables that represented the 19 three digit zip code
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categories as well as 2006 age (years), gender ( l = female and O = male), and the
propensity score (0.0 - 1.0). This model was estimated based on the actual high intensity
open program participation variable with 1 indicating program participation (or treatment)
and O indicating nonparticipation (or control). The model was used to estimate each
subjects' probability of high intensity open DM participation, which was used as an
endogenous variable in the 2SLS regressions.
Diagnostic statistics indicated that the logistic regression model was sound. In
particular, the likelihood ratio chi-square statistic was significant (x2 = 232.77, df = 21,p =
0.000) indicating that the model adequately fit the data, and the c-statistic was 0.786
indicating that the model discriminated effectively between the treatment and control
subjects. The model also correctly classified 75.2% of the subjects, using 14% as the
cutoff score. Moreover, the Somer's D and Gamma statistics for the model were 0.57 and
0.58, which indicated that it had good predictive ability. For comparison purposes, Linden
and Adams (2006) reported that their model was significant (p < 0.0001) and had very
good predictive ability based on the Somer's D and Gamma measures, which were 0.61
and 0.65.
Table 4 is similar to a table that Linden and Adams (2006) presented in their article
comparing the characteristics of the treatment and control groups using actual and
predicted program participation status. They reported that their predicted enrollment
model "compared favorably" to the actual participation data and that there were no
significant differences in the age and gender distributions for the predicted enrollment
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Table 4
A Comparison of Group Characteristics Based on Actual and Predicted High Intensity
Program Participation
Female
Group
N(o/o)
Age(SD)
Count(%)
Actual
Treatment
229(14.1)
46.6(14.25)
166(72.5)
Control
Predicted

Treatment
Control

1,398(85.9)

44.93(15.70)

986(70.5)

465(28.6)

48.47(14.23)

362(77.8%)

1,162(71.4)

43.84(15.81)

790(68.0%)

groups. They also noted that their predicted model slightly over-estimated program
participation. Their actual study groups consisted of 1,952(77%) program participants and
582(23%) control participants. However, their predicted study groups contained 2,029

(81 %) program participants and 505(19%) control participants. Based on this
information, they concluded that their results satisfied the IV regression assumption that Z
is associated with X.
The results of the enrollment prediction model developed for the present study do
not appear to compare favorably to the actual enrollment data because the model
substantially over predicted high intensity program participation by 236 subjects.
Significant differences also existed between the age and gender variables for the predicted
enrollment groups. Based on the reasoning used by Linden and Adams(2006), these
results appear to suggest that the zip code instruments are not related to the predicted
probability of program enrollment. However, this assumption can be tested by regressing
X on Z. If the null hypothesis is rejected at the 0.05 level, then statistically significant
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evidence exists that Zand X are related (Wooldridge, 2006). Linden and Adams (2006)
did not report employing this procedure in their article.
To perform this test in the present study, the researcher regressed the probability of
program enrollment on a scaled quantitative version of the zip code identifier variable
where the levels represented the number of subjects in each three-digit category (i.e., level
1 = 631 subjects and level 19 = 10 subjects). The results of this regression suggest that.Z
is related to X (t = 9.41,p = 0.000).36 To determine if the results were sensitive to the
estimated probability of program enrollment, the researcher regressed the program
participation probability's upper and lower 95% confidence limits (CL) on the scaled zip
code variable. The results indicated that the initial regression model was not sensitive to
the estimated probability of program enrollment (95% lower CL: t = 2.51 p = 0.021; 95%
upper CL: t = 34.36, p = 0.000). In addition, the researcher regressed the actual program
participation variable on the scaled zip code variable using logistic regression. The results
further indicated that Zand X are significantly related (Wald/= 15.91,p = 0.000). While
Table 3 does not appear to provide evidence that Zis related to X, the results of the above
regressions do provide evidence that Zand X are related.

36
Because some observers may argue that Z is actually a categorical variable, the researcher regressed
predicted program participation on 18 zip code dummy variables. This regression also revealed that Z and X
are related (F = 21.80, p =0.000). The researcher also regressed actual program participation on 18 dummy
zip code variables. This regression further indicated that X and Z are related (F = 3.56, p =0.000). However,
the R2 for this regression was 0.04, indicating that Z explain little variation in actual program participation.
The implications of this finding is explored further later in this chapter.
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Data Screening

Descriptive statistics for the study's outcome and independent variables are
presented in Table 5. The information shows that considerable variability exists in the
2007 age, utilization, and cost variables. (For consistency, the 2007 age variable was used
in the OLS and IV regression models because 2007 cost and utilizations were used as the
outcomes.) The information also shows that the propensity score and predicted program
Table 5
Descriptive Statistics for the Study Variables (N = 1,627)
Variables
Outcome Variables

Mean (SD)

Freguency (%)

Range

Hospital Days (2007)

0.99 (3.80)

0 - 64

ED Visits
(2007)

1.61 (3.18)

0 - 45

Diabetes-Related
Costs (2007)

$2,491.49
($7,366.45)

$0 - $144,705.10

46.16 (15.15)

2 - 90

Propensity Score

0.14 (0.15)

0.00- 1.00

Predicted Enrollment
Probably Score

0.14 (0.14)

0.00-0.96

Independent Variables
Age (2007)

Program Participation
(1 =yes)
Female (1 = yes)

229 (14%)
1,152 (70.8%)
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enrollment probability variables are very similar. These results are not surprising,
however, because the propensity score and probability of program participation variables
were calculated using essentially the same set of covariates. Due to the similarity between
the propensity score and program participation probability variables, including both in the
OLS and IV regression analyses may produce multicollinearity. Linden and Adams (2006)
did not report descriptive statistics for their study variables, so it is impossible to compare
their propensity score and program participation probability variables to the ones
developed for the present study. However, they did report checking their regression
models for multicollinearity, but detected none. The multicollinearity issue is examined
later in this section.
Boxplots and histograms for the quantitative variables as well as frequency
distributions for the qualitative variables were generated during the data screening process.
The boxplots revealed that univariate outliers were present in all of the quantitative
variables, and the histograms revealed that these variables were all positively skewed, with
the exception of the age variable that was approximately normally distributed. Skewness
and kurtosis statistics further indicated that the distributions for the utilization, cost, and
propensity score and program participation probability variables deviated substantially
from normality. 37 This finding may not be too problematic, however, because regression is
robust to violations of normality (Mendenhall & Sincich, 2003). The frequency

37 The skewness and kurtosis statistics for the variables were as follows: Age (-0.60, -0.91), ED Visits (4.50,
34.74), Hospital Days (7.55, 83.99), Cost (8.72, 119.38), Propensity Scores (3.79, 15.82), and Program
Participation Probability (3.53, 13.79). Ideally, these statistics should be close to zero (Tabachnick & Fidell,
2001).
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distributions for the gender and program participation variables did not reveal any aberrant
observations.
To examine the variables further for univariate outliers, standardized scores were
calculated for all six quantitative variables. Using 3.29 standard deviations as the
threshold for identifying univariate outliers, none were detected in the age variable, but
numerous outliers were found in the utilization, cost, and propensity score and program.
participation probability variables (Tabachnick & Fidell, 2001).38 Mahalanobis and
Cook's distances were next calculated to screen for multivariate outliers. Mahalanobis
distances were evaluated using the chi-square distribution with degrees of freedom equal to
the number of predictors in the model(/= 20.52, df= 5,p < 0.001).39,4° Cases with
Mahalanobis distances greater than 20.52 and Cook's distances greater than 1.0 were
identified as outliers (Tabachnick & Fidell, 2001). Using these measures, 54 multivariate
outliers were identified.
Outlier observations either represent contaminated data or accurate observations of
rare cases. Outliers due to contaminated data are usually either corrected or deleted.
Because the data came from the Virginia Medicaid Management Information System
(VaMMIS), the researcher assumed that the observations represented legitimate cases.

38

The number of univariate outliers were as follows: ED Visits (28), Hospital Days (31), Cost (23),
Propensity Score (44), and Program Participation Probability (50).
39
For the purposes of data screening, five predictors were used in the OLS regressions: program
participation, age, gender, propensity score, and the probability of program participation.
40 Tabachnick and Fidell (2001) report that the Mabalanobis distance statistic can be used to identify
multivariate outliers. In most large datasets, cases group around the point created by the intersection of the
means of all variables in the set. The Mabalanobis distance represents the distance that the cases are from the
intersection. Cases that are outside the group are multivariate outliers. Tabachnick and Fidell recommend
using a chi-square distribution and a very conservative probability estimate (p::: 0.001) to identifying
multivariate outliers based on their Mabalanobis distances.
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41

(However, this assumption could not be verified.)

Consequently, the researcher decided

against simply deleting the outliers and instead focused on examining how their presence
influenced the analytical results before determining their ultimate fate. This was
accomplished by regressing the outcomes on the independent variables with the outliers
included and excluded, examining residual plots, and applying transformations to the
variables to determine if they reduced the number of outliers or produced any noticeable
improvements in the fit of the regression models.
Each outcome was regressed on the independent variables with the propensity score
and program participation probability outliers included and excluded. Based on a review
of the model F statistics and p-values, R2 statistics, coefficient p-values, and residual plots
little appeared to be gained by excluding the outliers from the analysis. Each outcome
variable with the outliers included and excluded was next regressed on the independent
variables and the above statistical measures were reexamined. These results also indicated
that little would be gained by excluding the outliers from the regression analyses. Finally,
the regressions were performed with the multivariate outliers included and excluded, which
further indicated that eliminating the outliers would produce no substantive improvements
in the regression models. Based on this information, a decision was made to retain the
outliers in the dataset.
The natural logarithmic (i.e., log) and square root transformations were then
applied to the propensity score and program participation probability variables to
41 Claims data can contain inaccuracies (Linden et al., 2005). However, the researcher was unable to
compare the actual claims that were submitted by Medicaid providers to DMAS to verify the accuracy of the
data used in this study.
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determine ifthese transformations produced any improvements in the fit of the regression
models. Such transformations are usually recommended for skewed variables (Tabachnick
& Fidell, 2001). While the transformations improved the skewness and kurtosis measures
ofthe variables, the regression analyses indicated that they produced no substantive
improvements to the fit ofthe models.42•43 Consequently, the untransformed propensity
score and probability ofprogram participation variables were used in the OLS and IV
regression models.
The log transformation was next applied to the cost variable, while the square root
transformation was applied to the ED visits and hospital days variables.44 Log
transformations are generally applied to dollar outcomes, while square root transformations
are applied to count outcomes (Cohen et al., 2003; Mendenhall & Sincich, 2003).45 These
transformations improved the skewness and kurtosis statistics for the outcomes.46 An
examination ofthe residual plots for the transformed outcomes indicated that the
transformations appeared to satisfy the assumptions ofresidual normality, linearity, and
homoscedasticity. The log transformation also eliminated all univariate outliers in the cost
outcome variable, while the square root transformations only reduced the number of
42

The log transformation actually increased the kurtosis for the probability of program participation variable
from 13.79 to 52.82.
43 A decision was made against employing additional transformations due to the complexities associated with
interpreting regression coefficients for transformed variables (Gelman & Hill, 2007).
44
The natural log transformation does not calculate log transformed values for observations that are zero.
The log transformation did not calculate logs for 252 subjects who did not incur diabetes-related health care
costs during CY 2007. Zeros were inserted into the log transformed cost variable to replace these missing
values.
45
The researcher did not compare regression models between the original outcomes and their transformations
because models are not directly comparable (Cohen et al., 2003).
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outliers in the count outcomes. Residual histograms and p-p plots further revealed that the
log cost and square root ED visits variables were approximately normally distributed,
while the square root hospital days variable still remained skewed, although to a lesser
extent than the untransformed hospital days variable.
Because the square root transformation neither resulted in the elimination of all
outliers in the count variables nor produced a residual distribution that was approximately
normal for the hospital days variable, log and reciprocal transformations were applied to
these variables (Tabachnick & Fidell, 2001). However, the transformations were rejected
based on regression analyses, which indicated that they did not result in any substantive
improvements over the analyses performed using the square root transformation. While
the square root transformation may not be optimal for the hospital days variable, this
transformation was still applied to both count outcomes because: 1) it is viewed as an
acceptable transformation for count outcomes when using OLS regression (Cohen et al.,
2003; Mendenhall & Sincich, 2003), 2) it reduced variable skewness and kurtosis, and 3) it
improved residual normality, linearity, and homoscedasticity.
Finally, the data were screened for multicollinearity by generating a correlation
matrix and calculating variance inflation factors (VIFs). Bivariate multicollinearity was
defined as intercorrelations of at least 0.80, while multivariate multicollinearity was
defined as variance inflation factors (VIF) that exceed 10 (Stevens, 2002). All study
variables were included in the correlation matrix. A review of the intercorrelations
46 The skewness and kurtosis statistics for the log cost variable were -0.91 and 0.12 respectively, while these
measures were 1.26 and 1.53 for the ED Visits and 3.20 and I 1.71 for the Hospital Days square root
variables.
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revealed that a strong highly significant (p = 0.94, p = 0.000) correlation existed between
the propensity score and program participation probability variables. While only the
propensity score variable will be included in the OLS models, including both variables in
the second stage of the IV regression models may result in unreliable regression
coefficients, standard errors, confidence intervals, and p-values for the predictor variables.
VIFs were next calculated by regressing each transformed outcome on the independent
variables. None of the VIFs were greater than 10. However, the VIFs for the propensity
score and program participation probability variables were approximately 8.0 in all
regression models. While these VIFs did not meet the multivariate multicollinearity "rule
of thumb" adopted for this study, the high values are problematic and may produce
multicollinearity in the 2SLS models (Cohen et al., 2003).47
Because the present study sought to assess the feasibility of Linden and Adams
(2006) IV regression procedure, the IV regression models were generated using the
propensity score as an independent variable and the probability of program participation as
the endogenous variable. However, to test the sensitivity of the IV regression models to
the inclusion of these highly correlated variables, the propensity score variable was
stratified into five quintiles, with each quintile containing an approximately equal number
of subjects based on their propensity scores.48 The OLS and IV regression models were

47

When the probability of program participation was removed and the regressions redone, the VIFs for the
actual program participation variable were 1.22.
48
For each quintile, the number of subjects and the average propensity scores were as follows: quintile I
(325 subjects, 0.081 average propensity score), quintile 2 (326 subjects, 0.083 average propensity score),
quintile 3 (325 subjects, 0.103 average propensity score), quintile 4 (326 subjects, 0.110 average propensity
score), and quintile 5 (325 subjects, average propensity score 0.328).
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then redone using this stratified variable in place of the quantitative propensity scores to
determine if it influenced the regression models. (These regressions are referred to as the
block three models in the present study.) Including propensity scores as a quintile
covariate in multiple regression is an acceptable means of employing this procedure
(D'Agostino, 1998). In fact, Afifi et al. (2007) included a propensity score quintile
covariate in the two-part regression models they used to evaluate the Florida Medicaid DM
program.49
Ordinary Least Squares and Instrumental Variables Regression Models
The results of the ordinary least squares (OLS) and instrumental variables (IV)
regression models developed for the present study are presented in this section. To address
the study's research questions, three blocks of OLS and IV regression models were
generated. Each block contained six regression models. The OLS and IV regressions were
performed using STATA version 10.1.
In the first block, three IV regression models were developed using the procedure
employed by Linden and Adams (2006). Two-stage least squares (2SLS) regression was
used to generate the IV models. In the first stage, the probability of program participation
(the endogenous variable) was regressed on age, gender, and the propensity score variables
(the exogenous variables), plus the 18 dummy zip code instruments. In the second stage,
the outcome variables were regressed on the predicted program probability values from the

49 Afifi et al. (2007) actually used quintile indicators as covariates in their regression models. However,
indicator quintiles were not used as covariates in this study for two reasons: I) D'Agostino (1998) reports
that it is acceptable to include "the propensity score quintile itself' (p. 2276) as a covariate in regression and
2) using quintile indicators in the block three models would have complicated efforts to assess the sensitivity
of the regression models in all three blocks to the specific form of the propensity score variable.
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first stage plus the age, gender, and propensity score variables. In the OLS models, the
outcomes were simply regressed on the actual program participation, age, gender, and
propensity score variables.
To test the assumption that the IV estimates were not significantly related to the
outcomes, residuals from each IV model were regressed on the zip code instruments
(Linden & Adams, 2006). Nonsignficant model F statistics suggest that no direct
relationships exist between the instruments and the outcomes. The Sargon chi-square test
was used to test the assumption that at least some ofthe instruments were uncorrelated
with the disturbance terms in the IV models. 50 While not definitive, a nonsignificant p
value for this test suggests that the instruments and the disturbance term are uncorrelated
(Gujarati, 2003; Baum, 2006). Finally, the Hausman specification chi-square test was used
to determine ifsignificant differences exist between the OLS and IV coefficients (Ender,
n.d.; Greene, 2003; Hadley et al., 2003; Baum, 2006).51 Ifno significant differences exist,
then the OLS model becomes the default because its coefficients are more efficient
(Linden & Adams, 2006).
In the second block, the same procedures were performed as above except that the
actual high intensity program participation variable was used in the 2SLS regressions to
determine ifthe models were sensitive to the particular form ofthe endogenous variable.
50 According to Linden and Adams (2006), the IV assumption that Z is not associated with the unobserved
error cannot be "definitively" assessed. However, Wooldridge (2006) argues that if researchers have more
than one instrumental variable, they "can effectively test whether some of them are uncorrelated with the
structural error'' (p. 533 ).
51 Wooldridge (2002) indicates that the Hausman test is a test of the possible endogeneity of the problematic
independent variable (i.e., the treatment variable when subjects are assigned nonrandomly). If the
problematic variable is uncorrelated with the disturbance term, then the OLS and IV models should only
differ by sampling error.
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In the third block, the same procedures were performed as in the second block, but the
quantitative propensity score variable was replaced with a quintile variable to test the
sensitivity of the models to this variable's specific form.
The results of the three regression model blocks are presented in the following
subsections.
Block One OLS and IV Regression Models
The results for the block one OLS and IV regression models are presented in Table
6. To test the assumption that the IV estimates were not directly related to the outcomes,
residuals from each IV model were regressed on the 18 dummy zip code instruments
(Linden & Adams, 2006). The p-values for the model F-test suggested that no direct
relationships exist between the instruments and the residuals for the cost model (F = 1.28,
p = 0.183) and the hospital days model (F = 0.80,p = 0.707). However, a direct
Table 6
Block One: OLS and IV Regression Models Using Linden and Adams' Procedure
OLS Regression
Coefficient
Variable
95%CJ
(SE)
Outcome: Diabetes-Related Costs (Log)

p-value

Coefficient
(SE)

IV Regression
95%CJ

p-value

Intercept

3.11 (0.22)

2.68-3.54

0.000

3.11 (0.22)

2.67-3.55

0.000

Program

1.53 (0.20)

1.14 - 1.93

0.000

0.84 (1.37)

-1.84-3.52

0.538

Female

-0.06 (0.14)

-0.34-0.21

0.648

-0.06 (0.14)

-0.34-0.22

0.655

Age

0.04 (0.00)

0.03-0.05

0.000

0.04 (0.00)

0.03 -0.05

0.000

Propensity

3.71 (0.46)

2.79-4.62

0.000

4.36 (1.38)

1.67-7.06

0.002

Adjusted R2

0.16

Sargonx2
Hausmanx2

0.13
0.109
0.604
(continued)
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Outcome: Emergency Department Visits (Square Root)
Intercept

1.05 (0.08)

0.89- 1.22

0.000

1.05 (0.08)

0.89-1.22

0.000

Program

0.20 (0.08)

0.04-0.35

O.Ql 1

0.04 (0.52)

-0.97-1.05

0.940

Female

0.16 (0.05)

0.05-0.26

0.003

0.16 (0.05)

0.05-0.26

0.003

Age

-0.01 (0.00)

-0.01- -0.01

0.000

-0.01 (0.00)

-0.015--0.008

0.000

Propensity

0.78 (0.18)

0.43-1.13

0.000

0.93 (0.52)

-0.09-1.95

0.074

Adjusted

R2

0.05

0.05

Sargonx2

0.000

Hausmanx2

0.759

Outcome: Hospital Days (Square Root)
Intercept

-0.00 (0.08)

-0.15-0.15

0.993

-0.00 (0.08)

-0.15-0.15

0.989

Program

0.42 (0.07)

0.28-0.56

0.000

0.51 (0.47)

-0.42-1.44

0.283

Female

-0.01 (0.05)

-0.11-0.08

0.771

-0.01 (0.05)

-0.11-0.08

0.772

Age

0.00 (0.00)

-0.00-0.01

0.060

0.00 (0.00)

-0.00-0.01

0.062

Propensity

1.15 (0.16)

0.84-1.47

0.000

1.07 (0.48)

0.13-2.00

0.025

Adjusted

R2

0.08

0.07

Sargonx2

0.574

Hausmanx2

0.847

relationship appears to exist between the instruments and the residuals for the ED visits
model (F = 2.36,p = 0.001). This finding suggests that three-digit zip codes are not good
instruments for the endogenous variable in the ED visits model. The Sargon chi-square
test indicated that the zip code instruments were not associated with the disturbance terms
in the cost (p = 0.109) and hospital days (p = 0.574) IV models. However, the test found
that at least some of the instruments were associated with the disturbance term in the ED
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visits IV model (p = 0.000). This finding also provides evidence that three-digit zip codes
are probably not good instruments in the ED visits model.
The Hausman specification test indicated that there were no significant differences
between the OLS and IV models. Based on this information, the OLS models should be
used to interpret the effects of the high intensity DM program on the outcomes for the
1,627 diabetes study subjects because the parameter estimates for the OLS and IV models
were not significantly different. The implication is that the probability of program
participation variable (the endogenous variable in the first stage of the 2SLS equations)
may not actually be endogenous (i.e., correlated with the models' disturbance terms)
(Wooldridge, 2002). Nevertheless, care should be exercised when using the OLS models
to interpret the causal effects of the high intensity DM program because they may not
actually control for all overt and hidden biases. Failing to control for these biases can
result in incorrect regression coefficients, standard errors, confidence intervals, and p
values for the model covariates.
The information in Table 6 also shows that the probability of program participation
was not significant in the IV models. This finding is surprising since the program variable
is highly significant in the OLS models. It may be due to: 1) how the IV program variable
was calculated (i.e., it was estimated in a separate logistic regression model and then used
as the treatment variable in the first stage of 2SLS where it was estimated again using the
same variables that predicted it in the logistic regression model), and 2) the high
correlation between the program probability and propensity score variables may have
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resulted in larger variances for the IV estimators, which can translate into larger confidence
intervals and imprecise p-values (Wooldridge, 2006).
To investigate the second stage IV regression models further, variance inflation
factors (VIFs) were calculated for all independent variables. The VIFs for the propensity
score and probability of program participation variables were 10.3 in all IV regression
models indicating that multicollinearity was probably present. Multicollinearity is a
serious problem in OLS regression because it can produce large standard errors for the
coefficients. However, it is even more serious in 2SLS regressions because coefficient
variances will be larger due to: 1) the predicted value of the endogenous variable having
less variation than the actual endogenous variable and 2) the correlation between the
predicted value of the endogenous variable and the other exogenous variables being much
stronger than the correlation between the actual endogenous variable and the other
variables (Wooldridge, 2006). Because multicollinearity appears to be present in the block
one IV models, the overall results may be incorrect.
Because the diabetes-related cost variable was log transformed, the OLS regression
coefficients for the cost model are interpreted as percent changes (Wooldridge, 2006). 52
The program variable in the model represents the average effect of the high intensity
program on the outcome when the other covariates are held fixed. The results of this
model indicate that high intensity DM program participation is associated with a 153%
increase in diabetes-related health care costs on average when controlling for age, gender,
and propensity scores. The 95% confidence interval for the coefficient estimate indicates
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that the true program effect is probably between 114% and 193%. While the estimated
program effect may seem large, it should be noted that average diabetes-related costs for
the treatment and control groups were $7,990.39 and $1,590.74, respectively (t = -5.97,p
=0.000).53
The program estimate in the IV model is much smaller, suggesting that high
intensity program participation is only associated with an 84% increase in diabetes-related
health care costs on average. The 95% confidence interval for the IV program estimate (1.84 to 3.52) is also much larger than the estimate's OLS confidence interval. This is due
to the fact that the IV standard error of the estimate is larger (1.37) than the OLS standard
error (0.20).54 In IV regression, coefficient confidence intervals and standard errors are
usually larger than in OLS regression because the variance of the IV estimator is calculated
by incorporating R\r.,z (i.e., a measure of the strength of the linear relationship between X
and Z) into the denominator of the variance formula (Wooldridge, 2006).55 However, the
overall usefulness of this information is questionable because the program participation
variable is not significant (p = 0.538) and the IV cost model was rejected in favor of the
OLS model.
An examination of the coefficient estimates and confidence intervals for the other
independent variables reveals that the age and propensity score variables are significant in
52

According to Wooldridge (2006), when the dependent variable is log transformed, the interpretation of the
regression coefficient is as follows: % change in y = (I OO*coefficient)change in x.
This is equal to a 402% change in diabetes-related health care costs between the treatment and control
groups.
54 Wooldridge (2006) indicates that this is the "price paid" to get a consistent estimator of the outcome if the
treatment variable is endogenous.
53
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both the OLS and IV regression models. In particular, the OLS and IV age estimate (0.04)
and confidence intervals (0.03 to 0.05) were the same; however, the IV coefficient and
confidence intervals for the propensity score were larger than its OLS estimate (4.36) and
confidence intervals (1.66 to 7.06). The fact that the propensity score variable was
significant in both the OLS and IV models is not surprising because this variable
represents a "composite confounder" designed to reduce overt bias by controlling for 13
potential confounders (Newgard et al., 2004).
The coefficients in the ED visits and hospital days OLS and IV models are
interpreted differently because the square root transformation was applied to these
outcomes. In the OLS ED visits model, high intensity DM program participation is
associated with a 0.20 (p = 0.011) increase on average in the square root ofED visits,
while holding fixed the age, gender, and propensity score variables. 56 The 95% confidence
interval for the program variable is 0.04 to 0.35. The IV estimate is much smaller,
indicating that high intensity program participation is only associated with an average
increase of0.04 in the square root ofED visits when controlling for the effects ofthe other
covariates. The estimate's IV confidence interval (-0.97 to 1.05) is also larger than its OLS
confidence interval. However, these findings may also not be very informative because the
p-value ofthe IV program estimate is 0.940 and the IV model was rejected in favor ofthe
OLS model.
55 In IV regression, the asymptotic standard error of /3 is cri/SST *Kx,z while the asymptotic standard error of
x
1
{31 in OLS regression is cri/SSTx. Because R2 is always less than one, the IV variance is usually larger than
the OLS variance. In fact, the smaller the R2x,z, the larger the IV variance (Wooldridge, 2006).
56 Square root transformation estimates can be converted back to original units by squaring them. For
instance, high intensity DM program participation is associated with a 0.04 (or 0.202) increase in ED visits.
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The female, age, and propensity score variables were significant in the OLS ED
visits model, while only the female and age variables were significant in the IV model.
The variables' coefficient estimates, standard errors, confidence intervals, and p-values
were identical in both models. This finding is surprising because IV regression estimates
are usually larger than the OLS estimates (Winship & Morgan, 1999).
Finally, the OLS hospital days model indicates that the high intensity OM program
is associated with an average increase of0.42 (p = 0.000) in the square root ofhospital
days when controlling for the other covariates. The 95% confidence interval for this
variable is 0.28 to 0.56. The IV program effect estimate is larger than the OLS estimate.
The IV model estimates the average effect ofthe high intensity OM program to be 0.51
with a 95% confidence interval of-0.42 to 1.44. The wide confidence interval is due in
part to the coefficient's large standard error (0.47). However, the usefulness ofthe IV
estimate is also questionable because the variable's p-value was 0.283 and the IV model
was rejected in favor ofthe OLS model.
In addition, only the propensity score covariate was significant in both the OLS and
IV hospital days models. While the propensity score's OLS coefficient is larger (1.15)
than its IV coefficient (1.07), its IV standard error is larger (0.48) than its OLS standard
error (0.16). The variable's IV confidence interval is thus wider (0.13 to 2.00) than its
OLS confidence interval (0.84 to 1.47).
The adjusted R2 statistics for the six OLS and IV regression models are as follows:
diabetes-related costs (0.16 and 0.13), ED visits (0.05 and 0.05) and hospital days (0.08
and 0.07). While some observers may argue that the regression models are not practically

131
significant because the covariates did not account for much of the variability in the
outcomes, it is important to remember that the adjusted R2 statistic will always be smaller
than the R2 statistic because it penalizes for the inclusion of irrelevant variables in the
model. Thus, it is possible to have practically significant regression models that account
for a large portion of the variation in the outcome with small adjusted R2 statistics.
However, Linden and Adams (2006) report that small R2 statistics (in the 0.03 to 0.06
range) are generally reported in the health services research literature for these outcomes.57
In any case, it should be noted that R2 statistics will usually be smaller for IV models than
for OLS models. IV regression is intended to provide better estimates of the effect ofXon
Y when Xis related to the disturbance term. Goodness-of-fit measures are not a factor in
this process (Wooldridge, 2006).
For comparison purposes, Linden and Adams (2006) rejected their diabetes-related
cost and ED visits IV models, but accepted their hospital days IV model based on the
Hausman test results. They also found significant DM treatment effects in their OLS and
IV estimates for the cost and hospital days models, but did not find significant effects in
the ED visits model. In addition, they reported low adjusted R2 statistics for their OLS and
IV cost (0.095 and 0.094), ED visits (0.006 and 0.006) and hospital days (0.034 and 0.029)
models.

57 According to Wooldridge (2006), R2 statistics will be larger for OLS models than for IV models because

OLS "minimizes the sum of squared residuals" (p. 525). Wooldridge further reports that R2 statistics are not
very useful measures in IV regression.
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Block Two OLS and IV Regression Models
The results of the block two OLS and IV regression models are presented in Table
7. These models were developed in the same manner as the block one models, but the
actual program participation variable was used as the endogenous variable in the 2SLS
regressions. Model development for the second block began by testing to determine if the
assumption that the instruments are not directly related to the outcomes was met. This was
accomplished by regressing the residuals from each IV model on the zip code instruments.
The model F-tests indicated that no direct relationships existed between the instruments
and the residuals for the cost model (F = 1.38,p = 0.130) and the hospital days model (F =
0.86,p = 0.626). However, the F-test for the ED visits model indicated that a direct
relationship existed between the instruments and the residuals (F= 2.49,p = 0.001). These
results further suggest that three-digit zip codes may not be good instruments in the ED
visits model.
The Sargon test indicated that the instruments were not related to the disturbance
terms in the cost (p = 0.092) and hospital days (p = 0.552) models. However, the test
indicated that the instruments were related to the disturbance term in the ED visits model
(p = 0.000). This finding provides additional evidence that three-digit zip codes may not

be appropriate instruments for the treatment variable in the ED visits model.
The Hausman test revealed that no significant differences existed between the OLS
and IV models when using actual program participation as the endogenous variable. Based
on this information, the OLS models could be used to interpret the effects of the high
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Table 7
Second Block: OLS and IV Regression Models Using Actual Program Participation as the
Endog_enous Variable
Variable

Coefficient
(SE)

Intercept

OLS Regression
95%CJ

p_-value

Coefficient
(SE)

3.11 (0.22)

2.68-3.54

0.000

Program

1.53 (0.20)

1.14-1.93

Female

-0.06 (0.14)

Age

JV Regression
95%CJ

p_-value

3.11 (0.22)

2.68-3.54

0.000

0.000

0.84 (1.35)

-1.80-3.48

0.532

-0.34-0.21

0.648

-0.06 (0.14)

-0.34-0.21

0.650

0.04 (0.00)

0.03-0.05

0.000

0.04 (0.00)

0.03-0.05

0.000

Propensity

3.71 (0.46)

2.79-4.62

0.000

4.36 (1.36)

1.71-7.02

0.001

Adjusted R2

0.16

Outcome: Diabetes-Related Costs (Log)

0.16

Sargonx2

0.092

Hausmanx2

0.604

Outcome: Emergency Department Visits (Square Root)
Intercept

1.05 (0.08)

0.89-1.22

0.000

1.05 (0.08)

0.89-1.22

0.000

Program

0.20 (0.08)

0.04-0.35

0.011

0.04 (0.52)

-0.97-1.05

0.940

Female

0.16 (0.05)

0.05-0.26

0.003

0.16 (0.05)

0.05-0.26

0.003

Age

-0.01 (0.00)

-0.015 - -0.008

0.000

-0.01 (0.00)

-0.015 - -0.008

0.000

Propensity

0.78 (0.18)

0.43-1.13

0.000

0.93 (0.52)

-0.09-1.95

0.074

Adjusted R2

0.05

0.05

Sargonx2

0.000

Hausmanx2

0.759

Outcome: Hospital Days (Square Root)
Intercept

-0.00 (0.08)

-0.15-0.15

0.993

-0.00 (0.08)

-0.15-0.15

0.989

Program

0.42 (0.07)

0.28-0.56

0.000

0.51 (0.47)

-0.41-1.43

0.278

Female

-0.01 (0.05)

-0.11-0.08

0.771

-0.01 (0.05)

-0.11-0.08

0.770

(continued)
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Age

0.00 (0.00)

-0.00-0.01

0.060

0.00 (0.00)

-0.00-0.01

0.060

Propensity

1.15 (0.16)

0.84- 1.47

0.000

1.07 (0.47)

0.14-2.00

0.024

Adjusted R2

0.08

0.08

Sargon x2

0.552

Hausmanx2

0.847

intensity DM program on the outcome variables. This information suggests that the IV·
regression models developed for the present study were not sensitive to the particular form
of the endogenous variable included in the analysis.
The variables' coefficient estimates, standard errors, confidence intervals, and p
values in the block two models were very similar (and in some cases identical) to those in
the block one models. In particular, no insignificant (a = 0.05) variables in the block one
IV models were significant in the second block IV models. The 2SLS IV regression
models were screened for multicollinearity by calculating variance inflation factors (VIFs).
The VIFs for the predicted value of program participation from the first stage regression
and the propensity score variables were 10.3 in all regressions. Based on this information,
substantial multicollinearity was present in the models due to these variables. Thus, the
usefulness of the second block IV regression models appears questionable.
Block Three OLS and IV Regression Models
Table 8 contains the results of the block three OLS and IV regression models. In
these models, actual program participation was used as the endogenous variable; however,
the quintile propensity score was used in place of the continuous propensity score variable.
To test the assumption that the instruments were not directly related to the outcomes,
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Table 8
Block Three: OLS and IV Regression Models Using Actual Program Participation as the
Endogenous Variable and the Propensity Score Quintile Variable
Variable

Coefficient
(SE)

Intercept

OLS Regression
95%CJ

e-value

Coefficient
(SE2

2.88 (0.24)

2.40-3.35

0.000

Program

1.87 (0.20)

1.48-2.25

Female

-0.06 (0.14)

Age
Propensity

95%CJ

e-value

3.45 (0.33)

2.80-4.10

0.000

0.000

8.15 (1.33)

5.55-10.75

0.000

-0.34-0.22

0.658

-0.06 (0.18)

-0.41-0.30

0.751

0.04 (0.00)

0.03-0.05

0.000

0.04 (0.01)

0.03-0.05

0.000

0.25 (0.05)

0.15-0.34

0.000

-0.27 (0.12)

-0.52 - -0.03

0.028

Outcome: Diabetes-Related Costs (Log)

Adjusted

R2

JV Regression

0.08

0.15

Sargonx2

0.222

Hausmanx2

0.000

Outcome: Emergency Department Visits (Square Root)
Intercept

1.01 (0.09)

0.83- 1.19

0.000

1.06 (0.10)

0.86-1.26

0.000

Program

0.27 (0.07)

0.12-0.42

0.000

0.85 (0.40)

0.06- 1.64

0.035

Female

0.16 (0.05)

0.05-0.27

0.003

0.16 (0.06)

0.05-0.27

0.004

Age

-0.0 I (0.00)

-0.015 - -0.009

0.000

-0.01 (0.00)

-0.015 - -.008

0.000

Propensity

0.05 (0.02)

0.01-0.09

0.008

0.00 (0.04)

-0.07-0.08

0.964

Adjusted R2

0.05

0.04

Sargonx2

0.000

Hausmanx2

0.136

Outcome: Hospital Days (Square Root)
Intercept

-0.05 (0.09)

-0.22- 0.11

0.540

0.08 (0.10)

-0.12-0.29

0.415

Program

0.54 (0.07)

0.40-0.67

0.000

2.04 (0.41)

1.23-2.85

0.000

Female

-0.0 I (0.05)

-0.11-0.08

0.795

-0.0 I (0.06)

-0.12-0.10

0.837

(continued)
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Age

0.00 (0.00)

-0.000 - 0.006

0.073

0.00 (0.00)

-0.000 - 0.006

0.062

Propensity

0.07 (0.02)

0.03 - 0.10

0.000

-0.06 (0.04)

-0.13 - 0.02

0.138

Adjusted R2

0.06

0.04

Sargonx2

0.706

Hausmanx2

0.000

residuals from each IV model were regressed on the instruments. The model F-tests
indicated that no direct relationships existed between the instruments and the residuals for
the cost (F= 1.12,p = 0.324) and hospital days (F= 0.74,p = 0.768) models. However,
the F-test for the ED visits model indicated that a direct relationship existed between the
instruments and the outcome (F = 2.56,p = 0.000). This finding provides additional
evidence that three-digit zip codes are not good instruments to use in the ED visits model.
As with the previous blocks, the Sargon test indicated that the instruments were not
related to the disturbance terms in the cost (p = 0.222) and hospital days (p = 0.706)
models, but that at least some of the instruments were related to the disturbance term in the
ED visits model (p = 0.000). However, the Hausman test results in the block three models
were different from the test results in the previous blocks. In particular, the Hausman test
indicated that significant differences existed between the OLS and IV models for the cost
(p = 0.000) and hospital days (p = 0.000) outcomes. This information may indicate that the

OLS cost and hospital days models were inconsistent due to the endogeneity of the
program participation variable.
To determine if the block three models were influenced by multicollinearity, VIFs
were calculated for the 2SLS IV regression models. All VIFs were well below the 10.0
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threshold suggesting that multicollinearity was not present. These findings indicate that
the IV models developed for this study were sensitive to the quantitative form of the
propensity score variable. This is probably due to the fact that multicollinearity apparently
results when propensity scores and the estimated program probability variable are included
as covariates in the second stage of the 2SLS IV regression models.
Unlike the previous two model blocks, the coefficients for the program
participation variables were significant in all block three IV regression models. This result
may be due to multicollinearity that was present in the IV regression models of the two
previous blocks. The information in the block three cost models indicates that program
participation in the OLS model was associated with a 187% increase on average in
diabetes-related health care costs, while program participation was associated with an
average increase of 815% in health care costs in the IV model. While the IV program
estimate is substantially larger, the OLS estimate is closer to the estimate reported in the
first two blocks. The confidence intervals for the block three OLS estimate includes the
point estimate from the previous blocks; however, the IV confidence intervals are
extremely large and do not include the IV estimates from those blocks. 58 The results for
the program variable in the block three ED visits and hospital days models are similar to
those in the cost model.
For the other covariates, use of the quintile propensity score did produce some
changes in the coefficient standard errors and confidence intervals. However, it did not
58

While the confidence interval for the ED visits IV model includes the OLS point estimate, the confidence
intervals for the cost and hospital days IV models do not contain their respective OLS point estimates.
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produce any changes in the statistical significance of the coefficients except for the
propensity quintile variable in the hospital days model, which was nonsignificant (p =
0.138). In the previous blocks, the propensity score was significant (p = 0.025 and 0.024
for the block one and two models, respectively). The other covariates that were significant
in the first two blocks remained significant in the third block.
The information from the block three models suggests that the high intensity DM
program had a significant positive effect on diabetes-related costs, ED visits, and hospital
days. The direction and magnitude of the program coefficients is surprising because they
are all positive and considerably larger than the OLS coefficients. It would seem
reasonable to expect the DM program to have a negative effect on the outcomes because
the program is intended to achieve that result, and for the IV estimates to be smaller than
the OLS estimates (and also for the IV estimates' confidence intervals to include the OLS
estimates) if they are actually influenced by omitted variable bias. This finding may be
problematic because the fact that the IV estimates in the block three models are
considerably larger than the OLS estimates is not entirely consistent with omitted variable
bias in OLS regression (Wooldridge, 2006).
Several reasons may exist that account for these results. First, the positive program
effect may be a result of the high intensity DM participants having more advanced
illnesses than the standard intensity recipients and thus requiring more intensive health
care services. Second, the positive effect may be due to the fact that the individuals in the
high intensity program were selected for this intervention because they have higher health
care costs and utilizations. The regression models thus reflect the fact that the high
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intensity program by design is associated with increased health care costs and utilizations.
Third, enough time has not elapsed for the high intensity program to reduce health care
costs and utilizations. DM is intended to be a long-term process and it may take several
years before the high intensity program produces a negative effect in the study outcomes
(Afifi et al., 2007).
Fourth, the instrumental variables in the IV regressions are "weak," meaning that
the partial correlation between the instruments and the endogenous variable is low. If this
occurs, then the IV estimator will have large asymptotic bias, which may result in
inconsistent regression estimates, standard errors, and confidence intervals, thus making
model inferences very unreliable (Staiger & Stock, 1997; Wooldridge, 2006; Gelman &
Hill, 2007). One method to test for weak instruments is to calculate the model F-statistic
from the first stage IV regression. This statistic tests the hypothesis that the instruments do
not enter into the first stage regression (Staiger & Stock, 1997). The rule of thumb for
determining whether the instruments are weak is an F-statistic that is less than 10, which
implies that the model lacks substantive predictive power (Stock, n.d.).
To test for weak instruments, first stage F-statistics were calculated for each block
three IV regression model. The calculation yielded an F-statistic of 3.28 (p = 0.000) for
each model. 59 Based on this information, it appears that the zip code instruments are weak
59
F-statistics were also calculated for the block one and two first stage IV regression models. The F-statistic
for the first block models was 326.83 (p = 0.000), while the F-statistic for the second block models was 2.02
(p = 0.006). The fact that the F-statistic for the block one models was so large is probably not that
informative because the R2 statistic for the regression of the predicted values from the first stage on the
exogenous variables (excluding the instruments) was 0.90, which suggests a high level of multicollinearity
(Wooldridge, 2006). A similar analysis performed for the block two models also yielded an R2 statistic of
0.90. The multicollinearity is due to the fact that the predicted values are a linear function of the exogenous
variables including the instruments.

140
in the present study and probably contribute to the IV estimates' large coefficients,
standard errors, and confidence intervals. 60 As a result, the block three IV models are
probably biased and should not be used to interpret the effects of the DM program even
, though the Hausman test indicated that the IV cost and hospital days models should be
preferred over the OLS models. It should be noted that due to the large variances that IV
estimates tend to have, some researchers prefer to interpret treatment effects using OLS.
estimates even if they are biased (Winship & Morgan, 1999). Thus, the researcher would
probably have recommended interpreting the effects of the high intensity DM program
using the OLS models developed in this study even if the instruments were not weak
(assuming of course that the IV coefficients, standard errors, and confidence intervals were
as large as the ones presented in Table 6).
Summary

The objective of this study was to test the feasibility of an instrumental variables
(IV) regression procedure developed by Linden and Adams (2006) for evaluating disease
management programs. Their procedure involved using three-digit recipient zip codes as
instruments in two-stage least squares (2SLS) IV regression. As part of their procedure,
they used propensity scores as a covariate to control for overt biases and the predicted

60 Some observers may argue that this information contradicts the discussion on the association ofX and Z
presented on pages 74 and 75. That discussion differs from the above discussion because it focused on
whether a relationship existed between the instruments and the endogenous variable. The above discussion is
focused on the extent to which at least one of the instruments is useful for predicting program participation,
given the exogenous variables. Moreover, Morgan and Winship (2007) report that researchers do not agree
on how large the association between Zand X must be before IV regression can proceed. Generally,
researchers agree that z is too weak if the regression ofX on Z is not statistically significant at a small level.
However, if this regression is performed using a large dataset, a weak Zcan still produce significant results.

141
value of program participation, from a separate logistic regression model, as the
endogenous variable in their IV models.
The study found that propensity scores that appear to control for potential overt
biases in ordinary least squares (OLS) regression can be calculated using claims data from
the Virginia Medicaid Management Information System. To test the feasibility of Linden
and Adams' (2006) IV regression procedure, three blocks of OLS and IV regression
models were developed. The appropriateness of the IV models was determined, in part by
comparing them to OLS models, which are generally viewed as being more efficient
estimators.
The first block IV regression models used the predicted value of program
participation from a separate logistic regression as the endogenous variable and the
propensity score as an exogenous covariate. While the Sargon test revealed that the zip
code instruments were probably not good instruments in the ED visits IV model because
they were associated with the disturbance term, the Hausman test indicated that using
three-digit zip codes as instruments did not appear to produce IV models that were
significantly different than their OLS counterparts. The analysis performed for the present
study suggested that zip codes may not be good instruments to use in IV models that are
intended to estimate DM treatment effects. However, the results from the first block
models may be questionable because the models were biased due to multicollinearity,
which resulted from including both the predicted value of program participation and
propensity scores as independent variables in the second stage of 2SLS IV regression.
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In the second block models, actual program participation was used as the
endogenous variable to test the sensitivity of the IV models to this variable's specific form.
The analytical results were very similar to those reported in the first block models
suggesting that the IV models were not sensitive to the endogenous variable because no
significant differences were found between the OLS and IV models. However, these
results are also questionable due to multicollinearity that resulted from including both the
predicted value of program participation (calculated by regressing actual program
participation on the instruments and exogenous variables in the first stage of 2SLS
regression) and the propensity scores as covariates in the IV models.
Finally in the third block models, actual program participation was used as the
endogenous variable; however, a quintile propensity score was used in place of the
quantitative propensity score to test the sensitivity of the models to this variable's specific
form. The analysis revealed that the models were sensitive to this variable because
significant differences were found between the OLS and IV regression cost and hospital
days models. These results suggest that when multicollinearity is eliminated, using three
digit zip codes as instruments resulted in IV regression models that were preferable to the
OLS models presumably due to the endogeneity of the treatment variable. However, these
IV models should probably still be rejected because an examination of the first stage IV F
statistics revealed that the instruments were weak, which probably produced biased
coefficients, standard errors, and confidence intervals for the model covariates.

143
Chapter 5
Discussion and Conclusions

The present study examined the feasibility of an instrumental variables (IV)
regression procedure developed by Linden and Adams (2006) for use in disease
management (DM) program evaluations. In disease management, individuals are often
assigned nonrandomly to the treatment and control groups (i.e., they self-select into the.
programs). Nonrandom assignment can complicate efforts to evaluate DM programs
because the treatment (or participation) variable may be correlated with unobserved
confounding variables. Unless evaluators can control for these variables by including them
in regression models, DM program effect estimates may be biased. Linden and Adams
(2006) argue that IV regression using patient three-digit zip codes as instruments can be
used to derive unbiased DM treatment effect estimates by eliminating the correlation
between the treatment and unobserved confounding variables.
IV regression can be difficult to employ, however, because researchers must find
one or more instruments that are: 1) directly correlated with the treatment variable, but not
the outcome variable, and 2) uncorrelated with the unobserved variables that influence
treatment assignment (Wooldridge, 2006). Linden and Adams (2006) hypothesize that
participant three-digit zip codes meet these two assumptions and are thus valid instruments
for DM program participation. To test their hypothesis, they used IV regression to
evaluate the effects of participation in an Oregon managed care diabetes DM program on
three outcome variables: total diabetes costs, emergency department (ED) visits, and
hospital days. They assessed the appropriateness of their IV regression models by
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comparing them against comparable ordinary least squares (OLS) regression models.
Based on the analysis, Linden and Adams (2006) found that IV regression using zip code
instruments only appeared to produce an unbiased treatment effect estimate on the hospital
days outcome. While they noted that their procedure was successfully employed in one
model, they reported that it might not generalize to other DM programs.
The present study sought to test the generalizability of Linden and Adams' (2006)
IV regression procedure by using it to evaluate the effects of a high intensity Virginia
Medicaid diabetes DM program. The study was guided by three research questions:
1. Which statistical method provides the best unbiased estimates of high intensity DM
program participation on the outcome variables?
2. Do the parameter estimates and confidence intervals for the predictor variables
differ depending upon which statistical method is used?
3. What are the advantages and disadvantages of using OLS and IV regression to
evaluate high intensity DM program effectiveness?
The study hypothesis was that instrumental variables regression using three-digit zip code
instruments will provide an unbiased estimate of the effects of disease management
participation on a group of high intensity Virginia Medicaid diabetes patients enrolled in
the Healthy ReturniM DM Program. The remainder of this chapter focuses on answering
the research questions and discussing the study limitations, implications of the study
findings for the medical and health policy communities, future research possibilities, and
important study conclusions.

145
Research Question Analysis

Analytical findings for the three research questions are presented in this section,
which begins with a discussion of the best statistical method to use for evaluating the
effects of high intensity participation in the Virginia Healthy Returns'M DM program. An
examination of the ordinary least squares (OLS) and instrumental variables (IV) regression
coefficients and confidence intervals is then presented followed by a discussion of the
advantages and disadvantages of using OLS and IV regression in DM evaluations.
Best Statistical Methodfor Evaluating the High Intensity DM Program
The first research question focused on determining whether OLS or IV regression
using three-digit zip code instruments produced the best unbiased estimates of high
intensity DM program participation on the study outcomes. To address this research
question, three blocks of OLS and IV regression models were generated. The first block
was performed using the procedure employed by Linden and Adams (2006) where the
estimated probability of program participation from a separate logistic regression model
was used as the endogenous variable and age, gender, and a quantitative propensity score
variable were used as covariates. The second block was performed using actual program
participation as the endogenous variable and age, gender, and a quantitative propensity
score variable as covariates. Finally, the third block was performed using actual program
participation as the endogenous variable and age, gender, and a quintile propensity score
variable as covariates.
To test the IV regression assumption that Z is related to X, a series of simple
regressions were performed to determine if the instruments were related to both the
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predicted value of program participation and the actual program participation variables.
Residuals from each IV regression model were also regressed on the outcome variables to
test the assumption that the IV estimates were not directly related to the outcomes. The
Sargon chi-square test was used to test the assumption that at least some of the zip code
instruments were uncorrelated with the disturbance terms (i.e., instrument exogeniety) in
the IV models. The Hausman specification chi-square test was used to determine if
significant differences existed between the OLS and IV regression coefficients (i.e.,
treatment endogeniety). In addition, the IV regression models were checked for
multicollinearity by calculating variance inflation factors (VIFs). Finally, the relevancy of
the zip code instruments was tested by examining the first stage F-statistics from the IV
regressions to determine if the instruments were weak (i.e., instrument relevancy).61
The following observations are made based on the above analyses:
1) The assumption that Z is related to X appeared to be met based on the results of
the simple regressions that assessed this relationship. These results are
comparable to results reported by Linden and Adams (2006) and suggest that at
least some of the three-digit zip codes may be appropriate instruments for the
high intensity DM program participation variable.
2) The assumption that no direct relationships exist between the instruments and
the outcomes appeared to be fulfilled for the cost and hospital days IV
61Toe usefulness of instrumental variables regression depends on whether the instruments are valid. Invalid
instruments can result in meaningless IV regression models (Stock & Watson, 2007). To ensure that the
instruments are valid, Wooldridge (2006) and Stock and Watson (2007) recommend testing for the
endogeniety of the problematic explanatory variable, the exogeniety of the instruments, and the relevancy of
the instruments.
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regression models, but not for the ED visits IV models. This suggests that
three-digit zip codes may be appropriate instruments in the cost and hospital
days models, but not in the ED visits models. Linden and Adams (2006)
reported that no direct relationships existed between the zip code instruments
and outcomes in their IV regression models. 62
3) The assumption of instrument exogeniety was demonstrated in the cost and.
hospital days IV regression models, but not in the ED visits models. This
information further suggests that three-digit zip codes may be appropriate
instruments for use in the cost and hospital days models, but not in the ED
visits models. Linden and Adams (2006) did not report checking for instrument
exogeniety in their study.
4) The assumption of treatment endogeniety did not appear to be met in the first
two regression blocks, but did appear to be met in the block three IV cost and
hospital days models. This information indicates that the IV regression models
did not contribute to the prediction of the outcome variables in the first two
blocks, but may have contributed to the prediction of costs and hospital days in
the third block. Linden and Adams (2006) reported that treatment endogeniety
was only met for their hospital days IV model.

62 Linden and Adams (2006) assessed this assumption by regressing the residuals from each IV model on the
outcomes. However, Morgan and Winship (2007) report that this is actually "a strong and untestable
assumption" (p. 196). They argue that Z and Y will always be related after conditioning on X because Z is a
"collider" that is caused by both Zand U (or unobserved variables). Based on this information, the
assumption that no direct relationships exist between the instruments and the outcomes may not have actually
been achieved in the present study.
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5) Multicollinearity was detected in the first two IV regression blocks, but not in
the third IV regression block. Thus, the usefulness of the overall results from
the first two blocks may be questionable. Linden and Adams (2006) reported
that multicollinearity was not present in their regression models.
Multicollinearity apparently occurred in the present study when the predicted
value of program participation was combined with the quantitative propensity
scores in the second stage of the IV regressions because these two variables
essentially represent the same concept. As a result, the quantitative propensity
score variable was replaced with a quintile variable in the block three
regressions to eliminate multicollinearity from the models.
6) While statistical validity tests tended to favor the block three IV cost and
hospital days regressions, the assumption of instrument relevancy was not met
based on an examination of the first stage model F-statistics. First stage F
statistics provide a measure of the information content contained in the zip code
instruments (or the extent to which the instruments explain variation in the
treatment variable), given the other exogenous variables included in the IV
model. Because weak instruments can bias IV regression estimates, the results
of the block three models (as well as the other two blocks) may be unreliable
(Stock & Watson, 2007). This finding could explain why the block three IV
estimates appeared unstable compared to their OLS counterparts (Stock, n.d.).
Despite the fact that some of the above observations tended to favor the IV
regressions (i.e., evidence was obtained suggesting that Z is associated with X, Z is not
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associated with Y, and Xis not associated with U), the IV models are probably unstable
due to multicollinearity and weak instrument bias.63 Thus, OLS regression using a
propensity score covariate appears preferable in this study for estimating the "unbiased"
effects of high intensity participation in the Virginia Healthy Return�M DM Program. It
should be noted that this finding does not suggest that IV regression using three-digit zip
code instruments is inappropriate for estimating program effects in other DM evaluations
because it only applies to the present study. Different analytical results might be obtained
if this IV regression procedure is applied to other samples.
While the study hypothesis was not supported, an important analytical finding
involves the use of propensity scores as a control variable. The present study demonstrated
that propensity scores that control for some observable differences (i.e., overt biases)
between the treatment and control groups can be calculated using data from the Virginia
Medicaid Management Information System. When combined with OLS regression,
propensity scores may offer a parsimonious means of deriving less biased estimates of the
effects of the high intensity DM program on certain outcomes by controlling for many
observable variables that may account for nonrandom assignrnent. 64 In fact, propensity
scores combined with OLS regression are popular estimators in program evaluation
because the scores can act as a control function by containing information relevant for
estimating treatment effects (Wooldridge, 2002).
63 "U" refers to unobserved variables that are related to X and Y.
64
There are restrictions on the number of covariates that can be included in regression models. A general
rule is that there should be one predictor for every 20 subjects. Including all available covariates (kitchen
sink regression) may produce instability in the models, incorrect results, and decreased statistical precision
(Newgard et al., 2004).
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However, there are some limitations involved with using propensity scores as a
regression covariate. First, propensity scores can only control for observed covariates that
are available in a dataset. They will not control for unobserved confounders except to the
extent that they are correlated with the measured variables used to estimate the propensity
scores (Stukel et al., 2007). Researchers using propensity scores as a regression covariate
should therefore note that treatment effect estimates may still be biased due to unobserved
confounders.
Second, using propensity scores as a covariate may increase bias because
regression adjustment imposes a linearity constraint that may be unrealistic when modeling
treatment effects on some outcomes. While nonlinear terms can be added to regression
models, it may be difficult for researchers to know how nonlinear propensity scores should
be approximated. Failure to use the correct nonlinear approximations for variables may
bias treatment effect estimates due to regression model misspecification (Winship &
Morgan, 1999; Shadish et al., 2002).
Third, the ability of propensity scores to control for observed differences in
regression models may depend on their specific form. In particular, quantitative
propensity scores may offer a better means of controlling for preexisting differences than
quintile propensity scores because they can account for more variability in the observed
covariates than quintile scores. Information presented in Table 3 in Chapter 4
demonstrated that quantitative propensity scores could control for significant differences
between study groups on the nonwhite race, western region, hospital days, ED visits, and
diabetes-related cost variables. However, when the same regressions were performed
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using the quintile propensity scores, the regressions revealed that the quintile scores failed
to control for significant differences between the study groups on the hospital days and
cost variables (Appendix B). While the quintile propensity score variable may have
eliminated multicollinearity from the block three IV models, the ability of this particular
variable to control for observable differences may be limited.
Despite the above limitations, however, propensity scores can reduce bias in
estimating treatment effects in nonrandomized observational studies. When combined
with regression, this method may allow for stronger causal inferences in DM evaluations
by reducing bias due to nonrandom assignment. This in turn may help to prevent
inappropriate conclusions due to analyses performed on observational data that fail to
correct for selection bias (Newgard et al., 2004).

OLS and IV Regression Coefficients and Confidence Intervals
The second research question focused on determining if the OLS and IV regression
estimates differed. In general, OLS and IV estimates will differ because IV regression
produces a larger asymptotic variance, which can increase the magnitude of the
coefficients, standard errors, and confidence intervals (Winship & Morgan, 1999; Hadley
& Cunningham, 2004; Wooldridge, 2006). When supported by the results of statistical
tests that assess the validity of the IV models, differences between the OLS and IV
coefficients may suggest that the OLS estimates are inconsistent due to omitted variable
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bias and should be rejected in favor of the IV estimates (Hadley et al., 2003; Linden &
Adams, 2006; Wooldridge, 2006).65
To address the second research question, the researcher compared the OLS and IV
coefficients and confidence intervals for the variables in the three regression blocks. The
comparisons revealed that the block one, two, and three OLS and IV coefficients, standard
errors, and confidence intervals for the age and gender variables remained relatively
unchanged, while the program and propensity score OLS and IV estimates differed. This
finding could suggest that the age and gender estimates were not correlated with the error
term because their OLS and IV estimates were comparable in all regression blocks, while
the program and propensity score variables were correlated with the error term in the OLS
regressions (at least in the block three IV cost and hospital days models) (Lindrooth,
Hoerger, & Norton, 2000; Long et al., 2005; Linden & Adams, 2006). 66•67 However,
examining the differences between the OLS and IV estimates for the independent variables
may not be very meaningful in the present study due to the multicollinearity and weak
instrument bias that were encountered in the regression models.

Hadely et al. (2003) further argue that researchers should determine the appropriateness of IV estimates
based on the availability of important variables that could be used as covariates in OLS regression and the
extent to which the OLS and IV estimates are similar.
66
This finding seems feasible because age and gender were exogenous variables in the IV regressions. It is
also not very interesting because treatment effect estimates, rather than covariate estimates, are usually the
focus of program evaluation studies (Mohr, 1995). In addition, the observation is not entirely unexpected
because similar results were observed in other studies reviewed by the researcher (Hadley & Cunningham,
2004; Linden & Adams, 2006).
67
The propensity score variables developed for the present study may actually be endogenous because it is
doubtful that they contain information on all observable variables that account for nonrandom assignment
into the high intensity and standard intensity programs. Important excluded variables would thus be
subsumed under the error term.

65
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While IV regression can be used to overcome selection bias due to omitted
variables, it does not always offer a good solution to this issue because IV coefficient
estimates can be unstable due to large variances (Winship & Morgan, 1999). For this
reason, Hadley et al. (2003) recommend that researchers exercise some discretion in
accepting IV estimates based on statistical validity tests due to possible coefficient
instability. They further recommend that researchers who use IV regression to estimate
treatment effects in observational studies consider reporting both OLS and IV coefficient
estimates to establish a range of possible treatment effects on the outcomes.
IV estimates are usually larger than OLS estimates because IV regression only uses
a portion of the covariation in the treatment and outcome variables in the calculation
process. Using only a portion of the covariation represents a direct loss of statistical power
that can induce the IV estimators to exhibit increased sampling variance compared to that
exhibited by similar OLS estimators. Thus, an unbiased IV estimator can actually be
unstable compared to a biased and inconsistent OLS estimator. This issue can be
especially troubling if the instruments are weak (Morgan & Winship, 2007).
To better understand how IV regression can increase coefficient magnitudes and
how weak instruments can bias IV estimates by inflating coefficient variances, the
calculations used to produce OLS and IV estimators are briefly reviewed. For simplicity,
the calculations are limited to bivariate regressions (and one instrument for the IV
estimator) where the outcome (Y) is regressed on the treatment variable (X) (the logic
behind the calculations also applies to multiple regression). The OLS estimator forfh is
calculated as:
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This equation simply means that the OLS estimator equals the sample covariance between
the treatment (X) and outcome (Y) variables divided by the sample variance of the
treatment variable. The OLS estimator can be derived as long as the denominator is
greater than zero (i.e., meaning that there is variation in X). Equation 5 shows that the
OLS estimator has more statistical power, and is therefore more efficient, than the IV
estimator because it uses all of the covariation in the treatment and outcome variables in
the calculation process (Wooldridge, 2006). As a result, OLS estimates will tend to be
smaller and more efficient than IV estimates.
However, the IV estimator for ./h is calculated as:
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This equation demonstrates that the IV estimator will often be larger than the OLS
estimator because it is calculated as the covariance of the instrument (Z) and the outcome
(Y) divided by the covariance of the instrument (Z) and the treatment (X) variables. The
instrument and treatment variables must be correlated in order for this equation to be
solved. Equation 6 indicates that IV regression only uses a portion of the covariation in the
treatment and outcome variables in the calculation process because the numerator equals
the effect of the instrumental variable on the outcome, while the denominator represents
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the effect of the instrumental variable on the treatment variable. If the instrument is
dichotomous (as in the present study), then the numerator equals the mean outcome
difference between Z = 0 and Z = 1 and the denominator equals the mean effect of the
treatment (Wooldridge, 2006; Martens, Pestman, de Boer, Belitser, & Klungel, 2006).68
As previously mentioned, the IV coefficients, standard errors, and confidence
intervals can be very unstable if Z is weak. A weak instrument will bias the IV estimator
because the denominator in equation 6 will be small, which makes the estimator sensitive
to small changes.69 Because the covariance in the denominator behaves as a multiplier, a
small correlation will produce a large standard error and confidence interval, which can
make the coefficient estimate less reliable (Martens et al., 2006). Because the relationship
between the instrument and treatment variable is independent of sample size, a weak
instrument can produce an IV coefficient that contains no genuine information about the
causal effect of the treatment on the outcome (Morgan & Winship, 2007). The results of
the first stage IV F-statistics and second stage IV coefficients, standard errors, and
confidence intervals for the three regression blocks suggest that this process may have
occurred in the present study. 70
Before concluding this discussion, it is worth mentioning one additional issue that
may have contributed to the weak instrument bias encountered in the present study.
According to Linden and Adams (2006), the zip code instrument they proposed using is
68 The source for the equations is Wooldridge (2006).
69 In fact, Morgan & Winship (2007) report that weak instrument bias can "explode" the IV estimator due to
the small denominator.
70 This comment refers to the role that sample size plays in OLS regression. A larger sample can produce a
better OLS estimator (Stock & Watson, 2007).
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based, in part, on a natural experiment that assumes the existence of a high enrollment rate
zip code and a low enrollment rate zip code. The natural experiment that these geographic
boundaries model is how differences in zip codes are related to differences in DM
participation rates. Linden and Adams (2006) assume that because three-digit zip codes
mimic a natural experiment, geographic proximity will make DM participants and non
participants more similar on unmeasured confounders. They are not alone in their use 9f
geographic boundaries as instrumental variables. In fact, the use of naturally occurring
instruments has gained considerable popularity among many researchers who view them as
"gifts of nature" (Morgan & Winship, 2007).
However, not all researchers are convinced that naturally occurring boundaries
make good instruments. In particular, some argue that the variation supposedly induced in
the endogenous predictor by naturally occurring instruments is often either poorly
explained and/or not supported by relevant theories. Moreover, random variation created
by natural experiments does not necessarily ensure that the instrument has no direct effect
on the outcomes. As a result, instruments from natural experiments can be "black boxes"
that reduce their ability to produce unbiased treatment effect estimates needed for public
policy development and guidance (Morgan & Winship, 2007). These concerns may
explain why three-digit zip codes did not ultimately appear to be appropriate instruments
for the high intensity DM participation variable used in the present study.
Advantages and Disadvantages of Using OLS and IV Regression in DM Evaluations
The third research question concerned the advantages and disadvantages of using
OLS and IV regression to estimate treatment effects in DM evaluations. This research
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question was addressed through an assessment of what the researcher learned about these
methods during the present study. Because both methods use least squares to minimize the
sum of squared residuals, they have similar advantages and disadvantages. Nevertheless,
researchers planning to estimate the effects of DM interventions when selection bias is
present should still consider the advantages and disadvantages of both methods as well as
their own strengths and capabilities (i.e., knowledge of regression methods, computer
capabilities, access to data, etc.) before deciding upon which method (if either) to use.
An advantage of using OLS regression in DM evaluation is that OLS is a widely
recognized data analysis technique that is used by researchers in a variety of social science
disciplines to evaluate alternative explanations for study outcomes (Morgan & Winship,
2007). Because OLS regression allows researchers to control for (or fix) many correlated
factors that may simultaneously affect the outcome variable, they can use it to infer
causality when analyzing observational data (Wooldridge, 2006). In other words, OLS
regression can allow researchers using nonexperimental data to do what natural scientists
using experimental data can do: hold other factors fixed (Wooldridge, 2006). OLS
regression has thus become the common language that many researchers "speak" when
discussing the effects of social interventions on outcome variables (Stock & Watson,
2007). Using OLS regression can therefore allow DM evaluators to communicate their
findings to a wide audience of social scientists.
Another advantage of using OLS regression in DM evaluation is its computational
ease. All major statistical software programs include regression procedures that allow for
estimating linear and nonlinear relationships between both continuous and categorical
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variables in cross sectional and longitudinal datasets (Morgan & Winship, 2007). Because
these software programs can operate on personal computers, it should be very convenient
for many evaluators to use OLS regression to estimate DM program participation effects
(Kennedy, 2003). However, the evaluators must understand how to use and interpret OLS
regression in order for the results to be meaningful. Failure to understand the mechanics of
OLS regression can result in some very impressive looking findings that are essentially
meaningless.
Other advantages ofusing OLS regression in DM evaluations include its theoretical
properties that make it an unbiased and consistent estimator (Stock & Watson, 2007). For
instance, OLS is considered to be an unbiased estimator under the Gauss-Markov theorem
when certain statistical assumptions are met such as linearity, random sampling, no perfect
collinearity, zero conditional mean, and homoscedasticity. Moreover, when these
assumptions are met, OLS is viewed as the best linear unbiased estimator (BLUE) because
it has the smallest variance conditional on the values ofthe independent variables
(Wooldridge, 2006). Because it often produces the smallest variance compared to other
estimators, many social scientists view OLS regression as an efficient estimator. When
these characteristics are subsequently met, OLS can be an appropriate estimator to use in
DM evaluations.
However, using OLS regression may have certain disadvantages when the
statistical assumptions are not met. For instance, the validity ofregression inferences
depends partly on meeting the assumption oflinearity between the outcome and
independent variables. This assumption can be violated when the outcome is a
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dichotomous variable where y = 1 denotes one possible outcome and y = 0 denotes the
other possible outcome (i.e., patient received adequate care = 1, patient did not receive
adequate care = 0). While OLS regression can be used to model binary outcomes, it can
result in some problematic results (i.e., probability estimates that are above 1 or below 0,
nonnormal errors, and unequal variances).71 As a result, a probit or logistic estimator may
be more appropriate to use when the study outcomes are dichotomous because these
estimators force the predicted values ofthe outcomes to be between O and 1 (Cohen et al.,
2003; Mendenhall & Sincich, 2003; Wooldridge, 2006; Stock & Watson, 2007).
Regression inferences can also be invalid ifthe homoskedasticity assumption is
violated which can occur when the study outcome is a count variable, such as the number
ofparticipant hospitalizations or ED visits in a calendar year. While there are certain
variance-stabilizing transformations that can be applied to satisfy the homoskedasticity
assumption for OLS regression use, other estimators may be more appropriate. In
particular, the Poisson regression estimator or the negative binominal regression estimator
may be preferable when the outcome is a count variable. While OLS regression can be
used to model OM effects on count outcomes, failure to use a more appropriate estimator
may result in biased results (Mendenhall & Sincich, 2003; Wooldridge, 2006; Stock &
Watson, 2007).
In addition, the validity ofregression inferences can be questionable ifthe zero
conditional mean assumption is violated, which is a key assumption that must be met in
71

An OLS regression model is referred to as a linear probability model when the dependent variable is binary
because y can only assume two values O and 1. Because y-hat represents the predicted probability of success
in a probability model, the probability estimates must be between O and 1 (Stock & Watson, 2007).
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order for OLS regression to provide unbiased results. The zero conditional mean
assumption assumes that all important variables that are related to the outcome and the DM
treatment variable are included in the model (Wooldridge, 2006). Failure to meet this
assumption will result in omitted variable bias. For example, by failing to include factors
that determine high intensity DM participation such as personal motivation, the OLS
estimator ofthe slope in the regression ofdiabetes-related costs on high intensity program
participation (while controlling for age, gender, and propensity score) could be biased. In
other words, the mean ofthe sampling distribution ofthe OLS estimator may not equal the
true effect on diabetes-related costs ofa unit change in high intensity participation (i.e.,
moving from participant to nonparticipant) (Stock & Watson, 2007). Thus, the estimated
coefficient for the treatment variable cannot be interpreted as the effect ofthe high
intensity program because it also captures part ofthe effect ofthe omitted variables
(Ettner, 2004).
Because most DM programs allow subjects to self-select into the treatments, it is
very likely that OLS program effect estimates will be biased (or incorrect) due to omitted
variables bias (Linden & Adams, 2006). Therefore, the primary advantage ofusing
instrumental variables regression in DM evaluations is that it can offer a solution to
omitted variables bias. IV regression can produce an unbiased effect estimate when the
treatment variable (X) is correlated with the disturbance term (U) by dividing X into two
variation parts. The first variation part is correlated with U (the unknown determinates of
program participation), while the second variation part is uncorrelated with U. By using
one or more instrumental variables that isolate the second part, IV regression focuses on
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variation in X that is uncorrelated with U and disregards variation in X that is correlated
with U. IV regression can therefore derive unbiased treatment effect estimates by isolating
variation in X that is uncorrelated with U (Stock & Watson, 2007).
Other advantages of IV regression include ease of interpretation due to its
similarity with OLS regression, ease of calculation due to its inclusion in most statistical
software programs, and its popularity among certain groups of social scientists such as.
economists (Linden & Adams, 2006; Wooldridge, 2006). 72
The disadvantages of using IV regression in DM evaluation include the fact that
researchers must find one or more variables (Z) that are correlated with the program
participation variable (X), but not with the study outcomes (Y) or the unobserved variables
(U) that influence both X and Y. Moreover, the instrumental variables must be strongly
correlated with X in order for the regression coefficients to be reliable. Failure to use
instruments that explain most of the variation in X may seriously bias the IV estimator by
producing large standard errors and confidence intervals that do not contain the true value
of the coefficients (Stock & Watson, 2007). Finding suitable variables that meet these
often contradictory requirements can be very difficult in DM evaluation because evaluators
will typically only have access to administrative claims and enrollment data, which can
limit the number of suitable variables that can be used as instruments (Wooldridge, 2002;
Linden & Adams, 2006).

72 According to Wooldridge (2006), IV regression is second only in popularity to OLS regression in applied
econometrics.
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Other disadvantages of using IV regression in DM evaluation include the fact that
the method still needs to meet certain theoretical OLS assumptions, such as no
multicollinearity. Meeting this assumption can be especially difficult in two-stage least
squares (2SLS) IV regression because the predicted value ofX from the first stage is a
linear combination of both the instruments and the exogenous variables that function as
covariates in the second stage. However, failure to meet this assumption can bias IV
regression results due to large coefficient standard errors and confidence intervals
(Wooldridge, 2006).
Finally, another disadvantage of using IV regression in DM evaluation results from
the fact that IV estimates are only based on a portion of the covariation in the causal and
outcome variables. Using only a portion of the information in the data can result in a
direct loss of statistical power thus resulting in IV estimators that exhibit more sampling
variance than other estimators. As a result, a consistent and asymptotically unbiased IV
estimator may be outperformed by a biased and inconsistent OLS estimator (Morgan &
Winship, 2007).
Implication of Study Findings for the Medical and Policy Communities
The objective of the present study was to assess the feasibility of an instrumental
variables (IV) regression procedure for disease management (DM) evaluations rather than
to address clinically oriented issues concerning the quality and outcomes of DM services
for specific patients or policy oriented issues about the overall effects of high intensity
diabetes DM services on health care costs and utilizations. The study therefore focused on
issues that may be of interest to quantitatively oriented health services researchers rather
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than to clinicians (i.e., practicing physicians and other health care providers) or health
policy makers. While it may appear that both clinical and policy oriented inferences could
be made based on the study results, caution should be exercised if attempting to use them
for such purposes. For instance, some observers may conclude that the results suggest that
the high intensity DM participants did not receive appropriate care or even that high
intensity DM services are not effective because program participation was associated with
significant increases in diabetes-related costs, ED visits, and hospital days. However, DM
is a long-term process (Afifi et al., 2007) and the study results only represent subjects' one
year experience in a high intensity diabetes DM program. As a result, they do not reflect
changes that may occur in outcomes over time due to the program. Panel (or longitudinal)
data studies are probably more useful for program evaluations that seek to assess the
overall effects ofinterventions because they can account for changes that occur overtime
for the same group ofsubjects while holding constant unobserved factors that may affect
study outcomes (Wooldridge, 2006).
In any case, drawing inferences about the effects ofthe Virginia Healthy Returns5M
DM Program based on the results ofthis study are probably not appropriate because it has
only been in operation for two years. Therefore, policy makers should probably consider
the results ofa panel data study before making any summative decisions about the Healthy
Returns5M program or high intensity DM services.
The above discussion does not suggest that examining patient quality ofcare and
other clinical and policy oriented issues related to DM services is not important. In fact,
studying these issues is very important because chronic diseases, such as diabetes, asthma,
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hypertension, and coronary heart disease, affect approximately one fourth of all Americans
and account for almost 50 percent of all health care costs (Morisky et al., 2008). Thus,
efforts to improve the quality of care that chronically ill patients receive have been given
high priority and research needs to be directed toward determining if these interventions
result in both decreased utilization of high cost health care services and improved patient
health behaviors (Ofman et al., 2004).73
Addressing clinically oriented issues that may interest health care providers about
the effects of DM services on specific patients is probably beyond the immediate scope of
observational studies that employ IV regression methods to estimate treatment effects.
Instead, clinical trials (i.e., experimental studies) are more appropriate for answering
questions that are of immediate interest to physicians and other health care providers. In
well-designed clinical trials, all subjects are randomized to the study groups in order to
allow researchers to derive estimates of the average treatment effects for the entire
population of subjects eligible for the trials. Assuming that a particular patient is a random
draw from one of those populations, a physician could use the effect estimate from the trial
to determine what the expected outcome of the treatment would be for his or her patient.
In other words, clinical trials allow physicians to use the expected outcome of the
treatment to make decisions about specific patients (Newhouse & McClellan, 1998).
However, IV methods are more appropriate for addressing policy issues that
involve incremental decisions about health care services (i.e., whether additional chronic
73 In fact research has demonstrated that disease management can result in improved health status, improved
health b;haviors, and decreased health service utilizations for chronically ill patients (Lorig et al., 1999; Afifi
et al., 2007; Morisky et al., 2008).
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diseases should be included in a DM program or even if the DM program should continue
to operate) than decisions about specific patient treatments. In particular, effect estimates
that are derived using IV regression do not usually represent the average effect of an
intervention in the entire population because they only apply to the subpopulation of
patients who actually participated in the treatment. Specifically, IV estimates do not
represent the average effect on a random patient from the entire population, but rather the
average effect on an individual from the subpopulation that participated in the treatment.
This marginal population is often not identifiable by physicians because it may not be
immediately obvious to them that a particular patient is from that subpopulation. As a
result, IV estimates may be only indirectly applicable to physicians (Newhouse and
McClellan, 1998).
This does not mean, however, that physicians cannot use IV estimates for clinical
decisions. For instance, physicians may find IV estimates to be more relevant than clinical
trial estimates if their patients differ from the populations included in the trials. In that
case, the IV estimates may provide better insights into the likely effects of a particular
intervention than clinical trial results (Newhouse & McClellan, 1998).
Study Limitations

This study had several limitations. First, it was limited to diabetes recipients who
were continuously enrolled in the DM program during CY 2007. The study results are
thus not applicable to DM participants who have one of the other conditions covered under
the Virginia Healthy ReturnfM DM program. The results may also not be applicable to
diabetes program participants who enrolled after December 31, 2007 because they may be
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different from the study participants. The study is further limited because it only included
fee-for-service Virginia Medicaid recipients. As a result, the findings are not generalizable
to Virginia Medicaid recipients who receive diabetes DM services through one of the
State's managed care organizations.
Second, the study findings may be limited due to how the propensity score variable
was calculated. Propensity scores can control for overt bias if they are estimated using
important predictors of group membership. The propensity score method assumes that all
confounding variables that predict treatment assignment and are correlated with the
outcome are included in the logistic regression model (Shadish et al., 2002). The
predictors used to estimate the propensity scores in this study were selected for
accessibility rather than for the role they played in identifying DM recipients for the high
intensity intervention. It is very likely that important observable variables exist in the
Virginia Medicaid Management Information System that should have been included in the
propensity score model. However, the researcher was unable to include these variables for
logistical reasons (i.e., computer programming capabilities and time and effort needed to
develop the variables). As a result, the propensity scores used in the study are probably
biased due to omitted variables, which could influence the results of the OLS and IV
regression models developed for this study (D' Agostino & Kwan, 1995; Yanovitzky et al.,
2005; Baser, 2006). 74

74 The Healthy Returns'™ DM contractor identifies patients as either high intensity or standard intensity based
on a predictive modeling analysis of Medicaid claims data. Because the model is proprietary, the researcher
is not aware of which specific variables are used to identify DM patients.
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Third, the present study is limited due to the specific instrumental variables
procedure that was employed. The study only considered the feasibility of using patient
three-digit zip codes as instruments in a cross sectional analysis. The analytical results
suggested that three-digit zip codes were not appropriate instruments to use in such an
analysis. However, the IV estimation procedure can be used in time series and panel data
regression methods (Wooldridge, 2006). If three-digit zip codes are used as instrumet).ts in
an IV time series or panel data analysis, different results may be obtained. In addition, the
study is limited because only one instrument was considered. Other variables may exist in
the Virginia Medicaid Management Information System that could prove to be more
appropriate instruments than zip codes. However, identifying these instruments was
outside the scope of the present study.
Fourth, the study is limited because it focused on one statistical method for
adjusting for hidden selection bias in DM program evaluations, which did not prove
beneficial. Other methods exist for estimating program effects in observational studies that
may be more appropriate to use for evaluating the Healthy Return�M DM program.
Examples include the Heckman two-step method where a multiple regression model is
estimated for an outcome variable concurrently with a selection model that compares
program participants to nonparticipants on selected variables or fixed effects panel
regression models that adjust for fixed unobserved characteristics that may be associated
with selection into the treatment group (Schneider et al., 2007). These methods have been
used in similar studies, but were not considered in the present study.
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Future Research Possibilities
Several future research possibilities were identified during the present study.
While the study results suggested that participant three-digit zip codes were not useful
instruments in IV regression, the results are nevertheless limited to this particular study.
Different results may be obtained if the procedure is used on different samples or in
different ways. As a result, additional research could be performed using the IV regre_ssion
procedure in a cross sectional analysis of a different sample of Virginia Healthy Return/M
DM diabetes participants or on samples composed of participants with one of the other
chronic conditions that are covered under the program, such as congestive heart failure,
asthma, or coronary artery disease. Moreover, the IV regression procedure could be
employed in a cross sectional analysis of one or more samples of Virginia Medicaid
managed care DM participants.
If the results from these analyses support the results of the present study, then
enough evidence may exist to conclude that three-digit zip codes are not appropriate
instruments to use in DM evaluations. Researchers interested in using IV regression to
estimate the effects ofDM program participation should therefore focus attention on
identifying other variables that can serve as instruments.
Another potential research area involves using patient three-digit zip codes as
instruments in an IV time series (i.e., data collected over time on one or more variables) or
panel data (i.e., data constructed from repeated cross sections over time on a set of
subjects) data evaluation of a DM program. In fact, evaluating a DM program using time
series or panel data may be more insightful than using cross sectional data because it will
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allow evaluators to assess how the average effects ofDM participation on certain outcomes
change over time. Moreover, these methods are suitable forDM evaluations of Medicaid
programs (and maybe otherDM programs) because recipient level claims data are typically
compiled on both a monthly and yearly basis. IV regression using three-digit zip code
instruments could therefore be used to estimate the effects ofDM participation over time
(Wooldridge, 2006). 75
Another area of research could involve using a generalized method of moments
(GMM) IV estimator instead of a two-stage least squares (2SLS) IV estimator to test the
feasibility of using three-digit zip codes as instruments forDM participation in models
where the outcomes are count variables. While two-stage least squares regression is
probably the most commonly used IV method for both continuous and non-continuous
outcomes, other methods exist that may be more feasible for count outcomes such the
GMM IV method. The GMM IV method may be a better estimator than 2SLS regression
because it can specifically account for a count outcome's Poisson distribution. By
accounting for this particular distribution, results that are different from those derived in
the present study may be obtained because the regression estimates would probably
assume more plausible values (Johnston, Gustafson, Levy, & Grootendorst, 2008). 76
Another area for future research involves recalculating the propensity scores
developed in this study by including all observable variables that are used to assign
75
In this case, the analysis could probably focus on estimating the effect of another month ofJ?�
participation on outcomes such as health care costs, hospital days, or emergency department v1s1ts
(Wooldridge, 2006).
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Virginia Medicaid recipients to either the high intensity or standard intensity programs in
the logistic regression model that estimates the propensity scores. The propensity score
developed for the present study is most likely biased because it does not include all
variables that are used in the program assignment process. The ability of the propensity
score variable to control for overt selection bias could therefore be improved by
reestimating it using these variables and then reperforming the OLS regressions to derive
less biased effects of high intensity DM participation.
In addition, a potential research area may involve testing the feasibility of the self
care education that participants receive when they are enrolled in the Healthy Returns5M
Program and other DM programs. Self-care management emphasizes the central role that
patients play in managing their chronic illnesses. Appropriate self-care of chronic
conditions is an important element of DM because it can result in improved health status
and reduced health care utilizations for participants (Lorig et al., 2001 ). Because self
efficacy plays a role in the ability of individuals to manage their chronic conditions over
the long-term, such a study could be guided by self-efficacy theory. Self-efficacy is
important in DM because it involves the confidence that individuals have to perform
behaviors that are needed to successfully manage their chronic conditions. Variables that
could be used in such a study include health education components, health behaviors and
status, and health care utilizations and costs (Lorig et al., 2001; Marks et al., 2005).

76 In other words the count outcomes would not have to be transformed to meet the heteroskedasticity
assumption and the regression coefficients, standard errors and confidence intervals between the IV and OLS
models may be more comparable.
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Finally, another potential research area may involve examining the specific
demographic characteristics of Virginia's three-digit zip code areas in order to better
understand what these areas represent and how they may produce variation in the treatment
variable that is not associated with variation due to the unobserved determinates of
program participation. While the usefulness of this particular analysis may seem
questionable due to the results of the present study, other research may reveal that three
digit zip codes are feasible instruments to use in IV regression. If this occurs, then the
characteristics of the three-digit zip codes will need to be studied in order for researchers to
better understand how the zip codes induce variation in the DM participation variable. As
part of this analysis, the researchers could also determine which three-digit zip codes are
weak so they can discard them in order to use the most relevant zip codes as instruments in
their IV regression models (Stock & Watson, 2007). Failure to fully understand and
explain this variation may lessen the ability of the instruments to provide informative
information about the effects of the Virginia Healthy Return/M DM Program.
Conclusions
1bree important conclusions emerged from the present study. First, IV regression
using participant three-digit zip codes as instruments did not prove to be an effective
means of estimating the effects of high intensity participation in the Healthy Return/M DM
Program. Second, propensity scores developed using administrative claims and enrollment
data from the Virginia Medicaid Management Information System can be estimated that
control for preexisting observable differences between the study groups. Propensity scores
that control for overt bias can therefore be included in OLS regression models to derive
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less biased estimates of high intensity program participation. Third, several advantages
and disadvantages exist when using either OLS or IV regression. Researchers who plan to
evaluate DM programs using either of these regression methods should consider their own
personal strengths as well as the advantages and disadvantages of the methods before
committing to either approach. Failure to do this may result in the researchers finding
themselves in situations where they are unable to effectively use either method to evaluate
DM programs.
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Appendix A: An Overview of the Inverse Propensity Score Weighting Method
Propensity scores (PS) are often used in social science research to estimate
treatment effects through one or more of the following three methods: regression covariate
adjustment, stratification, or matching. A less frequently used method of employing
propensity scores involves using the inverse of the estimated propensity scores to develop
a weight for each study subject. The objective of propensity score weighting is to develop
weighted averages of the data that approximate what would have been derived through
randomized experiments (Gelman & Hill, 2007). According to Austin (2008), propensity
score weighting is rarely used in medical research. (Austin does not offer an explanation
for why propensity score weighting is rarely used.) As a result, the researcher decided to
briefly explore propensity score weighting in Appendix 1 using the dataset developed for
the present study. 1
As an alternative method of employing propensity scores, Robins and colleagues
suggest deriving an average treatment effect estimate by conducting a simple. regression of
the outcome on the treatment using inverse propensity score weights (IPSW) of 1/PS and
1/(1 - PS) for the treatment and control groups, respectively (Frank et al., 2008).2•3
Following this guidance, high intensity DM program participants (the treatment group) and
standard intensity participants (the control group) were weighted accordingly. By using
1 The researcher's objective in writing Appendix I was not to provide a detailed analysis of propensity score
weighting. Instead, the objective was to briefly explore its use for possible consideration in a future study.
Technically-oriented information on propensity score weighting can be found in sources such as Robins and
Rotnitzky (1995), Robins, Hernan, and Brumback, (2000), Lunceford and Davidian, (2004), Austin and
Mamdani, (2006), and Morgan and Winship (2007).
2 IPSW can also be used in multiple regressions (Gozalo & Miller, 2007).
3 Additional weighting procedures exist that can be used to estimate the treatment effect for the treated
subjects or the treatment effect for the control subjects (Gelman & Hill, 2007; Frank et al., 2008). However,
these procedures are not discussed in this appendix section.
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this procedure, the high-intensity DM participants were weighted more the lower their
propensity for enrollment in the high-intensity program, while the standard intensity
participants were weighted more the higher their propensity for enrollment in the high
intensity program (Frank et al., 2008). The weights were calculated using SAS version
9.1, while the regression analyses were performed using STATA version 10.1.
The comparison produced using the IPSW method focuses the analysis on the
strongest overlap in propensity scores. Specifically, it focuses on subjects who are most
likely to respond to change: individuals who received the treatment, but had a low
propensity for doing so, with individuals who did not receive the treatment, but had a high
propensity for doing so (Frank et al., 2008). Through this process, IPSW mimics
propensity score matching by essentially creating a hypothetical group of treatment
subjects who are similar to the control subjects in terms of all characteristics except actual
treatment assignment (Morgan & Winship, 2007; Ma, 2008). The estimate produced using
IPSW is referred to as the estimated effect for individuals at the margin of indifference
(EOTM) (Figure Al) (Frank et al., 2008).
There are several advantages of using the IPSW procedure over propensity score
matching, stratification, and regression adjustment. In particular, the IPSW method offers
a relatively intuitive process for controlling for overt bias that is easy to calculate and use
in regression analyses. Moreover, the IPSW method can improve estimation efficiency
because the full sample of subjects is retained in the analysis (however, not all subjects
contribute equally to average effect estimates due to the weighting scheme) (Frank et al.,
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Figure A 1. Propensity Score Overlap for the Treatment and Control Groups
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2008). In addition, the IPSW method can balance the treatment and control groups by
producing equal covariate distributions between the study groups (Ma, 2008). The major
concern with using this method is that some propensity score weights may have extreme
values that exert undue influence on the average treatment effect estimates. This concern
can be ameliorated, however, by examining the dataset to identify these weights and
trimming their values so they do not unduly influence average treatment effect estimates
(Frank et al., 2008).
For this analysis, extreme weights were identified as cases with standardized scores
greater than 3.29 (Tabachnick & Fidell, 2001). Thirty-two weights met this criterion and
were thus considered extreme. Using the procedure identified by Frank et al. (2008), these
weights were trimmed to a value of one greater than the next most extreme weight in the
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dataset, which was 12.62 (Frank et al., 2008).4 To test the sensitivity of the IPSW method
to these extreme values, each outcome was regressed on the program participation variable
weighted by both the trimmed and untrimmed weights. These simple regressions revealed
that the trimmed and untrimmed weighted program coefficients were very similar for the
ED visits and hospital days models, which may suggest that the extreme values did not
actually exert much influence in the regressions. However, the trimmed weighted program
coefficient for the diabetes-related cost model was higher (1.62) than the untrimmed
weighted coefficient (1.56). This finding could suggest that the extreme values did exert
some influence in the diabetes cost regression model.
The researcher next used the trimmed and untrimmed weights to assess covariate
balance between the study groups. This process was accomplished using a series of simple
linear probability models (i.e., the treatment variable was regressed on the covariate using
OLS regression) (Cohen et al., 2003; Wooldridge, 2006).5 The models were generated for
each covariate, which was weighted separately using the trimmed and untrimmed weights.
The results are presented in Table Al. The regressions revealed that the trimmed weights
did not control for significant differences between study groups on the 2006 diabetes
related cost variable (p = 0.015), while the untrimmed weights did control for all
significant differences between the study groups. (The untrimmed weighted results are
4 lbe average IPSW was 1.96 (SD = 2.82). The range of the weights was 1.00 to 32.51. Weights greater
than 11.62 were considered extreme based on having a standardized score greater than 3.29.
5
Some observers may argue that logistic regression should have been used to assess covariate balance. The
researcher decided against using logistic regression for two reasons: I) Wooldridge (2006) indicates that
linear probability models are often used in economics when the outcome is dichotomous, and 2) the logit
co=and in STATA version I 0.1 did not support analytic weights (i.e., weights that are inversely
proportional to the variance of the observations), which was the procedure used to employ the inverse
probability score weights in the present study. However, OLS regression in STATA supports using analytic
weights.
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similar to the results obtained using logistic regression to assess covariate balance, which
are presented in Table 3 in Chapter 4.) Because the covariates were similarly balanced
between study groups when using the trimmed and untrimmed weights, a decision was
made to report the results from the regressions using both weights because: 1) the extreme
untrimmed inverse propensity score weights may have exerted some influence in the
diabetes-cost regressions and 2) the untrimmed weights appeared to more effectively
control for covariate balance between study groups than the untrimmed weights.
Table Al. Simple Linear Probability Regressions to Assess Covariate Balance Using
IPSW (N = 1,627)*
Adjusted
Adjusted
p value
p value
(IPSW
(IPSW
Unadjusted
Untrimmed)**
Trimmed)**
Variables
p value**
0.211
0.528
0.546
Female
Nonwhite Race

0.001

0.351

0.378

Westem Region

0.001

0.367

0.489

Country of Origin US

0.101

0.701

0.224

English Language

0.508

0.096

0.127

US Citizen

0.135

0.777

0.137

Age

0.131

0.351

0.860

Hospital Days

0.000

0.211

0.313

ED Visits

0.000

0.873

0.414

Diabetes Related Costs

0.000

0.015

0.462

*Outcome variable is program participation (1 = high intensity participation and O = non
high intensity participation)
**a = 0.05
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The researcher next estimated the average effect of the high intensity DM program
by regressing the study outcome variables on the program participation variable weighted
using both trimmed and untrimmed inverse propensity scores.6 For comparison purposes,
additional multiple regression models were generated by regressing the outcomes on the
program participation and quantitative propensity score variables as well as the program
participation, age, gender, and quantitative propensity score variables. The estimated
effects of the high intensity DM program that were derived from the regressions are
resented in Table A2.
Four observations can be made about the information in Table A2. First, the
propensity score weights do not appear to add much to the program effect estimates in this
study because the weighted estimates are comparable to the unweighted estimates that
were calculated in the multiple regressions. In other words, none of the four regression
models in Table A2 are clearly dominant.
Second, the program effect estimates may be relatively stable because comparable
estimates were derived in the four regression models. However, readers should not
conclude that any of the models presented in Table A2 actually depict the "true" casual
effect of the high intensity program due to omitted variable bias (i.e., propensity scores can
only control for overt bias to the extent that important observable variables are included in
the calculation process and hidden bias to the extent that the included variables are
correlated with excluded unobserved variables).
6 Simple regression was used because the inverse propensity score weights account for the covariates
included in the propensity score models (Frank et al., 2008).
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Table A2. Estimated Effect ofHigh Intensity DM Participation on the Study Outcomes
95% CI*
Model
p value*
Coefficient (SE)*
Models Weighted by IPSW (Trimmed)**
Diabetes Related Costs

1.62 (0.12)

0.000

1.38-1.86

ED Visits

0.17 (0.05)

0.002

0.06-0.27

Hospital Days

0.37 (0.05)

0.000

0.26-0.48

Models Weighted by IPSW (Untrimmed)**
Diabetes Related Costs

1.56 (0.12)

0.000

1.32 - 1.79

ED Visits

0.19 (0.05)

0.000

0.09-0.30

Hospital Days

0.34 (0.05)

0.000

0.23-0.45

Models Using Propensity Score Covariate**
Diabetes Related Costs

1.53 (0.21)

0.000

1.13-1.94

ED Visits

0.19 (0.08)

0.013

0.04-0.35

Hospital Days

0.42 (0.07)

0.000

0.28-0.56

Models Using Age, Gender, and Propensity Score Covariates**
Diabetes Related Costs

1.53 (0.20)

0.000

1.14 - 1.93

ED Visits

0.20 (0.08)

o.oi 1

0.04-0.35

Hospital Days

0.42 (0.07)

0.000

0.28-0.56

*High intensity program effect coefficient, standard error,p Value, and 95% confidence
interval for each outcome variable.
** Study outcomes are transformed: diabetes-related costs (log), emergency department
visits (square root), and hospital days (square root).
Third, because the four regression models produced similar estimates, researchers
faced with similar results could use that information to depict a combination of approaches
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that may provide useful boundaries on the magnitude of the true program effect estimate.
However, the researchers must ensure that they aggressively controlled for both overt and
hidden biases if using these propensity score methods to bolster their argument that they
have derived true program effect estimates. In order to accomplish this, researchers would
probably need access to multiple "information rich" datasets to identify as many variables
as possible that may have directly or indirectly (through their correlations with important
unobserved variables) accounted for preexisting differences between the study groups.
These variables would then have to be included in the propensity score calculation process
in order for the scores to control for these counfounding variables. Failure to do this would
limit the ability of the researchers to argue persuasively that they have derived unbiased
boundaries for the true effect of the program.
Finally, the effect estimates produced in the third set of models are almost identical
to the effect estimates produced in the fourth set of models. This finding suggests that
simply including a propensity score covariate in a regression of the outcome on a treatment
variable may be just as effective as including a propensity score and other variables as
covariates in the regression, but this interpretation is dependent upon whether the other
variables were included in the propensity score calculation process. If the variables were
included, then little may be gained by including them and the propensity scores as
covariates in the regressions. If the variables were not included in the propensity score
calculation, then it may be more feasible to include them in the regression as covariates;
however, if the variables contribute to study group assignment, then they should be
included in the propensity score calculation.
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Based on the information presented in this appendix section, inverse propensity
score weights appear to offer a viable means of estimating average treatment effects in DM
evaluations that use observational data. 7 However, the determination of whether
propensity score weights, matching, stratification, or covariate adjustment are preferable in
a particular case will have to be made by the researchers based on their knowledge of the
study topic and relevant statistical methodologies.

7

Morisky et al. (2008) used inverse propensity score weights to adjust for attrition bias in �he study they
performed on the effects of Florida Medicaid's OM program on self-reported health behav10rs and outcomes.
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Appendix B: Simple Logistic Regression Analysis to Assess Covariate Balance Using the
Quintile Prorensity Score (N = 1,627)
Adjusted
Unadjusted
Treatment
Control
Variables
p-value**
p-value**
(n = 229)*
(n = 1,398)*
0.695
Female
0.546
166 (72.5%)
986 (70.5%)
Nonwhite Race

52 (22.7%)

198 (14.2%)

0.001

0.079

Westem Region

170 (74.2%)

1,166 (83.4%)

0.001

0.096

Country of Origin US

225 (98.3%)

1,343 (96.1%)

0.110

0.249

English Language

226 (98.7%)

1,386 (99.1%)

0.511

0.615

US Citizen

226 (98.7%)

1,355 (96.9%)

0.147

0.248

Age

46.6 (14.25)

44.93 (15.70)

0.131

0.468

Hospital Days

4.90 (29.75)

0.44 (1.91)

0.000

0.000

ED Visits

2.36 (3.65)

1.50 (3.20)

0.001

0.083

$7,473.33
($16,962.42)

$1,060.48
($2,380.31)

0.000

0.000

Diabetes Related Costs
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